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Resumo 
Este trabalho de investigação visou a preparação e caracterização de 
sistemas para o transporte e entrega de ADN. Esses sistemas são catiónicos e 
não virais e são constituídos por lípidos e polímeros. 
As monocamadas de Langmuir foram utilizadas para prever as 
interações entre o lípido catiónico DOTAP (Cloreto de trimetil(2,3-
dioleoilpropil)amónio) e o colesterol (CHOL) ou o seu derivado colesterol 
fluorado (heptafluorocolesterol, F7-CHOL). A mistura do DOTAP com cada um 
dos esteróis (rácio 1:1) origina monocamadas na fase líquida expandida, 
idênticas às do DOTAP. Verificou-se que a área por molécula das misturas é 
mais pequena que a esperada de acordo com a regra da adição aplicável no 
caso de ambos os compostos serem completamente miscíveis ou imiscíveis na 
monocamada. A adsorção de ADN na monocamada é similar para ambos os 
sistemas, o que sustenta a possibilidade da utilização de colesterol fluorado 
como lípido auxiliar na formulação de vetores para transfeção de ADN.  
A compactação de ADN e respetiva transfeção foram testadas para 
lipossomas constituídos pelo DOTAP e pelo colesterol fluorado (rácio molar 
1:1). Os resultados confirmaram que mais lipossomas do sistema DOTAP:F7-
CHOL são necessários para compactar a mesma quantidade de ADN quando 
comparado com o sistema DOTAP:CHOL e que a ligação lipossoma-ADN é 
mais forte no caso do sistema DOTAP:F7-CHOL/ADN. A estabilidade de ambos 
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os sistemas na presença de ADN é idêntica, bem como a eficiência de 
transfeção. 
Os vetores baseados em bola-anfifílicos foram produzidos por dois 
métodos distintos. Primeiro utilizou-se a metodologia de deposição de 
camadas. Após a adição de algumas camadas de polímeros para promover a 
estabilização do núcleo das micropartículas, camadas alternadas de ADN e 
bola-anfifílico (BA) foram depositadas. A presença quer do ADN quer do BA à 
superfície das micropartículas foi confirmada, visualmente, por microscopia 
confocal. A outra metodologia utilizada foi a formação de vesículas lipídicas 
preparadas com diferentes rácios molares de BA e DOTAP. O rácio molar que 
evidenciou melhor comportamento foi o de BA:DOTAP 1:5. As vesículas foram 
posteriormente complexadas com ADN (rácio mássico lípido:ADN 10:1). Os 
estudos de transfeção revelaram que o sistema BA:DOTAP possui um melhor 
potencial de transfeção com menos impacto na viabilidade das células do que 
o sistema de DOTAP. 
Copolímeros de quitosano e maltodextrina foram sintetizados por 
aminação redutiva, partindo de quitosano de baixo peso molecular. O grau de 
substituição, quantificado por espectroscopia de ressonância magnética 
nuclear, foi superior a 70% para rácios molares de 1:1 e 1:5 entre as unidades 
de glucosaminas do quitosano e uma molécula de maltodextrina. O elevado 
grau de substituição obtido gerou um composto solúvel em água a pH de 7.4. 
Adicionalmente, o copolímero forma, espontaneamente, nanopartículas 
esféricas com diâmetros de cerca de 300 nm. As moléculas de ADN interagem 
eficientemente com as nanopartículas do copolímero, evidenciando potencial 
para a aplicação deste sistema como transportador de ADN. 
Este estudo apresenta diferentes sistemas com possíveis aplicações na 
terapia génica. Estes sistemas exibem boas características como vetores de 
transfeção de ADN. 
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Abstract 
This doctoral thesis had as objectives the preparation and 
characterisation of cationic non-viral DNA delivery systems based on lipids 
and polymers. 
Langmuir monolayers were used to predict the interactions between 
the cationic lipid DOTAP (1,2-dioleoyl-3-trimethylammonium-propane, 
chloride salt) and cholesterol or its derivative heptafluorocholesterol 
(fluorinated cholesterol). The mixture of DOTAP with each of the sterols at 1:1 
molar ratios leads to monolayers in a liquid expanded state, similarly to that 
of DOTAP alone. The area per molecule of the mixtures was smaller than that 
expected according to the additivity rule applicable if the two components are 
either completely miscible or immiscible within the monolayer. The 
adsorption of DNA to the monolayer is similar for both systems, supporting 
the use of fluorinated cholesterol as helper lipid in DNA transfection vectors. 
Liposomes of the cationic lipid DOTAP and the fluorinated cholesterol 
(F7-CHOL) were tested at the molar ratios of 1:1 for DNA compaction and 
transfection. The results confirmed that more DOTAP:F7-CHOL liposomes are 
needed to compact the same amount of DNA as DOTAP:CHOL and that the 
liposome-DNA binding is stronger in the case of DOTAP:F7-CHOL/DNA system. 
The stability rates of both liposomes in the presence of DNA were similar as 
well as the transfection efficiencies. 
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Bolaamphiphile based vectors were prepared using two distinct 
methods: layer-by-layer (LbL) deposition method and hydration lipid film 
technique. Microparticles were coated with few polymer layers by LbL for 
stabilization, followed by deposition of DNA and bolaamphiphile (BA) layers, 
alternately. The amount of DNA present on the layers was 0.035 ± 0.005 
mg/mL as estimated by ethidium bromide assays. The presence of both DNA 
and BA molecules at the surface of the microparticles was confirmed by 
confocal laser scanning microscopy. Vesicles of the bolamphiphile and DOTAP 
were also prepared using different molar ratios of each molecule. The ratio 
that exhibited better behaviour was BA:DOTAP 1:5. The vesicles were then 
successfully complexed with DNA at the lipid:DNA ratio of 10:1 (w:w). 
Transfection studies revealed that the BA:DOTAP mixed system has a higher 
transfection potential with less impact on cell viability than DOTAP system. 
Graft copolymers of chitosan and maltodextrin were synthesised by 
reductive amination of a low molecular weight chitosan. The degree of 
substitution is 70% or above, as quantified by nuclear magnetic resonance 
spectroscopy, at molar ratios of chitosan glucosamine units and maltodextrin 
of 1:1 and 1:5. The high substitution degree generates a water-soluble 
compound at pH 7.4. In addition, the copolymer self-assembles into spherical 
nanoparticles with diameters of about 300 nm. DNA molecules interact 
efficiently with the copolymer nanoparticles indicating a potential application 
of the system for DNA delivery.  
The current study presents different systems with possible applications 
in gene therapy. These systems exhibit good characteristics as DNA 
transfection vectors. 
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Chapter 1  
1. Introduction 
The gene therapy concept states that a human disease might be 
treated if the correct genetic material is supplied to the targeted cell. The new 
genetic material can correct or supplement the defective genes responsible 
for the disease progression (Mansouri, 2004). Different gene therapeutics to 
treat diseases such as cancer, AIDS and neurological disorders are currently in 
clinical trials (Biffi, 2006; Ginn, 2013; Li, 2005; Strayer, 2005). 
In gene therapy, the development and study of DNA vectors with high 
transfection efficiency and low toxicity is extremely important. Ideally, a DNA 
delivery system with therapeutic purposes should have high transfection 
efficiency and high specificity to the target cell to reduce the side effects. The 
system should in addition be small, stable, biodegradable, easy to prepare and 
should allow the DNA release and expression (Mansouri, 2004; Patil, 2005). 
Nanoparticles and nanocapsules offer many advantages in gene therapy due 
to their versatile chemical structures, surface functionalities and the ability to 
obtain controlled sizes. 
The focus of this PhD research work is to prepare and characterise 
non-viral DNA delivery systems based on lipids and polymers. These systems 
avoid some of the problems associated to viral vectors such as high toxicity 
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and the generation of a strong immune response. Other advantages of non-
viral vectors are easy formulation and assembly (Patil, 2005). 
Non-viral vectors are typically positively charged such as cationic 
liposomes prepared with 1,2-dioleoyl-3-trimethylammonium-propane, 
chloride salt (DOTAP) or cationic nanoparticles made of chitosan. These 
systems compact efficiently the DNA through electrostatic interactions 
leading to the formation of complexes (Morille, 2008). In this thesis the 
preparation of three different non-viral systems is described.  
One system is based on fluorinated compounds (fluorinated modified 
cholesterol) mixed with the cationic lipid DOTAP. Fluorinated cationic 
liposomes have shown a higher transfection potential in in vitro and in vivo 
studies when compared to their analogues (Krafft, 2001). Also, these 
compounds exhibit good properties regarding the transport and protection of 
active principles in the blood stream (Riess, 2002). The use of fluorinated 
cholesterol in cationic liposomes for DNA delivery is described in the point of 
view of the helper lipid effect. Cholesterol is normally added to lipid-based 
DNA vectors to help the fusion of the liposome with the membrane, but also 
to increase the stability and decrease the toxicity of the system. The use of 
fluorinated cholesterol might increase further the stability of the system due 
to its high hydrophobic character and protect DNA molecules from 
degradation in the blood stream, increasing the half-life of the system 
(Boulanger, 2004). 
A second carrier was prepared with bolaamphiphiles, which are 
molecules with two hydrophilic end groups connected by a hydrophobic tail. 
Bolaamphiphiles are described to self-assemble in water and form packed 
monolayer lipid membranes (Forbes, 2006). A bolaamphiphile molecule with a 
hydrophobic chain of 22 carbon atoms, trimethylamine-quaternized at one 
end and with a hydroxyl group at the other end was synthesised. The carriers 
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containing this molecule were prepared by two different approaches. One 
strategy was to use the layer-by-layer technique to assemble bolaamphiphile 
and DNA layers on a microparticle core that could eventually be removed to 
originate micro- or nanocapsules (Sukhorukov, 2007). A different approach 
was to incorporate the bolaamphiphile in vesicles composed of the cationic 
lipid DOTAP. This mixture is expected to form stable vesicles with small sizes 
even in dry state due the two polar heads and the long carbon chain present 
in the bolaamphiphile (Jain, 2010).  
A DNA vector system based on chitosan conjugates is also proposed. 
Chitosan is a non-toxic and natural biodegradable cationic polymer with low 
immunogenicity and high biocompatibility (Jayakumar, 2010). These 
properties made chitosan one of the more used polymers for gene therapies. 
However, this molecule shows some problems, like solubility at physiological 
pH and side effects as hypocholesterolemia if applied in high doses, limiting its 
application. To overcome these complications and to improve its ability to 
transfect genetic material, this cationic polymer was modified by grafting a 
neutral polymer. Maltodextrin was chosen because it is a non-ionic excipient 
that enhances gene expression and has low toxicity (Huang, 2002).   
This thesis is organised into seven chapters. This chapter, introduction, 
covers the objectives and scope of the proposed work. Chapter 2, nano-
systems for gene delivery, contains an overview of the non-viral vectors 
concerning their applications in gene therapy and their advantages and 
disadvantages. Chapter 3, interaction of DNA with lipid monolayers, covers the 
use of Langmuir lipid monolayers to predict the interactions between the 
fluorinated cholesterol and DOTAP and to study the interaction of DNA 
molecules with the monolayer. Chapter 4, compaction process of DNA by 
fluorinated liposomes, is dedicated to the characterisation of DOTAP 
liposomes mixed with fluorinated cholesterol and the comparison of this 
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system with the well-known DOTAP:cholesterol liposomes. In chapter 5, 
bolaamphiphile-based vectors, the potential application of a new synthesised 
bolaamphiphile in DNA carriers is discussed and in chapter 6, chitosan-N-
maltodextrin conjugates, the synthesis of chitosan-graft-maltodextrin 
copolymers, their assembly into nanoparticles and their interaction with DNA 
are described. Finally, chapter 7, concluding remarks, summarises the main 
findings of this thesis. 
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 Chapter 2 
2. Nano-systems for gene 
delivery 
Human diseases might be treated by the transfer of genetic material 
into specific cells in order to correct or supplement defective genes 
(Alderuccio, 2009; Buckley, 2011; Fischer, 2010). Gene therapy is been studied 
in clinical trials for different type of diseases such as cancer (Brannon-Peppas, 
2004; Li, 2005; Ramesh, 2001), HIV/AIDS (Kiem, 2012; Strayer, 2005), diabetes 
(Callejas, 2013; Jean, 2011), cystic fibrosis (Mitomo, 2010; Pringle, 2009) and 
neurological disorders (Biffi, 2006; Kim, 2009; Manfredsson, 2010).  
There are many processes to perform gene therapy treatments such as 
gene addition, gene correction/alteration and gene knockdown that could be 
used individually or in combination (Kay, 2011). Gene knockdown acts by 
introducing siRNA (short interfering RNA) or miRNA (mediated gene 
regulation circuits of RNA) to block or cleave a gene transcript, by selecting 
the sequences that should be replicated, eliminating the defective sequences 
(Summerton, 2007). Gene correction/alteration is not a common technique, 
however it is acquiring some interest by using artificially engineered nucleases 
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to cut the genome at a specific location, driving the cell endogenous 
mechanisms to repair the introduced break through natural processes (Urnov, 
2010).  
Gene addition is one of the more commonly used techniques and 
basically introduces a new sequence of DNA without removal of the 
endogenous mutated gene. The therapeutic gene needs to reach the interior 
of the cell and it will be treated by the subsequent cell processes. For this 
route of gene therapy, the limitation step is the carrier used to transport the 
genetic information through the human body and the ability to cross the cell 
membrane. It is known that DNA sequences and free oligonucleotides are 
rapidly degraded by serum nucleases in the blood when injected 
intravenously (Miguel, 2003). Thus, a vehicle is necessary to compact and 
protect the genetic material. The process is called DNA transfection (Figure 
2.1). 
 
 
 
 
Figure 2.1. Schematic representation of the DNA transfection process (Patil, 
2005a). 
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An ideal DNA delivery system should have high transfection efficiency 
with high specificity to the target cell, as well as low toxicity and 
immunogenicity. The system should be small, stable, biodegradable, simple 
and allow the release, delivery and expression of the DNA (Mansouri, 2004; 
Patil, 2005a). The development of novel nano-systems as DNA vectors with 
these properties is extremely important.  
Gene delivery vehicles can be divided into two main categories, viral 
and non-viral particles that can be complexed with DNA molecules. 
2.1. Viral Vectors 
The main advantage of using viral vectors is that they are highly 
efficient in delivering genetic material through the cell membrane (Atkinson, 
2010). The viral life cycle can be divided into two phases: infection and 
replication. The infection is the penetration of the viral genome into the cell, 
after which the expression occurs, releasing viral regulatory products used for 
viral replication. Viral–based gene therapy vectors encapsulate a modified 
genome that after expression transduce therapeutic genetic material (Kay, 
2001).  
Engineering genetically a virus DNA sequence is neither simple nor 
easy and it raises concerns about their safety. Misguided preparations can 
influence not only the efficacy of the system but also its toxicity and 
immunogenicity. These reasons and the high cost of preparation represent 
the major disadvantages of viral systems, because it is necessary to introduce 
a new disease to prevent or cure the genetic disorder and re-administration of 
the vector will be inefficient due to the immune response against the virus 
(Nayak, 2010). One of the more common viruses used in gene therapy are 
retrovirus and lentivirus, adenovirus and adeno-associated viruses and Herpes 
simplex virus (Saraswat, 2009).  
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Retrovirus and lentivirus can be modified to infect mammalian cells. 
When the virus is modified, it loses the ability of replicate and therefore it 
only affects one cell. Once it is in the cell it will integrate the chromosome of 
the host genome and provide a stable long expression of the transgene. 
However this integration has the negative effect of an inherent risk of 
insertional mutagenesis on future cells originated from the dividing process. 
Lentivirus suppressed this step, since it only transfects non-dividing cells and 
therefore will not be harmful to other cells (Atkinson, 2010; Mitomo, 2010).  
Adenovirus vectors are appropriated to carry large sequences of DNA. 
However a severe immune response of the host leads to a limited action of 
the adenoviral DNA on the targeted cell, resulting in a transient expression of 
the therapeutic gene that is lost over time (Walther, 2000). The viral sequence 
is kept as an episome instead of a chromosome. The episome is constituted by 
closed circular DNA that can be replicated by the nucleus but it is lost during 
cell division. Nevertheless, after an appropriate modification the genetic 
information can be maintained active at least during the life of the host cell. 
Yet, the immune response will attack also the host cell probably in few weeks. 
Repeated doses of this virus will also be destroyed (Atkinson, 2010). High 
dosages of a first dose can induce severe toxicity. These problems affect the 
efficacy of this vector and are its bigger disadvantage (Kay, 2011). 
Adeno-associated viral vectors represent an alternative to adeno virus. 
This is a non-pathogenic single stranded DNA virus that lacks of viral coding 
sequences and is not associated with any disease, so it does not have 
problems concerning toxicity or inflammatory responses (Walther, 2000). 
They have the ability to infect both dividing and non-dividing cells and can 
transduce on a broad range of in vivo tissues. Although the biggest 
disadvantage of these systems is the limitation on the size of the therapeutic 
gene, which cannot be higher than 5 kb (Li, 2005). 
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Herpes simplex virus (HSV) has a large capacity to encode therapeutic 
genes and can infect a large number of cell types. Due to its ability to persist 
in a latent state after the first infection, this virus provides the potential for a 
long term expression of the therapeutic gene (Kay, 2001). However, the lack 
of experience with recombinant herpes virus in patients and the difficulties on 
target specific cells as well as toxicity revealed to be limitations for this system 
(Saraswat, 2009). 
Recombination of different types of virus or the combination of viral 
vectors with non-viral delivery systems could be the solution to optimise 
these carriers in order to obtain efficient vehicles with promising properties 
for gene therapies. Recently a new generation of non-viral vehicles with some 
of viral properties has risen. Virosomes combine the therapeutic gene with 
fusogenic viral envelope proteins (Bomsel, 2011; Moser, 2011; Sharma, 2010). 
In conclusion, viral vectors have superior transfection efficiencies, but 
their use is dramatically limited by their severe side effects. However and 
despite their disadvantages, viral vectors represent more than 50% of the 
vectors used currently in clinical trials for gene therapeutics (Ginn, 2013; 
Lonez, 2008; Ramesh, 2001). 
2.2. Non-viral vectors 
Non-viral vehicles exhibit low transfection efficiency but properties like 
biocompatibility and potential for a large scale production make these 
systems very attractive for gene therapy. There are numerous non-viral 
systems that have reached clinical trials in the last few years (Ginn, 2013; 
Mintzer, 2009; Seow, 2009).  
Naked DNA injections in live tissue are a non-viral method to transfect 
DNA into cells. This method consists in the injection of oligonucleotides or 
small interfering RNA (siRNA) directly to the targeted sites. The in vivo 
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expression for this therapy is effective for intravascular delivery into liver and 
muscle tissues. However the efficiency of transfection on skeletal or cardiac 
muscle is relatively low and variable (Herweijer, 2003; Luo, 2000). The use of 
mechanical and electrical procedures to deliver DNA into specific locations is 
limited. Electroporation, an electrical method, is used to facilitate the DNA 
transfection, by applying high voltage electrical current. As a result, high cell 
mortality is verified, making this strategy inadequate for clinical use. 
Mechanical strategies by means of applied pressure and particles 
bombardment are limited to external tissues, like muscle, mucosal and skin, 
because to reach internal organs an invasive procedure (through surgery) is 
needed, which will carry risks for the patient. Despite its difficulty to 
standardise, this methodology has reached clinical trials and, currently, 
represents 18% of trials for gene therapies (Ginn, 2013; Gu, 2011; Morishita, 
2011). 
The complexation of DNA with lipids (lipoplexes), polymers 
(polyplexes) and other non-viral vectors appear as an alternative methodology 
to classical vectors based on viruses (Morille, 2008; Zhu, 2010). One of the 
best properties of positively charged molecules is that they interact efficiently 
with negatively charged groups of DNA, mainly by electrostatic interactions, 
with DNA loadings close to 100%. This becomes a fast and easy method to 
prepare delivery systems that do not require an encapsulation step. However, 
the size of the complex can depend significantly on the type of cationic 
structure used and the preparation conditions including DNA concentration, 
pH, buffer, presence of salts and the N/P (nitrogen/phosphate) charge ratio  
(Kamimura, 2011; Leal, 2007; Sennato, 2008). Studies revealed that the 
optimal mean diameter of the vehicles for gene transfer is 50-60 nm (Gao, 
2005; Laouini, 2013; Rodríguez-Pulido, 2009). Nevertheless, the positive 
overall charge of the generated DNA complex will interact with the negative 
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charged cell membrane and can promote forced endocytosis of larger vectors, 
increasing its uptake by cells and, consequently, improving DNA delivery 
(Lonez, 2008; Mansouri, 2004; Zelphati, 1996). 
2.2.1. Lipid-based systems 
Lipids are amphiphilic molecules that have the ability to self-form, in 
the presence of aqueous solutions, stable structures named liposomes. A lipid 
molecule is constituted by a head group (hydrophilic) and a hydrophobic tail 
composed mainly by a hydrocarbon chain. Due to the hydrophobic tail, when 
in contact with aqueous solutions they rearrange themselves to form a 
bilayer, where the lipid tails are oriented to the interior of the bilayer and the 
hydrophilic group is in contact with the water molecules. The size of the 
formed structures is easily controlled (50- 200 nm) applying methods such as 
freeze-thaw cycles, sonication and membrane extrusion (Dua, 2012; Honda, 
2013; Jesorka, 2008).  
Liposomes have several advantages over the viral systems. The low 
immunogenicity is one of the main advantages of liposomes. Also they are 
synthetic, relatively cheap to produce and do not induce cell contamination. 
Liposomal systems are stable and protect the DNA from nuclease degradation 
during transport. Additionally, liposomes can be prepared to target a specific 
group of cells. The principal disadvantages of these systems are the low 
transfection efficiency and some risk of inflammatory toxicity (Kamimura, 
2011; Seow, 2009) 
Liposomes can be used to transport and delivery DNA and drugs. 
Anionic liposomes, like DMPG (1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-
glycerol)]) can interact efficiently with positively charged drugs (Drulis-Kawa, 
2010; Rodrigues, 2001; Shimanouchi, 2012). Studies with DNA molecules 
show that these vectors have limitations due to the inefficient entrapment. 
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Both liposomes and DNA possess negative charges, leading to a poor 
association. Therefore not many studies have been developed with this 
system for DNA delivery. However, it has been reported in the literature that 
DOPG (1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]) mixed with DOPE 
(1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) can be complexed with DNA 
in the presence of calcium ions (Ca2+) and transfect effectively the DNA (Patil, 
2004; Patil, 2005b). 
On the other hand, cationic liposomes interact efficiently with DNA 
molecules due to the opposite charges. Cationic liposomes are known to have 
more affinity to the cell surface or endothelial glycoproteins facilitating the 
crossover of the system through the membrane (Rao, 2010). 
There are numerous type of cationic lipids used for gene delivery 
(Geusens, 2011). DOTMA (1,2-di-O-octadecenyl-3-trimethylammonium 
propane) was the first cationic lipid to be used. Currently, it is used in several 
studies and it is part of the Lipofectin® formulations, the first commercial 
formulation used as a standard to evaluate the effectiveness of the new 
transfection reagents, despite its toxicity (Tarahovsky, 2009). DOTAP (1,2-
dioleoyl-3-trimethylammonium-propane, chloride salt) is a monovalent 
cationic aliphatic lipid first synthesised by Leventis and Silvius (Leventis, 1990). 
It has a high potential for transfection studies combined with its low toxicity, 
becoming one of the more used cationic lipids in gene therapy studies 
(Caracciolo, 2012). Other cationic lipids also used are DC-Chol (3β-[N-(N',N'-
dimethylaminoethane)-carbamoyl]cholesterol hydrochloride) (Caracciolo, 
2005; Muñoz-Úbeda, 2010); multivalent aliphatic lipids such as DOGS 
(dioctadecylaminoglycylspermine) and DOSPA (2,3 Dioleyloxy-N-
[2(sperminecarboxaminino)ethyl]-N,N-dimethyl-1-propanaminium 
trifluroacetate). DOSPA is one of the lipids present in Lipofectamine®, one of 
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the more used commercial formulations available as reagent to assess 
transfection in cell experiments (Pedroso de Lima, 2003). 
The transfection efficiency of cationic liposomes is dependent on the 
lipid molecule, the presence of helper lipids, the lipid/DNA ratio and which 
cells are targeted. Helper lipids, like cholesterol or DOPE (dioleoyl 
phosphoethanolamine), are normally neutral in charge and are used to 
improve the system stability, reduce the toxicity of cationic lipids and increase 
the half-life of liposomes and their transfection efficiency in in vivo studies 
(Crook, 1998; Hui, 1996; Miguel, 2003; Xu, 2008; Zhang, 2004). To improve the 
formulations based on cationic lipids, a new generation of lipids modified with 
fluorine atoms has emerged. 
Fluorine is the most electronegative of the elements and it has a high 
ionisation potential and a very low polarizability (Kissa, 1994). Thereby, liquid 
fluorocarbons present low van der Waals interactions and low cohesive 
energy densities (Riess, 1994a). Consequently these fluorocarbons show very 
low surface tensions, excellent spreading properties, high fluidity, low 
dielectric constant and high compressibility (Krafft, 1998). The larger surface 
exhibited by these fluorinated chains combined with the low polarizability 
results on enhanced hydrophobicity. They show both hydrophobic and 
lipophobic properties at the same time (Krafft, 2001; Riess, 2009).  
Many fluorocarbons are biocompatible, even at large doses they 
appear to be innocuous and physiologically inactive. No toxicity, carcinogenic, 
mutagenic effects or immunological reactions have been described for pure 
fluorocarbons with a molecular weight ranging from 460 to 520 g/mol. A 
phase I clinical trial revealed that perfluorooctyl bromide emulsion at a 
dosage of 1.2 or 1.8 g of fluorocarbon/kg do not present side effects in 
healthy humans (Krafft, 2001; Leese, 2000; Riess, 1984). 
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Fluorinated amphiphiles have increased tendency to self-assemble in 
water when compared to their hydrogenated analogues due to the strong 
hydrophobic character of the fluorinated chains (Krafft, 2003). They also have 
a lower critical micellar concentration than the hydrogenated analogues 
(Shinoda, 1972). Fluorinated lipids have been synthesised and tested as the 
main cationic lipid of DNA vectors (analogues of cationic DOSPA) as well as the 
helper lipid (analogues of DOPE) (Gaucheron, 2000; Gaucheron, 2001a; 
Gaucheron, 2001b; Gaucheron, 2002; Klein, 2010; Otmane Boussif, 2001). 
They have shown advantages over their hydrogenated analogues and cationic 
polymers (polyethylenimine) regarding the transfection potential (Huh, 1996). 
Due to the strong tendency to self-assemble, fluorinated lipids prevent the 
interaction of DNA with lipophilic or hydrophilic molecules responsible for 
lipofection inhibition, and protect DNA from degradation in the bloodstream 
since hemolytic activity is strongly suppressed (Boulanger, 2004; Riess, 1991; 
Riess, 1994b).  
Bolaamphiphile lipids differ from conventional lipids because they 
have two hydrophilic heads in opposite sides of the molecule instead of one. 
These head groups are connected through a hydrocarbon chain (Fuhrhop, 
1986). The more known natural bolaamphiphile is the monolayered 
membrane of thermophilic and acidophilic archaebacteria, as Sulfolobus 
solfataricus or Sulfolobus acidocaldarius species (Baek, 2010; Rosa, 1986). 
These molecules exhibit promising applications in gene therapy (Dakwar, 
2012; Nuraje, 2012). They have enhanced physical stability due to the 
presence of the two polar groups. These molecules can be symmetrical or 
asymmetrical with respect to the charge present on the head groups. It is 
possible to synthesise a molecule with the same head group at both ends or 
with a positively charged group at one end and a neutral group at the other. 
According to the charges, the molecules will rearrange to form stable vesicles 
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that could be used to encapsulate, transport and deliver an active principle 
(Brunelle, 2009; Grinberg, 2010; Kaufman, 2013).  
The self-assembly of bolaamphiphiles into structures can be very 
different, depending on its characteristics. If the bolaamphiphile has 
symmetrical head groups, it will have a tendency to generate monolayered 
vesicles. However if the head groups are asymmetrical, the rearrangement 
could be very different. Usually, they form monolayer lipid membranes when 
the head groups are smaller or about of the same size of the hydrophobic 
core. For bigger head groups, the molecules could form bilayered structures 
that are more rigid and can have crystal shapes. In crystal assemblies, three 
types of arrangements can occur. Considering a and b the head groups of an 
asymmetrical bolaamphiphile, the bilayer could be assembled in a parallel 
way, where the a head group is oriented to the inner space and the b head 
groups to the outer space or vice-versa with respect to the head groups 
(Figure 2.2.a/b). This orientation will depend on the forces present on the 
head groups and in the solution bulk or surface. These bolaamphiphiles can 
also organise themselves in an antiparallel way, where the a head group is 
oriented to a b head group, forming in the inner space a sequence of a-b-a in 
one layer to the corresponding sequence b-a-b on the other (Figure 2.2.c) 
(Fuhrhop, 2004).  
Despite the influence of the head groups on the assembly of these 
structures, the hydrophobic part of the molecule also plays an important role 
on the way that these molecules self-assemble. Long carbon chains usually 
lead to monolayered lipid membranes, similar to liposomes, while short 
hydrocarbon chains generate vesicles like micelles (Jain, 2010; Jain, 2012; 
Popov, 2010). The presence of double bonds between carbons or other 
groups in the hydrophobic chain confers rigidity to the molecule and could 
lead to a U-shaped orientation of the molecule in which the hydrophilic 
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groups are aligned on the same side and the U bend is in the opposite side, 
generating a bilayered vesicle (Meister, 2007; Yan, 2009). 
 
 
Mixtures of bolaamphiphile with lipids are used to improve the 
properties of the transport vector (Caschera, 2011). The lipids present 
assembled according a bilayer vesicle and the bolaamphiphile can be 
intercalated if the size of its hydrophobic part is close to twice of the size of 
the hydrophobic part of the lipid molecule (Halter, 2004). Bolaamphiphile 
molecules can also acquire the U-shape to better blend within the bilayer (Gu, 
2003; Hutter, 2012; Moss, 1991). 
 
 
 
Figure 2.2. Schematic representation of possible arrangements of asymmetrical 
bolamphiphiles in crystals: a) parallel a,a; b) parallel a,b; c) antiparallel a,b and 
b,a (Fuhrhop, 2004). 
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2.2.2. Polymeric carriers 
Polymeric gene vectors are prepared by complexation of cationic 
polymers with anionic DNA molecules generating nanospheres with diameters 
ranging from 50 to 700 nm (Pannier, 2004). Polyplexes or polymer-DNA 
complexes are internalised by cells through endocytosis or membrane fusion, 
due to the overall positive charge of the complex, and the DNA release 
happens upon endosomal escape by proton-sponge mechanism (Boussif, 
1995; Jewell, 2008). These vectors are more stable and less toxic than 
liposome systems and condense more DNA (Mansouri, 2004). Other 
advantages of these systems include low immunogenicity, versatility of 
physicochemical properties and easy manufacture (Merdan, 2002). Cationic 
polymers typically interact with DNA in a stronger way, through electrostatic 
interactions, leading to the formation of complexes with multiple DNA 
molecules. Therefore the size of the particles is related mostly with the 
polymer physical properties than the DNA molecule size (Mintzer, 2009). 
However, biocompatibility and, principally, transfection efficiency still have to 
be improved.  
Polymer vectors strongly depend on the nature of the polymer and 
their molecular weight and on the ionic strength of the solutions. 
Modifications on the polymer structure confer specific physiological and 
physicochemical properties that help with the DNA uptake and the tissue 
targeting (Merdan, 2002). 
Polyethylenimine (PEI) is one of the more used polymers in gene 
therapeutics. It can be synthesised in different lengths, be branched or linear 
and can be functionalised for better compatibility. Regarding polymer vectors, 
PEI presents good results when it comes to transfection efficiency (Pun, 2004). 
It condenses DNA efficiently forming homogeneous spherical nanoparticles. 
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Branched PEI has a higher molecular weight being more cytotoxic, but also 
condenses more DNA since it possesses more available positive charges, 
forming smaller nanoparticles. Linear PEI with low molecular weight shows 
higher transfection efficiency values and lower cytotoxicity when compared to 
branched PEI (Park, 2006). Despite its valuable characteristics, PEI showed 
high toxicity in in vivo trials, mostly due to the high amount of positive charges 
and the non-biodegradability of the compound. In order to reduce its toxicity, 
studies were performed to graft other polymers like polyethylene glycol 
(PEG), a non-ionic hydrophilic polymer (Petersen, 2002) or β-cyclodextrin (β-
CD), a sugar polymer with low toxicity  (Pun, 2004). 
Poly(L-lysine) (PLL) is a homopolypeptide that combined with its 
biodegradable nature make it an ideal polymer for DNA transfection. PLL with 
a molecular weight above 3 kDa can effectively bind DNA molecules to form 
stable complexes. However, at physiological pH, all primary amine groups of 
PLL are protonated, which hampers the release of DNA by the endosomes 
and, therefore, has a weak transfection efficiency. In addition, PLL complexes 
exhibit a high cytotoxicity (Morille, 2008). To overcome these problems, a 
numerous of biodegradable PLL conjugates have been synthesised. Poly(lactic-
co-glycolic acid)(PLGA)-grafted-PLL conjugates showed reduced toxicity and 
enhancements on the transfection efficiency (Jeong, 2002). Ester-linked PLL-
PEG multiblock copolymers combined with various ratios of histidine residues 
promote gene transfer and reduce the cytotoxicity when compared to the 
non-derivatised PLL (Bikram, 2004). Polylysine has non-specific cell targeting. 
Derivatisation of PLL molecules with targeting moieties is one of the recurrent 
solutions for this problem. Hepatic cell targeting uses galactose (Han, 2000) or 
lactose (Choi, 1998) moieties. Tumor tissue targeting was achieved by 
conjugating PLL to folate (Cho, 2005) or transferrin (Wagner, 1991) molecules. 
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In order to target leukaemia T-cells a specific JL1 antigen was coupled to 
polylysine (Suh, 2001). 
Natural polysaccharides or carbohydrates are used in gene therapy 
due to their properties such as biodegradability, reduced toxicity, long half-life 
in the blood stream and the ability to target cells of the liver, spleen, lung and 
spinal-cord (Liu, 2008). Numerous saccharides are used in gene delivery such 
as dextran (Bisht, 2009), amylose (Kaneko, 2007) and cyclodextrin (Teijeiro-
Osorio, 2009).  
Nanoparticles of chitosan and its derivatives are studied in the 
pharmaceutical field as drug carriers and DNA delivery systems (Pannier, 
2004; Patel, 2012). Chitosan is a linear polymer of β-(1-4)-linked-D-
glucosamine monomers with randomly distributed N-acetyl-D-glucosamine 
units obtained by partial deacetylation of chitin, a natural polysaccharide 
found principally in crustacean shells such as shrimps and crabs (Jayakumar, 
2010b). It is a non-toxic and natural biodegradable cationic polymer with low 
immunogenicity and high biocompatibility. Other advantages of this 
macromolecule include stability, versatility of physicochemical properties and 
the possibility of modification by attaching cell compatible ligands 
(Jayakumar, 2010a). However, problems related to chitosan delivery systems 
have been reported: the pH dependence (chitosan is insoluble at neutral pH); 
the control of particle size, shape and polydispersity due to the variability of 
chitosan molecular weight; the limitation of chitosan application in humans 
due to hypocholesterolemia caused by high doses of chitosan; the in vitro 
transfection rate of DNA-chitosan nanoparticles is very much dependent on 
the cell type (Masotti, 2009; Patil, 2005a; Sato, 2001).  
The systems are typically prepared either by complexation of the 
cationic polymer with anionic DNA or by encapsulation/entrapment of the 
active principle in the chitosan matrix. Chitosan colloidal systems have 
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normally a size ranging from a few nanometres to 500 nm (Agnihotri, 2004; 
Felt, 1998; Liu, 2008; Nguyen, 2009). They have been used in non-
conventional drug delivery for nasal, ocular and peroral administration in 
order to prolong the contact time and protect DNA from nuclease degradation 
(Mansouri, 2004; Saranya, 2011).  
There are many factors influencing the gene expression or drug 
delivery using chitosan systems (Kim, 2007; Mao, 2010). Kiang et al. tested 
chitosan molecules with different molecular weight and degree of 
deacetylation and determined that these properties play a key role in the 
optimisation of the formulations for DNA transfection (Kiang, 2004). An 
alternative approach to improve chitosan properties is to chemically modify 
its structure by grafting other molecules (Dünnhaupt, 2012; Gao, 2008; 
Kaneko, 2007; Zhou, 2011). Mathew et al. conjugated folic acid with 
carboxymethyl chitosan to produce nanoparticles capable of targeting and 
controlling the release of 5-fluorouracil, an anticancer drug used in 
chemotherapy (Mathew, 2010). Park et al. suggested grafting dextran to 
galactosylated chitosan for targeting genes to hepatocytes (Park, 2001). 
Unmodified chitosan was also grafted to dextran molecules of different 
molecular weights, resulting in compounds with different degrees of 
substitution and water solubility at different pH (Janciauskaite, 2008). 
Dendrimers are spherical, highly branched polymers. They consist of a 
central core molecule, where highly branched arms grow to form a tree-like 
structure (Chen, 2000). The ramification happens in a well-ordered and 
symmetrical way with the repetition of the same sequence of reactions, 
producing monodisperse nanoparticles. Dendrimers are classified by the 
number of generations, which corresponds to the number of repeated 
branching sequences that are performed during the synthesis. High 
generation dendrimers (10) have superior transfection efficiencies when 
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compared to low generation dendrimers (2) (Zhu, 2010). Polyamidoamine 
(PAMAM) is one of the more popular dendrimers. It is safe, non-immunogenic 
and has a high capacity regarding transfection efficiency, due the presence of 
primary and tertiary amines (Vaidya, 2011). The primary amine groups play an 
important role on the DNA binding, producing compact nanoparticles and 
promoting the cellular uptake. The tertiary amines favour the release of DNA 
into the cytoplasm by disabling the endosomes (Vaidya, 2011). 
2.2.3. Inorganic based nanoparticles 
Apart from liposomal and polymeric vectors, some new DNA vehicles 
have gained attention in the last few years. Inorganic nanoparticles allies 
optical, magnetic and other physical properties to the inertness, stability and 
ease of functionalization, making them an attractive alternative to organic 
vehicles (Huang, 2011). 
Metal based nanoparticles hold a high potential for applications in 
both diagnostic imaging and targeted drug delivery. Normally, these 
nanoparticles are delivered in colloidal formulations with increased circulatory 
half-life and carry large amounts of drug due to its extremely small sizes with 
large surface areas (Naahidi, 2013). Gold nanoparticles (AuNPs) are one of the 
more studied metals as delivery system. They are easy to synthesise with 
different sizes, and the process is simple, cheap and reliable. Studies have 
shown that these nanoparticles are biocompatible, non-toxic and that their 
negative charged surface can be easily functionalised with diverse 
macromolecules (Li, 2009; Parveen, 2012). Bhattarai et al. modified the 
surface of gold nanoparticles with chitosan. This formulation formed 
complexes with plasmid DNA and exhibited higher transfection efficiency in 
the stomach and intestine after oral delivery, when compared with 
Lipofectin® formulation (Bhattarai, 2008). Li et al. coated gold nanoparticles 
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with DDAB (didodecyldimethylammonium bromide, a cationic lipid). These 
nanoparticles can complex to lipoplexes in order to condense more DNA 
molecules. This combined system had higher transfection efficiency when 
compared to the lipoplexes alone (Li, 2010). 
Quantum dots (QDs) are nanoparticles with broad applications in 
imaging detection and targeting. Quantum dot refers to a specific kind of 
nanoparticles with crystalline structure and composed by a semiconducting 
material, such as cadmium sulphite or cadmium selenide. These materials 
possess unique optical properties, which associated with its small size (2-10 
nm) and the flexible surface chemistry make them ideal systems for gene 
therapy (Vengala, 2012). QDs nanoparticles are known to induce toxicity. To 
overcome this problem, surface functionality with polymers or peptides has 
been done and the systems showed reduced cytotoxicity and enhanced 
uptake in vitro and in vivo (Clarke, 2010; Daou, 2009; Tan, 2010). Zhang et al. 
proposed water-soluble QDs modified with aminoethanethiol hydrochloride 
and sodium thioglycolate, which interact with plasmid DNA through 
electrostatic interactions. This system revealed to have high transfection 
efficiencies and lower cellular toxicity when compared to Lipofectamine 
2000® formulation (Zhang, 2012).  
Magnetic nanoparticles (MNPs) have been widely used for 
biotechnological and biomedical applications. These nanoparticles have the 
ability to target a specific site and thereby reduce the systemic distribution of 
the cytotoxic compounds in vivo. The MNPs are dispersed in organic or 
inorganic liquid carriers that will be injected into the vascular system and 
driven to the targeted site by application of a magnetic field. The genetic 
material is released by changing the physiological conditions, for example 
(Veiseh, 2010). Super paramagnetic iron oxide nanoparticles (SPIONs) are one 
of the more used MNPs in biomedical applications. Based normally on 
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magnetite (Fe3O4) or maghemite (γ-Fe2O3), they are biocompatible and 
biodegradable nanoparticles with small sizes up to 500 nm in diameter. 
SPIONs are hydrophobic particles with large surface area to volume ratio. 
Coating these MNPs with synthetic or natural polymers, such as PEI, chitosan, 
dextran, PEG and PLL generates biostable and non-toxic carriers (Kami, 2011). 
Fouriki et al. used MNPs composed by iron oxide cores coated with PEI 
derivatives. Plasmid DNA was coupled to the MNPs and the system showed 
higher transfection potential and lower toxicity when compared with the 
commercial formulation Lipofectamine 2000® (Fouriki, 2012). 
2.3. References 
Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. (2004). Recent advances 
on chitosan-based micro- and nanoparticles in drug delivery, Journal 
of Controlled Release, 100, 5. 
Alderuccio, F.; Chan, J.; Scott, D.W.; Toh, B.-H. (2009). Gene therapy and bone 
marrow stem-cell transfer to treat autoimmune disease, Trends in 
Molecular Medicine, 15, 344. 
Atkinson, H.; Chalmers, R. (2010). Delivering the goods: viral and non-viral 
gene therapy systems and the inherent limits on cargo DNA and 
internal sequences, Genetica, 138, 485. 
Baek, K.; Kim, Y.; Kim, H.; Yoon, M.; Hwang, I.; Ko, Y.H.; Kim, K. (2010). 
Unconventional U-shaped conformation of a bolaamphiphile 
embedded in a synthetic host, Chemical Communications, 46, 4091. 
Bhattarai, S.R.; K.C, R.B.; Aryal, S.; Bhattarai, N.; Kim, S.Y.; Yi, H.K.; Hwang, 
P.H.; Kim, H.Y. (2008). Hydrophobically modified chitosan/gold 
nanoparticles for DNA delivery, Journal of Nanoparticle Research, 10, 
151. 
  
 
26 NANO-SYSTEMS FOR GENE DELIVERY 
 
Biffi, A.; Capotondo, A.; Fasano, S.; Carro, U.d.; Marchesini, S.; Azuma, H.; 
Malaguti, M.C.; Amadio, S.; Brambilla, R.; Grompe, M.; Bordignon, C.; 
Quattrini, A.; Naldini, L. (2006). Gene therapy of metachromatic 
leukodystrophy reverses neurological damage and deficits in mice, 
The Journal of Clinical Investigation, 116, 3070. 
Bikram, M.; Ahn, C.-H.; Chae, S.Y.; Lee, M.; Yockman, J.W.; Kim, S.W. (2004). 
Biodegradable Poly(ethylene glycol)-co-poly(l-lysine)-g-histidine 
Multiblock Copolymers for Nonviral Gene Delivery, Macromolecules, 
37, 1903. 
Bisht, S.; Maitra, A. (2009). Dextran–doxorubicin/chitosan nanoparticles for 
solid tumor therapy, Wiley Interdisciplinary Reviews: Nanomedicine 
and Nanobiotechnology, 1, 415. 
Bomsel, M.; Tudor, D.; Drillet, A.-S.; Alfsen, A.; Ganor, Y.; Roger, M.-G.; Mouz, 
N.; Amacker, M.; Chalifour, A.; Diomede, L.; Devillier, G.; Cong, Z.; 
Wei, Q.; Gao, H.; Qin, C.; Yang, G.-B.; Zurbriggen, R.; Lopalco, L.; 
Fleury, S. (2011). Immunization with HIV-1 gp41 Subunit Virosomes 
Induces Mucosal Antibodies Protecting Nonhuman Primates against 
Vaginal SHIV Challenges, Immunity, 34, 269. 
Boulanger, C.; Di Giorgio, C.; Gaucheron, J.; Vierling, P. (2004). Transfection 
with fluorinated lipoplexes based on new fluorinated cationic lipids 
and in the presence of a bile salt surfactant, Bioconjugate Chemistry, 
15, 901. 
Boussif, O.; Lezoualc'h, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; 
Demeneix, B.; Behr, J.P. (1995). A versatile vector for gene and 
oligonucleotide transfer into cells in culture and in vivo: 
polyethylenimine, Proceedings of the National Academy of Sciences, 
92, 7297. 
  
 
NANO-SYSTEMS FOR GENE DELIVERY 27 
 
Brannon-Peppas, L.; Blanchette, J.O. (2004). Nanoparticle and targeted 
systems for cancer therapy, Advanced Drug Delivery Reviews, 56, 
1649. 
Brunelle, M.; Polidori, A.; Denoyelle, S.; Fabiano, A.S.; Vuillaume, P.Y.; 
Laurent-Lewandowski, S.; Pucci, B. (2009). A structure-activity 
investigation of hemifluorinated bifunctional bolaamphiphiles 
designed for gene delivery, Comptes Rendus Chimie, 12, 188. 
Buckley, S.M.K.; Rahim, A.A.; Chan, J.K.Y.; David, A.L.; Peebles, D.M.; Coutelle, 
C.; Waddington, S.N. (2011). Recent advances in fetal gene therapy, 
Therapeutic Delivery, 2, 461. 
Callejas, D.; Mann, C.J.; Ayuso, E.; Lage, R.; Grifoll, I.; Roca, C.; Andaluz, A.; 
Ruiz-de Gopegui, R.; Montane, J.; Muńoz, S.; Ferre, T.; Haurigot, V.; 
Zhou, S.; Ruberte, J.; Mingozzi, F.; High, K.; Garcia, F.; Bosch, F. 
(2013). Treatment of Diabetes and Long-term Survival Following 
Insulin and Glucokinase Gene Therapy, Diabetes, DOI: 10.2337/db12-
1113. 
Caracciolo, G.; Caminiti, R. (2005). Do DC-Chol/DOPE-DNA complexes really 
form an inverted hexagonal phase?, Chemical Physics Letters, 411, 
327. 
Caracciolo, G.; Amenitsch, H. (2012). Cationic liposome/DNA complexes: from 
structure to interactions with cellular membranes, European 
Biophysics Journal, 41, 815. 
Caschera, F.; de la Serna, J.B.; Löffler, P.M.G.; Rasmussen, T.E.; Hanczyc, M.M.; 
Bagatolli, L.A.; Monnard, P.A. (2011). Stable Vesicles Composed of 
Monocarboxylic or Dicarboxylic Fatty Acids and Trimethylammonium 
Amphiphiles, Langmuir, 27, 14078. 
Chen, W.; Turro, N.J.; Tomalia, D.A. (2000). Using ethidium bromide to probe 
the interactions between DNA and dendrimers, Langmuir, 16, 15. 
  
 
28 NANO-SYSTEMS FOR GENE DELIVERY 
 
Cho, K.C.; Kim, S.H.; Jeong, J.H.; Park, T.G. (2005). Folate Receptor-Mediated 
Gene Delivery Using Folate-Poly(ethylene glycol)-Poly(L-lysine) 
Conjugate, Macromolecular Bioscience, 5, 512. 
Choi, Y.H.; Liu, F.; Park, J.S.; Kim, S.W. (1998). Lactose-Poly(ethylene Glycol)-
Grafted Poly-l-Lysine as Hepatoma Cell-Targeted Gene Carrier, 
Bioconjugate Chemistry, 9, 708. 
Clarke, S.; Pinaud, F.; Beutel, O.; You, C.; Piehler, J.; Dahan, M. (2010). 
Covalent Monofunctionalization of Peptide-Coated Quantum Dots for 
Single-Molecule Assays, Nano Letters, 10, 2147. 
Crook, K.; Stevenson, B.J.; Dubouchet, M.; Porteous, D.J. (1998). Inclusion of 
cholesterol in DOTAP transfection complexes increases the delivery 
of DNA to cells in vitro in the presence of serum, Gene Therapy, 5, 
137. 
Dakwar, G.R.; Hammad, I.A.; Popov, M.; Linder, C.; Grinberg, S.; Heldman, E.; 
Stepensky, D. (2012). Delivery of proteins to the brain by 
bolaamphiphilic nano-sized vesicles, Journal of Controlled Release, 
160, 315. 
Daou, T.J.; Li, L.; Reiss, P.; Josserand, V.r.; Texier, I. (2009). Effect of 
Poly(ethylene glycol) Length on the in Vivo Behavior of Coated 
Quantum Dots, Langmuir, 25, 3040. 
Drulis-Kawa, Z.; Dorotkiewicz-Jach, A. (2010). Liposomes as delivery systems 
for antibiotics, International Journal of Pharmaceutics, 387, 187. 
Dua, J.S.; Rana, A.C.; Bhandari, A.K. (2012). Liposome: methods of preparation 
and applications, International Journal of Pharmaceutical Studies and 
Research, 3, 14. 
Dünnhaupt, S.; Barthelmes, J.; Iqbal, J.; Perera, G.; Thurner, C.C.; Friedl, H.; 
Bernkop-Schnürch, A. (2012). In vivo evaluation of an oral drug 
  
 
NANO-SYSTEMS FOR GENE DELIVERY 29 
 
delivery system for peptides based on S-protected thiolated chitosan, 
Journal of Controlled Release, 160, 477. 
Felt, O.; Buri, P.; Gurny, R. (1998). Chitosan: A unique polysaccharide for drug 
delivery, Drug Development and Industrial Pharmacy, 24, 979. 
Fischer, A.; Hacein-Bey-Abina, S.; Cavazzana-Calvo, M. (2010). 20 years of 
gene therapy for SCID, Nature Immunology, 11, 457. 
Fouriki, A.; Clements, M.A.; Farrow, N.; Dobson, J. (2012). Efficient 
transfection of MG-63 osteoblasts using magnetic nanoparticles and 
oscillating magnetic fields, Journal of Tissue Engineering and 
Regenerative Medicine, 10.1002/term.1508.n/a. 
Fuhrhop, J.-H.; Wang, T. (2004). Bolaamphiphiles, Chemical Reviews, 104, 
2901. 
Fuhrhop, J.H.; Fritsch, D. (1986). Bolaamphiphiles form ultrathin, porous and 
unsymmetric monolayer lipid membranes, Accounts of Chemical 
Research, 19, 130. 
Gao, H.; Shi, W.; Freund, L.B. (2005). Mechanics of receptor-mediated 
endocytosis, Proceedings of the National Academy of Sciences of the 
United States of America, 102, 9469. 
Gao, Y.; Xu, Z.; Chen, S.; Gu, W.; Chen, L.; Li, Y. (2008). Arginine-chitosan/DNA 
self-assemble nanoparticles for gene delivery: In vitro characteristics 
and transfection efficiency, International Journal of Pharmaceutics, 
359, 241. 
Gaucheron, J.; Santaella, C.; Vierling, P. (2000). Highly Fluorinated 
Lipospermines for Gene Transfer: Synthesis and Evaluation of Their in 
Vitro Transfection Efficiency, Bioconjugate Chemistry, 12, 114. 
Gaucheron, J.; Boulanger, C.; Santaella, C.; Sbirrazzuoli, N.; Boussif, O.; 
Vierling, P. (2001a). In Vitro Cationic Lipid-Mediated Gene Delivery 
  
 
30 NANO-SYSTEMS FOR GENE DELIVERY 
 
with Fluorinated Glycerophosphoethanolamine Helper Lipids, 
Bioconjugate Chemistry, 12, 949. 
Gaucheron, J.; Santaella, C.; Vierling, P. (2001b). Improved in vitro gene 
transfer mediated by fluorinated lipoplexes in the presence of a bile 
salt surfactant, The Journal of Gene Medicine, 3, 338. 
Gaucheron, J.; Santaella, C.; Vierling, P. (2002). Transfection with fluorinated 
lipoplexes based on fluorinated analogues of DOTMA, DMRIE and 
DPPES, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1564, 
349. 
Geusens, B.; Strobbe, T.; Bracke, S.; Dynoodt, P.; Sanders, N.; Gele, M.V.; 
Lambert, J. (2011). Lipid-mediated gene delivery to the skin, 
European Journal of Pharmaceutical Sciences, 43, 199. 
Ginn, S.L.; Alexander, I.E.; Edelstein, M.L.; Abedi, M.R.; Wixon, J. (2013). Gene 
therapy clinical trials worldwide to 2012 – an update, The Journal of 
Gene Medicine, 15, 65. 
Grinberg, S.; Kipnis, N.; Linder, C.; Kolot, V.; Heldman, E. (2010). Asymmetric 
bolaamphiphiles from vernonia oil designed for drug delivery, 
European Journal of Lipid Science and Technology, 112, 137. 
Gu, Q.; Zou, A.; Yuan, C.; Guo, R. (2003). Effects of a bolaamphiphile on the 
structure of phosphatidylcholine liposomes, Journal of Colloid and 
Interface Science, 266, 442. 
Gu, Y.; Zhang, J.; Guo, L.; Cui, S.; Li, X.; Ding, D.; Kim, J.-M.; Ho, S.-H.; Hahn, W.; 
Kim, S. (2011). A phase I clinical study of naked DNA expressing two 
isoforms of hepatocyte growth factor to treat patients with critical 
limb ischemia, The Journal of Gene Medicine, 13, 602. 
Halter, M.; Nogata, Y.; Dannenberger, O.; Sasaki, T.; Vogel, V. (2004). 
Engineered Lipids That Cross-Link the Inner and Outer Leaflets of 
Lipid Bilayers, Langmuir, 20, 2416. 
  
 
NANO-SYSTEMS FOR GENE DELIVERY 31 
 
Han, J.; Il Yeom, Y. (2000). Specific gene transfer mediated by galactosylated 
poly-l-lysine into hepatoma cells, International Journal of 
Pharmaceutics, 202, 151. 
Herweijer, H.; Wolff, J.A. (2003). Progress and prospects: naked DNA gene 
transfer and therapy, Gene Therapy, 10, 453. 
Honda, M.; Asai, T.; Oku, N.; Araki, Y.; Tanaka, M.; Ebihara, N. (2013). 
Liposomes and nanotechnology in drug development: Focus on 
ocular targets, International Journal of Nanomedicine, 8, 495. 
Huang, H.-C.; Barua, S.; Sharma, G.; Dey, S.K.; Rege, K. (2011). Inorganic 
nanoparticles for cancer imaging and therapy, Journal of Controlled 
Release, 155, 344. 
Huh, N.W.; Porter, N.A.; McIntosh, T.J.; Simon, S.A. (1996). The interaction of 
polyphenols with bilayers: Conditions for increasing bilayer adhesion, 
Biophysical Journal, 71, 3261. 
Hui, S.W.; Langner, M.; Zhao, Y.L.; Ross, P.; Hurley, E.; Chan, K. (1996). The 
role of helper lipids in cationic liposome-mediated gene transfer, 
Biophysical Journal, 71, 590. 
Hutter, T.; Linder, C.; Heldman, E.; Grinberg, S. (2012). Interfacial and self-
assembly properties of bolaamphiphilic compounds derived from a 
multifunctional oil, Journal of Colloid and Interface Science, 365, 53. 
Jain, N.; Arntz, Y.; Goldschmidt, V.r.; Duportail, G.; Mély, Y.; Klymchenko, A.S. 
(2010). New Unsymmetrical Bolaamphiphiles: Synthesis, Assembly 
with DNA, and Application for Gene Delivery, Bioconjugate 
Chemistry, 21, 2110. 
Jain, N.; Goldschmidt, V.; Oncul, S.; Arntz, Y.; Duportail, G.; Mély, Y.; 
Klymchenko, A.S. (2012). Lactose-ornithine bolaamphiphiles for 
efficient gene delivery in vitro, International Journal of 
Pharmaceutics, 423, 392. 
  
 
32 NANO-SYSTEMS FOR GENE DELIVERY 
 
Janciauskaite, U.; Rakutyte, V.; Miskinis, J.; Makuska, R. (2008). Synthesis and 
properties of chitosan-N-dextran graft copolymers, Reactive and 
Functional Polymers, 68, 787. 
Jayakumar, R.; Chennazhi, K.P.; Muzzarelli, R.A.A.; Tamura, H.; Nair, S.V.; 
Selvamurugan, N. (2010a). Chitosan conjugated DNA nanoparticles in 
gene therapy, Carbohydrate Polymers, 79, 1. 
Jayakumar, R.; Prabaharan, M.; Nair, S.V.; Tokura, S.; Tamura, H.; 
Selvamurugan, N. (2010b). Novel carboxymethyl derivatives of chitin 
and chitosan materials and their biomedical applications, Progress in 
Materials Science, 55, 675. 
Jean, M.; Alameh, M.; Buschmann, M.D.; Merzouki, A. (2011). Effective and 
safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA 
therapeutic nanocomplexes in an animal model of type 2 diabetes, 
Gene Therapy, 18, 807. 
Jeong, J.H.; Park, T.G. (2002). Poly(l-lysine)-g-poly(d,l-lactic-co-glycolic acid) 
micelles for low cytotoxic biodegradable gene delivery carriers, 
Journal of Controlled Release, 82, 159. 
Jesorka, A.; Orwar, O. (2008). Liposomes: Technologies and Analytical 
Applications, Annual Review of Analytical Chemistry, 1, 801. 
Jewell, C.M.; Lynn, D.M. (2008). Surface-mediated delivery of DNA: Cationic 
polymers take charge, Current Opinion in Colloid & Interface Science, 
13, 395. 
Kami, D.; Takeda, S.; Itakura, Y.; Gojo, S.; Watanabe, M.; Toyoda, M. (2011). 
Application of Magnetic Nanoparticles to Gene Delivery, 
International Journal of Molecular Sciences, 12, 3705. 
Kamimura, K.; Suda, T.; Guisheng, Z.; Dexi, L. (2011). Advances in Gene 
Delivery Systems, Pharmaceutical Medicine - New Zealand, 25, 293. 
  
 
NANO-SYSTEMS FOR GENE DELIVERY 33 
 
Kaneko, Y.; Matsuda, S.I.; Kadokawa, J.I. (2007). Chemoenzymatic synthesis of 
amylose-grafted chitin and chitosan, Biomacromolecules, 8, 3959. 
Kaufman, Y.; Grinberg, S.; Linder, C.; Heldman, E.; Gilron, J.; Freger, V. (2013). 
Fusion of bolaamphiphile micelles: A method to prepare stable 
supported biomimetic membranes, Langmuir, 29, 1152. 
Kay, M.A.; Glorioso, J.C.; Naldini, L. (2001). Viral vectors for gene therapy: the 
art of turning infectious agents into vehicles of therapeutics, Nature 
Medicine, 7, 33. 
Kay, M.A. (2011). State-of-the-art gene-based therapies: The road ahead, 
Nature Reviews Genetics, 12, 316. 
Kiang, T.; Wen, J.; Lim, H.W.; Leong, K.W.K.W. (2004). The effect of the degree 
of chitosan deacetylation on the efficiency of gene transfection, 
Biomaterials, 25, 5293. 
Kiem, H.-P.; Jerome, Keith R.; Deeks, Steven G.; McCune, Joseph M. (2012). 
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease, Cell 
Stem Cell, 10, 137. 
Kim, S.U.; de Vellis, J. (2009). Stem cell-based cell therapy in neurological 
diseases: A review, Journal of Neuroscience Research, 87, 2183. 
Kim, T.-H.; Jiang, H.-L.; Jere, D.; Park, I.-K.; Cho, M.-H.; Nah, J.-W.; Choi, Y.-J.; 
Akaike, T.; Cho, C.-S. (2007). Chemical modification of chitosan as a 
gene carrier in vitro and in vivo, Progress in Polymer Science, 32, 726. 
Kissa, E.; Fluorinated Surfactants: Synthesis, Properties, Applications, Vol. 50, 
Marcel Dekker, United States of America, 1994. 
Klein, E.; Ciobanu, M.; Klein, J.; MacHi, V.; Leborgne, C.; Vandamme, T.; Frisch, 
B.; Pons, F.; Kichler, A.; Zuber, G.; Lebeau, L. (2010). "HFP" fluorinated 
cationic lipids for enhanced lipoplex stability and gene delivery, 
Bioconjugate Chemistry, 21, 360. 
  
 
34 NANO-SYSTEMS FOR GENE DELIVERY 
 
Krafft, M.P.; Riess, J.G. (1998). Highly fluorinated amphiphiles and colloidal 
systems, and their applications in the biomedical field. A 
contribution, Biochimie, 80, 489. 
Krafft, M.P. (2001). Fluorocarbons and fluorinated amphiphiles in drug 
delivery and biomedical research, Advanced Drug Delivery Reviews, 
47, 209. 
Krafft, M.P.; Goldmann, M. (2003). Monolayers made from fluorinated 
amphiphiles, Current Opinion in Colloid & Interface Science, 8, 243. 
Laouini, A.; Charcosset, C.; Fessi, H.; Holdich, R.G.; Vladisavljevic, G.T. (2013). 
Preparation of liposomes: a novel application of microengineered 
membranes - investigation of the process parameters and application 
to the encapsulation of vitamin E, RSC Advances, 3, 4985. 
Leal, C.; Moniri, E.; Pegado, L.; Wennerstrom, H. (2007). Electrostatic 
attraction between DNA and a cationic surfactant aggregate. The 
screening effect of salt, Journal of Physical Chemistry B, 111, 5999. 
Leese, P.T.; Noveck, R.J.; Shorr, J.S.; Woods, C.M.; Flaim, K.E.; Keipert, P.E. 
(2000). Randomized safety studies of intravenous perflubron 
emulsion. I. Effects on coagulation function in healthy volunteers, 
Anesthesia and Analgesia, 91, 804. 
Leventis, R.; Silvius, J.R. (1990). Interactions of mammalian cells with lipid 
dispersions containing novel metabolizable cationic amphiphiles, 
Biochimica et Biophysica Acta (BBA) - Biomembranes, 1023, 124. 
Li, C.; Bowles, D.E.; van Dyke, T.; Samulski, R.J. (2005). Adeno-associated virus 
vectors: potential applications for cancer gene therapy, Cancer Gene 
Therapy, 12, 913. 
Li, D.; Li, P.; Li, G.; Wang, J.; Wang, E. (2009). The effect of nocodazole on the 
transfection efficiency of lipid-bilayer coated gold nanoparticles, 
Biomaterials, 30, 1382. 
  
 
NANO-SYSTEMS FOR GENE DELIVERY 35 
 
Li, D.; Li, G.; Li, P.; Zhang, L.; Liu, Z.; Wang, J.; Wang, E. (2010). The 
enhancement of transfection efficiency of cationic liposomes by 
didodecyldimethylammonium bromide coated gold nanoparticles, 
Biomaterials, 31, 1850. 
Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. (2008). Polysaccharides-based 
nanoparticles as drug delivery systems, Advanced Drug Delivery 
Reviews, 60, 1650. 
Lonez, C.; Vandenbranden, M.; Ruysschaert, J.-M. (2008). Cationic liposomal 
lipids: From gene carriers to cell signaling, Progress in Lipid Research, 
47, 340. 
Luo, D.; Saltzman, W.M. (2000). Synthetic DNA delivery systems, Nature 
Biotechnology, 18, 33. 
Manfredsson, F.P.; Mandel, R.J. (2010). Development of gene therapy for 
neurological disorders, Discovery medicine, 9, 204. 
Mansouri, S.; Lavigne, P.; Corsi, K.; Benderdour, M.; Beaumont, E.; Fernandes, 
J.C. (2004). Chitosan-DNA nanoparticles as non-viral vectors in gene 
therapy: strategies to improve transfection efficacy, European Journal 
of Pharmaceutics and Biopharmaceutics, 57, 1. 
Mao, S.; Sun, W.; Kissel, T. (2010). Chitosan-based formulations for delivery of 
DNA and siRNA, Advanced Drug Delivery Reviews, 62, 12. 
Masotti, A.; Ortaggi, G. (2009). Chitosan Micro- and Nanospheres: Fabrication 
and Applications for Drug and DNA Delivery, Mini-Reviews in 
Medicinal Chemistry, 9, 463. 
Mathew, M.E.; Mohan, J.C.; Manzoor, K.; Nair, S.V.; Tamura, H.; Jayakumar, R. 
(2010). Folate conjugated carboxymethyl chitosan-manganese doped 
zinc sulphide nanoparticles for targeted drug delivery and imaging of 
cancer cells, Carbohydrate Polymers, 80, 442. 
  
 
36 NANO-SYSTEMS FOR GENE DELIVERY 
 
Meister, A.; Weygand, M.J.; Brezesinski, G.; Kerth, A.; Drescher, S.; Dobner, B.; 
Blume, A. (2007). Evidence for a Reverse U-Shaped Conformation of 
Single-Chain Bolaamphiphiles at the Air−Water Interface, Langmuir, 
23, 6063. 
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Chapter 3 
3. Interaction of DNA with lipid 
monolayers 
Interfacial research investigates the thermodynamics of the adsorption 
layers at the liquid interface in order to better understand the equilibrium 
process at the surface of liquids or at the interface between two liquids 
(Fainerman, 1998). Mixed monolayers of insoluble lipids usually present 
deviations to the Langmuir adsorption isotherm and the equation of state for 
adsorption layers, due to different molar area values. Also the ability for 
reorientation and aggregation of some lipids interferes with the fluid state of 
the monolayers (Fainerman, 1998). 
The application of emerging technology with high resolutions at the 
nanoscale level allows a deeper study of the thermodynamics involved in the 
interfacial equilibrium through Langmuir monolayers. Techniques as pressure-
area isotherms, surface potential, Brewster angle microscopy (BAM) and 
infrared reflection-absorption spectroscopy (IRRAS) were used to study 
interactions in two-dimensional arrangements of amphiphilic molecules 
(Buschow, 2001; Butt, 2006; Maltseva, 2005). These methods allow a 
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considerable knowledge on interactions between different species, their 
molecular orientation and defects, the shape and texture of the domains and 
the two-dimensional lattice structure. These techniques are also used to 
mimic the binding of polyelectrolytes to the interface (peptides, proteins, 
DNA) and to simulate enzymatic reactions at the membrane surfaces 
(Brezesinski, 2003).  
The study using Langmuir monolayers provided information about the 
lipid mixtures, DOTAP and cholesterol or fluorinated cholesterol that was 
useful for the studies with liposomes. A comparative study between 
cholesterol and fluorinated cholesterol as the helper lipids in DOTAP systems 
was performed using Langmuir monolayer studies (Gromelski, 2006; Symietz, 
2004). Pressure-area isotherms, surface potential and Brewster angle 
microscopy measurements were carried out to gain information about 
molecular distribution and mixing behaviour of the lipids in the monolayer. 
The DNA adsorption process at the monolayer interface was studied by 
vibrational spectroscopy (Brezesinski, 2003). DNA is expected to adsorb from 
the subphase to the interface due to electrostatic forces and to induce 
changes in the density and composition of the interface layer, which is 
detected by infrared reflection absorption spectroscopy (Gromelski, 2006). 
3.1. Lipid Monolayer experiments 
3.1.1. Chemicals 
DOTAP (1,2-dioleoyl-3-trimethylammonium-propane, chloride salt, 
MW 698.542), cholesterol (ovine wool, > 98%, MW 386.355) and F7-
cholesterol (25,26,26,26,27,27,27-heptafluorocholesterol, MW 512.587) 
(Figure 3.1) were purchased from Avanti Polar Lipids, Inc. Salmon testes DNA 
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and PBS (phosphate buffered saline: 0.01 M phosphate buffer, 0.0027 M 
potassium chloride and 0.137 M sodium chloride, pH 7.4) were purchased 
from Sigma-Aldrich. The deionised water was purified with Milli-Q apparatus 
with the specific resistance of 18.2 MΩ∙cm. Chloroform (Merck) was used to 
dissolve the lipids. 
 
3.1.2. Pressure/area Isotherms 
The early research on Langmuir monolayers stated that different two-
dimensional phases exist or co-exist. Monolayer phases are classified in 
gaseous (G), Liquid-expanded (LE), Liquid-condensed (LC) and solid (S), as 
visible in Figure 3.2. The monolayer compressibility varies according to the 
sequence G>LE>LC>S, and it is determined by measuring the surface pressure-
 
 
DOTAP  
 
  Cholesterol  Heptafluorocholesterol 
 
Figure 3.1. Chemical structures of DOTAP, CHOL (cholesterol) and F7-CHOL 
(heptafluorocholesterol). 
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molecular area (π-A) isotherms under equilibrium conditions (Vollhardt, 
2006).  
 
The lateral surface pressure π of the monolayer is the difference 
between the surface tension (γ) of pure water (72.8 mN/m at 20°C) and water 
covered with monolayer (Gromelski, 2004; 2006): 
  = :	
 − :
	 (3.1) 
The surface pressure is a measurement of the cohesive energy present 
at the interface. The lipid molecules will interact with each other through 
attractive and repulsive forces (Freire, 2007). The air/water interface 
possesses an excess of free energy from the difference in environment 
between the surface molecules and those in the bulk. This interfacial free 
energy is responsible for the surface tension. The surface pressure-area 
isotherms were recorded using a PTFE Langmuir film balance system (Riegler 
& Kirstein, Potsdam, Germany), represented on Figure 3.3. 
 
 
 
Figure 3.2. Representative phases of a surface pressure-area isotherm of a 
Langmuir monolayer. 
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Monolayers of DOTAP, cholesterol, F7-cholesterol or their mixtures 
were obtained by spreading the solution of lipids in chloroform at a 
concentration of 1 mM on the buffer surface (PBS buffer or PBS containing 0.1 
mg/mL of DNA). The surface tension was determined with a continuous 
Wilhelmy-type pressure measuring system using a 10 mm wide filter paper as 
plate. The monolayers were compressed at a constant velocity of 5 
Å2/molecule/min and at a temperature of (20 ± 1)°C. The average area per 
molecule A of an ideal mixture was calculated by the additivity relationship 
considering the molar fraction X of each component,  
 A= X1A1 + X2A2  (3.2) 
3.1.3. Surface Potential 
Cells need an electric field and concentration profiles of ions in the 
proximity of their membranes to exist. These parameters are described by the 
classical Gouy-Chapman (GC) model of electrical double layer (EDL). However 
 
 
 
Figure 3.3. Langmuir film balance system. 
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deviations from that rule happen in non-homogeneously charged surfaces, 
like the lipid water interface of many mixtures (Shapovalov, 2006). 
Surface potential experiments provide additional information on the 
packing and orientation of the lipid molecules at the monolayer. The potential 
of the surface is read as a function of the area per molecule and depends on 
the monolayer phase. At larger areas per molecule the surface potential is 
close to zero. It remains constant till a critical area is reached on compression, 
increasing or decreasing depending on the charge of the lipids in study 
(Oliveira, 1997). These critical areas normally coincide with the increase of the 
surface pressure values on Langmuir isotherms, indicating that the monolayer 
become more structured than before, due the compression effect. 
Surface potential measurements were recorded using a homemade 
device (V. L. Shapovalov, Institute of Chemical Physics, RAS, Moscow, Russia) 
that combines a Kelvin probe sensor and a Wilhelmy plate in order to record 
at the same time the surface potential and the surface pressure isotherm. 
Briefly, a 250 x 100 x 8 mm3 Teflon trough with a single barrier (asymmetric 
compression) contains a gold-plated electrode of 10 mm diameter that 
vibrates at ca. 80 Hz. The reference electrode was made of Ag/AgCl 
(Shapovalov, 2006). Surface potential and surface pressure was set to zero 
before spreading the monolayer onto the subphase and the results are 
recorded at the same conditions described above. Final surface potential data 
were referenced to the surface potential of a subphase without the 
monolayer. 
3.1.4. Brewster Angle Microscopy (BAM) 
BAM technique was first developed to clarify the structural 
characteristics of amphiphilic substances at the air-water interface.  It 
provides information on the morphology of the monolayers including the 
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inner structure of the formed domains as well as heterogeneities in thin films 
(Melzer, 1997). Inhomogeneities on the monolayer can be from lipid density 
variation at the water surface (Symietz, 2004).  
A clean and perfect interface between two media with different 
refractive index has no reflection if it is illuminated by parallel (p)-polarised 
light under a unique angle of incidence, called Brewster angle (α). For the 
air/water interface, the Brewster angle is 53.1° (Henon, 1991; Kaercher, 
1993). The formation of a thin film with a different refractive index changes 
the optical status that is now reflecting the light and producing an image of 
the monolayer (Rodríguez Patino, 1999). The occurrence of domains with 
higher molecular densities will reflect the light and be visible as brighter areas 
compared with the dark background of the water surface. 
The system used is available commercially (BAM2, Nanofilm 
Technology Ltd., Germany; 20 mW laser, wavelength 514 nm, resolution 3 
μm) and consists of a CCD camera that detects the p-polarised light of the 
diode laser reflected from the surface for film characterisation. The Brewster 
angle for air-water interface is 53.1°. The recorded images were analysed with 
the existing software and corrected for the perspective of observation under 
the Brewster angle with a spatial resolution of about 2 µm. 
3.1.5. Infrared Reflection Absorption 
Spectroscopy (IRRAS) 
Infrared reflection absorption spectroscopy of lipid monolayers at the 
air/water interface contributes with unique molecular structure and 
orientation information from the film compounds. Parameters as lipid chain 
conformation, tilt angle and presence of DNA molecules at the interface could 
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be determined with this technique via changes in vibrational frequencies 
(Brezesinski, 2003; Gromelski, 2004). 
IRRAS is based on the observation that when mid-IR radiation reaches 
the aqueous monolayers, a fraction of the light is reflected from the molecular 
compounds of the thin film at the surface. Light in a well-defined polarisation 
state, either parallel (p-polarised) or perpendicular (s-polarised) to the plane 
of incidence, impinges onto the surface at a well-defined and controlled angle 
of incidence, which is reflected and detected at the same angle (Mendelsohn, 
2010). Table 3.1 shows some of the more important Mid-IR group frequencies 
of phospholipids and DNA (Banyay, 2003; Blume, 1996; Gromelski, 2006). 
 
 
 
 
 
Wavenumber 
(cm
-1
) 
Symbol Description 
DNA characteristic bands 
1720-1710 ν(C=O) DNA base pairing 
1225-1220 νas(PO2
-) Asymmetric PO2
- stretching (B form) 
1090-1085 νs(PO2
-) Symmetric  PO2
- stretching of  backbone (A/B form) 
1069-1044 ν(C-O) C-O stretching of backbone 
970 ν(C-C) C-C stretching of backbone (B form) 
Phospholipid characteristic bands 
3400-3700 ν(O-H) H-O-H stretching 
2925 νas(CH2) Asymmetric CH2 stretching (LE phase) 
2918 νas(CH2) Asymmetric CH2 stretching (LC phase) 
2855 νs(CH2) Symmetric CH2 stretching (LE phase) 
2849 νs(CH2) Symmetric CH2 stretching (LC phase) 
1740 ν(C=O) C=O stretching 
 
 
Table 3.1. More common Mid-IR group frequencies of phospholipids and DNA 
(Banyay, 2003; Blume, 1996; Gromelski, 2006). 
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IRRAS spectra were recorded using an IFS 66 FTIR spectrometer 
(Bruker, Germany) equipped with a liquid nitrogen cooled MCT detector. The 
spectrometer was coupled to a Langmuir film balance, placed in a sealed 
container, to guarantee a constant water vapour atmosphere. The IR beam 
was focused on the water surface of the Langmuir trough at an angle of 
incidence equal to 40° and was polarised vertically (s) using a KRS-5 (thallium 
bromide and iodide mixed crystal) wire grid polariser. FTIR spectra were 
collected at 8 cm-1 resolution with 400 scans and subtracted from the 
spectrum of the reference trough (PBS buffer). The waiting time for DNA 
adsorption was the same in all experiments and was 1 hour (Gromelski, 2006).  
 
3.2. Results and Discussion 
3.2.1. DOTAP/F7-cholesterol monolayers 
The surface pressure-area (π-A) isotherm of DOTAP on phosphate 
buffered saline (PBS) is characteristic of a liquid-expanded phase and has an 
initial pressure increase at 105 Å2/molecule. The addition of cholesterol 
(CHOL) or F7-cholesterol (F7-CHOL) to DOTAP (chemical structures shown in 
Figure 3.1) at 1:1 ratio leads to the same overall liquid-expanded phase 
behaviour with a decrease in the area per molecule (Figure 3.4). The 
isotherms of the pure CHOL monolayer and the pure F7-CHOL monolayer on 
PBS buffer are identical and are characteristic of a condensed phase, showing 
small changes in average molecular area with increasing surface pressure. The 
initial increase is at 55 Å2/molecule and their limiting area A0 (extrapolation of 
the linear part of the isotherm to π = 0) is 40 Å2/molecule. The lateral 
interactions between DOTAP and the sterols were analysed by calculating the 
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average area per molecule within the mixed monolayer as a function of lipid 
concentration at the surface pressures of 5 and 35 mN/m (Table 3.2). A 
negative deviation to the ideal mixing or complete demixing is observed 
experimentally, particularly at 5 mN/m, supporting the condensing effect of 
the sterols. BAM analysis of DOTAP/CHOL 1:1 shows domains at surface 
pressures below 15 mN/m, which disappear completely when the pressure 
reaches 20 mN/m (Figure 3.4).  
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Figure 3.4. Pressure-area isotherms of monolayers of DOTAP, cholesterol 
(CHOL), F7-cholesterol (F7-CHOL), DOTAP/cholesterol 1:1 mixture 
(DOTAP/CHOL) and DOTAP/F7-cholesterol 1:1 mixture (DOTAP/F7-CHOL) on PBS 
buffer and of DOTAP/F7-cholesterol 1:1 mixture on 0.1 mg/mL of DNA dissolved 
in PBS. Brewster angle microscopy images of the mixtures of DOTAP and the 
sterols at different surface pressures are also shown. 
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The domains have well-defined shapes. DOTAP/F7-CHOL mixture 
forms domains only at π = 0 mN/m, demonstrating that their miscibility is not 
complete, but the monolayer is homogeneous immediately when the surface 
pressure is increased (Figure 3.4).  In the case of DOTAP/CHOL 1:1 monolayer 
a demixing is observed indicating a miscibility gap between two liquid phases: 
liquid-disordered with more DOTAP and liquid-ordered with more CHOL. The 
isotherms are not sensitive enough to distinguish between these two phases 
because the difference in the molecular area must be very small and will even 
decrease on increasing pressure because the upper critical miscibility point 
will be approached. This is a phase diagram very similar to the one observed 
for 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/CHOL system 
(Okonogi, 2004; Wagner, 2008). In the case of DOTAP/F7-CHOL there is only a 
liquid-ordered phase. 
Coupling of DNA to DOTAP or mixtures of DOTAP and the sterols (1:1 
ratio) leads to the expansion of the monolayers, indicating a partial 
penetration of the DNA (isotherm shown for the DOTAP/F7-CHOL case, Figure 
 
 
 
 
Lipid Monolayer Am (Å
2) Calculated Am (Å
2) ∆V (mV) 
π = 5 mN/m 35 mN/m 5 mN/m 35 mN/m 35 mN/m 
DOTAP 88.3 57.7  - - + 560 
CHOL 39.8 35.3  - - + 430 
DOTAP/CHOL 1:1 57.2  42.0  64.1 46.5 + 540 
F7-CHOL 40.5 36.4  - - − 620 
DOTAP/F7-CHOL 1:1 55.6 42.3 64.4 47.1 + 20 
 
 
Table 3.2. Average molecular area (Am) and surface potential (∆V) of the lipid 
monolayers at constant surface pressures. 
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3.4). The molecular areas in the monolayers are larger when DNA is in the 
subphase. This might be due to an expanding effect of adsorbed DNA. This 
shift to larger molecular areas is observed at all pressures studied showing 
that partially penetrated DNA is not squeezed-out by compression. As shown 
in a previous study, the amount of adsorbed DNA increases with increasing 
electrolyte concentration up to physiological values (Shapovalov, 2010). This 
has been explained by the fact that the ionic atmosphere around a 
macromolecule becomes more compact and stable with increasing ionic 
strength. For this reason, the reduction of the effective charge requires larger 
amounts of DNA for the compensation of the overall monolayer charge.  
The surface potential (ΔV) of DOTAP monolayers on PBS buffer is 
positive and increases gradually with pressure as it is described for 
phospholipids in the fluid phase, which is attributed to an increase in 
molecular density (Figure 3.5) (Miller, 1987; Möhwald, 1995).  
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Figure 3.5. Surface potential isotherms of monolayers of DOTAP, cholesterol 
(CHOL), F7-cholesterol (F7-CHOL), DOTAP/cholesterol 1:1 (DOTAP/CHOL) and 
DOTAP/F7-cholesterol 1:1 (DOTAP:F7-CHOL) on PBS buffer. 
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Condensed CHOL monolayers show a positive ΔV whereas the 
potential of F7-CHOL monolayers for similar surface pressures is highly 
negative, comparably to that observed for amphiphiles with perfluorocarbon 
chain (Figure 3.5 and Table 3.2) (Andreeva, 2008; Shibata, 1996). The mixtures 
of DOTAP and the sterols show that the ΔV lies between the values of the 
pure lipid monolayers (Table 3.2). The ΔV of DOTAP/CHOL 1:1 monolayers is 
highly positive whereas that of DOTAP/F7-CHOL 1:1 is close to zero (Figure 3.5 
and Table 3.2).  
The sterols increase the structural order of the DOTAP hydrocarbon 
acyl chains by stabilising forces (hydrogen bonding and van der Waals 
attraction) and lead to an increase in the packing density of the monolayer. 
The condensing effect of CHOL on fluid monolayers has been known for a long 
time (Demel, 1967; Leathes, 1925; Stockton, 1976). Although the process by 
which CHOL induces this effect is not completely understood, it has recently 
been suggested that the molecule maximises the hydrocarbon contacts, 
minimising the contact of lipophilic groups with the aqueous phase and forms 
a contiguous hydrophilic surface (template model) (Daly, 2011). The 
fluorination of the CHOL tail does not induce significant changes on this 
condensing effect (Kauffman, 2000). This indicates that the attractive 
interaction between DOTAP and the fluorinated CHOL is not affected by the 
lipophobicity character of CF3 groups (O'Hagan, 2008) and most likely depends 
on the head group and on the sterol ring. This relates also to the fact that the 
molecular areas of CHOL and F7-CHOL monolayers are comparable, which 
strongly suggests that they orient similarly in a vertical way at the interface 
throughout compression with the OH group towards the polar interface 
(Kauffman, 2000). The ΔV of a charged monolayer results from different 
contributions. The dipole moments of the lipid molecules, µ⊥,m (vertical 
component of the molecular dipole moment), the change in orientation of the 
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water molecules at the monolayer-subphase interface, the type of charges in 
the head groups and the counter charges in the subphase (diffuse layer 
potential): 
 ∆V =
µ⊥,m
ε ⋅ε0 ⋅A
+ψ  (3.9) 
where ε0 is the absolute permittivity of vacuum, ε  is the relative permittivity 
of the monolayer considering the contributions of the hydrocarbon chains, 
polar heads and hydration water, A is the area per molecule, ψ  is the diffuse 
double layer contribution (that can be calculated by the Gouy–Chapman–
Stern theory) (Miller, 1987; Möhwald, 1995; Oliveira, 1997; Truzzolillo, 2008). 
The surface pressure values are given with respect to the free water (buffer) 
surface, hence the influence of water molecules can be excluded. Besides 
opposite signs, similar absolute potential values have been measured for the 
same hydrophilic group but different chains (fluorinated or hydrocarbon) 
excluding the predominance of the water structure on the potential (Miller, 
1987). DOTAP is fully charged at pH 7.4 (Zuidam, 1997). The ΔV value of 
DOTAP monolayer is thus a result of the double-layer potential and the dipole 
moments of the molecules (Bordi, 2006; Truzzolillo, 2008). The polarisation of 
the carbonyl groups may largely contribute to the positive values of ΔV 
(inferred by studies with phospholipid monolayers, either non-ionic or 
negatively charged) considering the molecular arrangement in which the 
oxygen is deeper in the subphase than the carbon atom yielding to the correct 
polarity (orientation of the dipoles with negative ends toward the water) 
(Miller, 1987; Möhwald, 1995). In addition, a contribution from the methyl 
groups terminating the aliphatic tails has to be taken into account (Möhwald, 
1995; Vogel, 1988). For uncharged monolayers, only the dipole moments 
contribute to the ΔV and for CHOL monolayers the positive values can be 
attributed to the dipole moment of the C-OH (C3) group (Kauffman, 2000). 
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The presence of CHOL in DOTAP monolayers only slightly decreases the ΔV 
value when compared to pure DOTAP (Table 3.2). The dipole potential varies 
inversely with molecular area and dielectric constant. CHOL decreases the 
molecular area of DOTAP monolayer and it is known to reduce the dielectric 
constant of the membrane interface (Haldar, 2012). On the other hand, the 
surface potential of the charged monolayer also depends directly on the 
diffuse layer potential, which is proportional to the charge density at the 
interface (Truzzolillo, 2008), which is lower in the case of DOTAP/CHOL 
monolayers. The highly negative dipole moment for F7-CHOL monolayers 
results from the polarisation of the fluorinated side chain (Kauffman, 2000). 
Fluorination of terminal methyl group or the upper part of hydrocarbon 
chains of lipids results in negative dipoles at the monolayer-air boundary, due 
to the preferred orientation of the hydrophobic CF3 group toward air (Bernett, 
1963; Fox, 1957; McIntosh, 1996; Vogel, 1988). The surface potential 
oscillations observed for F7-CHOL are probably due to the fact that in the 
coexistence region of a 2D-gas and a condensed monolayer, the monolayer is 
not homogeneous and the measured values strongly depend on particular 
experimental conditions (Shapovalov, 2006). The dipole moment of F7-CHOL 
most likely cancels partly that of DOTAP leading to an overall ΔV close to zero 
for the two-component monolayer (Table 3.2).  
3.2.2. DNA interaction with DOTAP/F7-
cholesterol monolayers 
IRRA spectra of the monolayers of DOTAP and DOTAP mixed with 
sterols on 0.1 mg/mL of salmon testes DNA in PBS buffer also showed 
adsorption of DNA to the interface, indicated by the presence of the 
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characteristic band at 970 cm-1 (spectra shown for surface pressures of 35 
mN/m, Figure 3.6.a).  
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Figure 3.6. Different regions of the IRRAS spectra of monolayers of (1) DOTAP, 
(2) DOTAP/F7-cholesterol 1:1, (3) F7-cholesterol, (4) DOTAP/cholesterol 1:1 and 
(5) cholesterol on PBS buffer (dashed line) and on 0.1 mg/mL DNA dissolved in 
PBS buffer (solid line) subphases. Different regions of the IRRA spectra are 
presented in separate plots and the spectra are offset for clarity: DNA marker 
bands (a), CH2 stretching vibrations (b), and OH stretching band (c). The surface 
pressure is in all cases 35 mN/m. 
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The region between 900 and 1800 cm-1 is rich in DNA marker bands 
(Dittrich, 2011). The band at 970 cm-1 is caused by 2´endo deoxyribose 
conformation of the DNA backbone. In the 1000-1250 cm-1 region, one can 
see the vibrations of phosphate groups. The band at 1223 cm-1 corresponds to 
the phosphate group asymmetric stretching, while the band at 1088 cm-1 is 
given by the symmetric stretching. For DOTAP/F7-CHOL mixtures the 
characteristic band of C-F stretching of pure F7-CHOL at 1223 cm-1 can 
interfere with the asymmetric band from the phosphate group of DNA, but 
the increase in that band is clearly evident when DNA is in the subphase. The 
region between 3000 and 3800 cm-1 gives information about surface layer 
thickness through the OH stretching vibration band (Dopico, 2007). The 
intensity of OH stretching vibration band increases in the presence of DNA, 
indicating an increase in surface layer thickness. The DOTAP head group is 
positively charged at pH 7.4, which enables the electrostatic interaction with 
DNA even in the presence of other salt ions. The symmetric and asymmetric 
CH2-valence vibrations (bands between 2850 and 2920 cm
-1) provide 
qualitative information about hydrocarbon chain conformation (Macphail, 
1984; Snyder, 1982). The monolayers of DOTAP and of its mixture with sterols 
exhibit a high amount of gauche conformers because CH2 symmetric and 
asymmetric stretching bands are at 2854 and 2924 cm-1, respectively (Figure 
3.6.b). These values are in accordance with a liquid-expanded phase and do 
not change on compression (Table 3.3). The adsorption of DNA at the 
interface does not induce significant changes on the phase state of the 
monolayers.  
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CHOL has the CH2 symmetric stretching band at 2850 cm
-1, indicating 
an all-trans conformation (condensed phase). The same is valid for F7-CHOL 
CH2 stretching bands. The CH2 asymmetric stretching band is not considered 
in this case since it contains significant overlapping contributions from methyl 
groups (Lewis, 1998). In the case of pure CHOL and F7-CHOL monolayers, DNA 
is not detected at the interface. From direct observation of the intensity of the 
symmetric stretching band of the phosphate group (1088 cm-1) of DNA it is 
possible to perform a comparison of the different systems. When the amount 
of positively charged lipids decreases, a decreasing in the amount of absorbed 
DNA is visible. This decrease of the band intensity is more noticeable for the 
mixture of DOTAP and F7-CHOL. The difference in OH-band intensities around 
3600 cm-1 between DOTAP, DOTAP/CHOL and DOTAP/F7-CHOL also indicates 
a smaller amount of adsorbed DNA for the mixture with the fluorinated 
cholesterol.  
 
 
  
 
Lipid Monolayer on PBS or DNA/PBS 
νsCH2 (cm
-1) 
π=5 mN/m 35 mN/m 
DOTAP 2854 2854 
CHOL 2850 2850 
DOTAP/CHOL 1:1 2854 2854 
F7-CHOL 2850 2850 
DOTAP/F7-CHOL 1:1 2854 2854 
 
 
 
Table 3.3. Symmetric CH2 vibration band of the lipid monolayers obtained by 
IRRAS. 
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3.3. Conclusions 
The use of F7-CHOL as the helper lipid in cationic non-viral gene 
vectors is proposed. The effect of this neutral lipid on the structure of 
monolayers formed by the cationic lipid DOTAP was studied and compared 
with that of CHOL. Both isotherms and IRRAS results demonstrate that the 
mixtures of DOTAP and the sterols (1:1 molar ratio) are in the liquid expanded 
state. The mixtures appeared homogeneous at pressures between 30-35 
mN/m, which is considered the lateral pressure in liposomes and will have 
implications for the ability of the lipoplexes formed by these lipids to 
condense DNA. F7-CHOL and CHOL induce a condensing effect on DOTAP 
monolayers but BAM showed that CHOL is less miscible with DOTAP than F7-
CHOL. CHOL and F7-CHOL orient similarly in a vertical way at the interface 
throughout compression with the OH group towards the polar interface, as 
concluded from the surface potential measurements and molecular areas. 
From IRRAS results, it is possible to conclude that a smaller amount of DNA is 
adsorbed at DOTAP/F7-CHOL monolayers when compared with DOTAP/CHOL. 
Since the isotherms of the mixtures show very similar molecular areas, similar 
charge densities are expected in the mixed monolayers. The only possible 
explanation for the moment is a different miscibility behaviour between 
DOTAP and CHOL or F7-CHOL, respectively. If CHOL is less miscible with 
DOTAP, more patches containing different amounts of CHOL and therefore 
different charge densities are expected. This is in line with the BAM 
experiments showing a homogeneous DOTAP/F7-CHOL monolayer at any 
lateral pressure above zero. This leads to a homogeneous monolayer with a 
smaller charge density compared to that of the DOTAP/CHOL mixtures, which 
shows the coexistence of cholesterol-rich and cholesterol-poor domains up to 
20 mN/m, indicating the coexistence of patches with higher or smaller charge 
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densities in the mixed monolayer. The patches with the higher charge density 
are responsible for the attraction of a larger amount of DNA. According to 
these results, F7-CHOL and DOTAP are completely miscible, and DNA adsorbs 
to this mixed monolayer even at ionic strength close to the physiological 
values, thus F7-CHOL is a promising candidate for the preparation of gene 
delivery vectors. 
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 Chapter 4 
4. Compaction process of DNA 
by fluorinated liposomes 
Numerous cationic lipids have been synthesised and tested for gene 
delivery in cell cultures, animal models and patients who take part in clinical 
trials (Morille, 2008; Zhu, 2010). Gene therapy uses plasmid DNA or cellular 
RNA interference machinery to turn off gene expression in cancer cells or 
other diseased cells (Aagaard, 2007; Morille, 2008). The use of naked nucleic 
acids is limited by the presence of serum nucleases and thus it is only valid for 
direct injection of the macromolecule on tissues that are easily accessible 
such as skin and muscle (Morille, 2008). These lipids are usually used for gene 
delivery in the form of liposomes that are complexed with DNA through 
electrostatic interactions. The toxicity of these complexes, named lipoplexes, 
is related to the charge ratio between the cationic liposomes and DNA plus 
the dose that is administered (Lv, 2006). Also, the toxicity of such systems in 
cell cultures is attributed to the free liposomes present in the mixture, as the 
separate components of the lipoplexes do not show any toxicity when 
injected in mice models (Xu, 1999). Thus the study of the interaction between 
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liposomes and nuclei acids as well as the physicochemical characterisation of 
such complexes is critical for the development of novel DNA vectors. 
The use of fluorinated cholesterol as helper lipid in DOTAP liposomes is 
described and their colloidal properties are compared with that of 
DOTAP:cholesterol liposomes (Crook, 1998). When administered 
intravenously, cationic liposome–DNA complexes are rapidly cleared from the 
bloodstream (Audouy, 2002). Fluorinated liposomes have the advantage of 
long-term self-stability (Ravily, 1997). Their half-live time in the blood stream 
is similar to pegylated liposomes (Santaella, 1993). Although fluorinated 
systems seem to have high transfection potency, their use as gene vectors is 
still poorly explored (Boulanger, 2004; Gaucheron, 2001b; Gaucheron, 2002). 
In this work, liposomes of mixtures of DOTAP and heptafluorocholesterol 
were produced and used to form complexes with DNA, which were 
characterised experimentally by measurements of hydrodynamic diameter, 
electrophoretic mobility, fluorescence and turbidity. The compaction of DNA 
by fluorinated liposomes was also theoretically analysed by a 
phenomenological theory addressed by Nguyen and Shklovskii (Nguyen, 
2001a; b). This theory provides phase diagrams of the systems including the 
charge inversion and re-entrant condensation processes among the 
lipoplexes. These phase diagrams contain information about the liposome and 
DNA concentration necessary to have either anionic or cationic isolated 
lipoplexes or clusters of lipoplexes. By predicting them, it is possible to know 
the optimum values of DNA and liposome concentrations for an efficient 
transfection from a physicochemical standpoint. 
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4.1. Experimental details 
4.1.1. Chemicals 
DOTAP (1,2-dioleoyl-3-trimethylammonium-propane, chloride salt, 
MW 698.542), cholesterol (ovine wool, > 98%, MW 386.355) and F7-
cholesterol (25,26,26,26,27,27,27-heptafluorocholesterol, MW 512.587) 
(Figure 3.1) were purchased from Avanti Polar Lipids, Inc. DNA 
(Deoxyribonucleic acid sodium salt from calf thymus, type I), Hepes buffer (4-
(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid, ≥ 99.5%), Tris buffer (2-
amino-2-(hydroxymethyl)-1,3-propanediol, ≥ 99.9%) and the probe ethidium 
bromide (EtBr, 3,8-Diamino-5-ethyl-6-phenylphenanthridinium bromide, ≥ 
95.0%) were supplied by Sigma-Aldrich. The deionised water was purified with 
Milli-Q apparatus with the specific resistance of 18.2 MΩ∙cm. Chloroform was 
from Merck. 
4.1.2. Preparation of Liposomes, DNA 
solution and lipoplexes 
Liposomes were prepared by the thin lipid film hydration method 
(Figure 4.1) (Palmerini, 2006; Sharma, 1997). Briefly, the appropriate lipid 
mixture (DOTAP:cholesterol or DOTAP:F7-cholesterol 1:1 molar ratio) was 
dissolved in chloroform, which was then evaporated under vacuum using a 
rotating apparatus. 
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The lipid film was hydrated with 10 mL of 10 mM Hepes buffer pH 7.4 
(ionic strength 0.00325 M). The suspension was vortexed for 15 minutes and 
extruded through Whatman filters of decreasing sizes (up to 100 nm pore size 
membranes) using a pressure extruder apparatus. The total lipid 
concentration was 5 mM. DNA was dissolved in 10 mM Hepes buffer at a 
concentration of 1 mg/mL (stock solution), which was kept at 4°C under 
magnetic stirring for at least 1 day. Liposome-DNA complexes were prepared 
by adding equal volumes of DNA solution at a constant concentration (final 
concentration was 0.05 mg/mL) and liposome suspension at different 
concentrations (final concentrations ranging from 0.05 and 0.50 mg/mL). DNA 
solution was added drop wise to the liposomes and the mixture was kept 
under magnetic stirring for at least 15 minutes.  
4.1.3. Dynamic light scattering 
Light scattering effects are an optical phenomenon where the particles 
interact with light that strikes them and some of that light is deflected from its 
original direction. The intensity of the scattered light depends on many 
 
 
 
Figure 4.1. Lipid film hydration method. 
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factors, such as: wavelength of the incident light, shape and size of the 
scattering particles, optical properties of the scatters and the angle of 
observation. The light scattering can be classified as static or dynamic 
depending on how the intensity is measured. If the time-averaged total 
intensity is measured as a function of scattering angle, concentration or both 
it is called static light scattering. In dynamic light scattering what is measured 
is the temporal variation of the intensity, and it is represented as the intensity 
autocorrelation function. The variation of the intensity with time contains 
information on the random motion of the particles due to their kinetic energy 
and can be used to measure the diffusion coefficient of the particles. The 
hydrodynamic radius of the particle is calculated by means of the diffusion 
coefficient and the Stokes-Einstein equation (Hiemenz, 1997): 
  =  = 	
 (4.1)  
In the first part of this equation,  is the Boltzmann constant,  is the 
absolute temperature of the dispersion and  is the Stokes coefficient that is 
equal to 6, where  is the viscosity and  is the hydrodynamic radius, 
which gives the particle size (Hiemenz, 1997). 
The hydrodynamic diameter of liposomes and lipoplexes was 
measured at room temperature with a Malvern Zetasizer Nano instrument by 
dynamic light scattering (DLS) at 173°. The results were averaged from five 
measurements for each sample and were obtained for at least three 
independent procedure of sample preparation. The final concentration of 
liposomes varied from 0.05 to 0.50 mg/mL (0.1–1.0 mM) and the 
concentration of DNA was 0.05 mg/mL. 
  
 
76 COMPACTION PROCESS OF DNA BY FLUORINATED LIPOSOMES 
 
4.1.4. Electrophoretic mobility 
The electrokinetic phenomena can be defined by a liquid that moves 
tangential to a charge surface, so it combines effects of motion and electrical 
phenomena, which are interpreted to yield a quantity known as the zeta 
potential (ζ). There are four phenomena related with the term electrokinetic: 
electrophoresis, electroosmosis, streaming potential and sedimentation 
potential. Electrophoresis refers to movement of a particle in a stationary 
liquid when an electric field is applied. So this method measures the velocity 
at which the particles move in a liquid induced by an electrical field (Butt, 
2006; Hiemenz, 1997). 
Around each particle there is an electrical double layer with a high 
concentration of opposite charged ions. That layer can be divided into two 
parts, an inner region, called stern layer, where opposite charged ions are 
strongly bond to the particle surface and an outer region or diffuse layer, 
where the ions are loosely bond to the particle. The zeta potential is the 
potential at the point where the bound Stern layer ends and the mobile 
diffuse layer begins (Butt, 2006; Hiemenz, 1997). 
When an electric field is applied, the particles are attracted towards 
the electrode with opposite charge, but forces including viscosity tend to 
oppose this movement. When the equilibrium of forces is established, the 
particles move with a constant velocity. This velocity is normally called 
electrophoretic mobility () and depends on the strength of the electric field 
or voltage gradient, the dielectric constant (), the viscosity () and the zeta 
potential (ζ). Henry’s equation gives the relationship between these four 
properties (Butt, 2006; Hiemenz, 1997): 
  = 	  (4.2)  
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Zeta potential magnitude gives the indication of potential stability of 
the colloidal system.  Generally a suspension is unstable if zeta potential is 
between -30 mV to 30 mV. So in this case the particles might flocculate. The 
stability is reduced at the isoelectric point (iep) where the zeta potential is 
zero at the hydrodynamic interface. This can be confused with the point of 
zero charge (pzc), where the surface charge (solid-liquid interface) is zero 
(Butt, 2006; Hiemenz, 1997). 
The electrophoretic mobility μe of liposomes and lipoplexes was 
measured at room temperature with a Malvern Zetasizer Nano series 
instrument by laser Doppler velocimetry (LDV), where the light scattered at an 
angle of 17° is converted into a zeta potential distribution. The results were 
averaged from five measurements for each sample and were obtained for at 
least three independent procedure of sample preparation. The final 
concentration of liposomes varied from 0.05 to 0.50 mg/mL (0.1–1.0 mM) and 
the concentration of DNA was 0.05 mg/mL. 
4.1.5. Fluorescence spectroscopy 
Luminescence is the emission of light from any substance when 
excited at a specific wavelength. Depending on the nature of the excited 
state, luminescence can be classified as fluorescence (excited singlet states) or 
phosphorescence (excited triplet states). Briefly, a fluorophore is excited from 
the ground electronic state to a higher vibrational level of energy. Collisions 
with other molecules cause the excited molecule to lose its excess of 
vibrational energy until it reaches the lowest vibrational level of the excited 
electronic state. From this level the molecule can return to any of the 
vibrational levels of the ground state, emitting its energy in the form of 
fluorescence. Typically, the emission spectrum is collected at the wavelength 
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with maximum fluorescence intensity of the excitation spectrum and vice 
versa (Lakowicz, 2006). 
Fluorescence measurements are commonly executed in steady-state 
but time-resolved measurements can also be done. Steady-state 
measurements are performed with constant illumination of the sample by a 
continuous beam of light and the emission spectrum is recorded due to the 
nanosecond scale of fluorescence (Lakowicz, 2006). 
Steady-state fluorescence measurements were carried out using a 
Perkin-Elmer LS-50B luminescence spectrometer (REQUIMTE, Department of 
Chemistry, Faculty of Pharmacy, University of Porto). The DNA concentration 
was kept constant (0.025 mg/mL) and liposomes were added at liposome-
DNA mass ratio (L/D) varying from 0 to 10, similarly to the other 
characterisation studies. Ethidium bromide (EtBr) was added to DNA solution 
at a DNA:EtBr mass ratio of 6:1. Fluorescence emission spectra were recorded 
between 560-700 nm at an excitation wavelength of 540 nm, emission and 
excitation band slits of 10 nm and scan rate of 400 nm/min. All spectra were 
subtracted to the spectra of blanks (buffer or buffer plus liposomes at the 
same concentrations that were used for the formation of lipoplexes).  
4.1.6. Transmission Electron Microscopy 
Transmission electron microscopy (TEM) gives real space images 
allowing a direct interpretation of the structure geometry (Buschow, 2001). In 
TEM technique, an electron beam is transmitted through the sample under 
observation and the applied intensity depends on the thickness of the sample 
and the concentration of atoms in that sample (Ebnesajjad, 2006; Hiemenz, 
1997).  The electrons have the same energy and wavelength as they are 
accelerated by the same voltage. TEM is not a surface-sensitive method 
because the electrons pass through the whole sample (Butt, 2006). The 
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produced image is a two-dimensional projection of the entire object, including 
the surface and the internal structures. Different contrast is obtained due to 
the thickness and composition of the material and the absorption of electrons 
in the material. 
TEM (Jeol JEM-1400, JEOL) images allow a morphological analysis of 
the liposomes and its complexes. Liposomes were prepared as reported in 
section 4.1.2, but in this case the hydration solvent used was 5% sucrose 
solution in 10 mM HEPES buffer. Sucrose allows rigidity and consequent 
stability of the vesicles after the drying process. Each sample of vesicles (5 µL) 
was placed on copper grids (Formvar/carbon on 400 mesh – Agar) and let to 
adsorb for 5 minutes. The staining was performed with 2% (w/v) of filtered 
aqueous solution of uranyl acetate for 45 seconds. Dried grids were visualised 
at 80 kV and digital Images were collected at a magnification of 200 000 x. 
4.1.7. Complexation theory 
As in previous works (Barrán-Berdón, 2012; Muñoz-Úbeda, 2010; 
Muñoz-Úbeda, 2011; Rodriguez-Pulido, 2009), we have used the 
complexation theory of Nguyen and Shklovskii to study lipoplexes formed by 
cationic liposomes and DNA (Nguyen, 2001a; b). This phenomenological 
theory describes the complexation of a long flexible charged polyelectrolyte of 
contour length l, with oppositely charged spherical and rod-like particles. 
According to these authors, the free energy of the system formed by negative 
charged polyions and cationic liposomes F(N,x), can be expressed as the sum 
of the free energy of a complex formed by a single liposome and N polyions, 
Fc(N,x), the free energy of the aggregates Fa(N,x), and the free energy of the 
remaining free polyion in the solution, Fp(N,x). If we particularise for our case 
in which polyions are DNA molecules, the theory predicts that for a given 
concentration of DNA (P), the state of the system can be described in terms of 
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the DNA concentration in the limit of new negligible small liposome 
concentration (P0). To this end, a minimising calculation of the function F(N,x) 
with respect to N and x is required. As a consequence, a phase diagram can be 
obtained to characterise the whole complexation process in which lipoplexes 
experience aggregation (condensation) and disaggregation (reentrant 
condensation) as a function of the liposome-DNA ratio. Namely, for a given 
concentration of DNA and growing concentration of liposomes (S), lipoplexes 
experience aggregation at some critical concentration, Sa, below the 
isoneutrality, and remain in this aggregated (or condensed) state up to 
another concentration, Sd, above the isoneutrality. For concentrations of 
liposomes higher than Sd, clusters of lipoplexes start to disaggregate as a 
consequence of a charge inversion process (Nguyen, 2001a; b). In order to 
build the corresponding phase diagram, the theory provides two equations 
that can be solved in terms of the phenomenological parameters P0 and E0. P0 
is related to the DNA concentration in the limit of negligible liposome 
concentrations whereas E0 is related to the energy gained per complex by 
forming the aggregates (compared to a free neutral isolated liposome-DNA 
complex in solution): 
   !1 + $%&'(  ) = * − *,-. !$ '( /%&) (4.3) 
 
 0  !1 − $%&'(  ) = * − *,-. !−$ '( /%&) (4.4) 
 
where q and Q are the total charge of DNA and liposomes respectively,  is 
the thermal energy, Ce is the electrical capacitance. This last parameter can be 
calculated as 1 = 4πε,ε51 + κ75 if liposomes are assumed to be spherical 
particles of radius a immersed in an electrolytic solution characterised by the 
dielectric permittivity ε,ε and a reciprocal Debye length κ7. Accordingly, 
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knowing the phenomenological parameters P0 and E0, this set of equations 
allows the calculation of the two boundary concentrations of liposomes Sa and 
Sd for each DNA concentration. Apart from this theory, there are other 
theoretical and computer simulation studies that contribute to a better 
understanding of DNA complexes. For instance, theoretical analysis of the 
physical properties of cationic and zwitterionic lipid-DNA complexes based on 
a coarse-grained molecular model implemented by Monte Carlo (MC) 
simulations (Farago, 2006; Farago, 2007). Coarse-grained and Molecular 
Dynamics Simulations have been applied to study charged dendrimers in the 
presence of multivalent salt solution as well as their complexation with linear 
polyelectrolyte (Tian, 2009; 2010a; b; 2011). Also, numerical calculations of 
the mean-field electrostatic free energy of a zwitterionic lipid monolayer and 
DNA support the experimental observations where DNA adsorbs onto a 
zwitterionic lipid monolayer in the presence of divalent cations (Bohinc, 2012; 
Mengistu, 2009).  
4.1.8. Turbidity measurements 
The turbidity of the equilibrium phase is related to the formation of a 
non-soluble phase that may precipitate or remain stable for short or long 
periods of time (Espinosa-Andrews, 2007). Turbidity measurements can be 
assessed by absorbance kinetic studies, since aggregation leads to an increase 
of the average size of the scattered particles. Then, a spectrophotometer 
working with a visible wavelength is capable of detect and analyse the 
aggregation kinetics of many colloidal systems (Peula-García, 2010).   
Ultraviolet-visible spectroscopy (UV-Vis) refers to absorption 
spectroscopy in the UV-Vis spectral region. Molecules can absorb the energy 
in the form of ultraviolet or visible light to excite photons from the ground 
  
 
82 COMPACTION PROCESS OF DNA BY FLUORINATED LIPOSOMES 
 
state to an excited state. This technique is complementary to fluorescence 
spectroscopy, previously described (Lakowicz, 2006). 
The stability studies of the liposome suspensions were performed by 
turbidity measurements as a function of DNA concentration at room 
temperature using a UV-1700 PharmaSpec Spectrometer (Kyoto, Japan). 
Absorbance kinetic data were obtained at 570 nm, during 180 seconds, with 
an interval of 2 seconds. The liposome concentration was 0.5 mM and DNA 
was added at concentrations ranging from 0.003 to 0.150 mg/mL. The 
reported data are the average of 4 independent measurements. The Fuchs 
stability ratio W (or stability factor) was determined from these data. This 
magnitude is a criterion for the stability of the colloidal system: W = kr / ks 
where the rate constant kr describes rapid coagulation and ks is the rate 
constant for the slow coagulation regime. Thus, the inverse of the stability 
ratio provides a measure of the effectiveness of collisions leading to 
coagulation. Information on the kinetics-aggregation constants of dimer 
formation can be directly derived from the initial slopes of the absorbance vs. 
time curves (dAbs/dt) (Peula-García, 2010). Accordingly, plotting W as a 
function of the electrolyte concentration in a double-logarithmic scale 
becomes useful to estimate the critical coagulation concentration (CCC), 
which is generally defined as the minimum concentration of electrolyte 
required to induce coagulation (W = 1). The CCC value is therefore related to 
destabilisation processes (i. e. low CCC means low stability) and its value has 
been previously determined for the case of anionic liposomes in the presence 
of divalent cations (Martín-Molina, 2012). In the present study, however, DNA 
plays the role of the electrolyte so the CCC in this case would be the minimum 
concentration of DNA required to induce coagulation of liposomes. On the 
other hand, in some cases the stability curves can exhibit an increase of W for 
electrolyte concentrations larger than the CCC. This phenomenon is usually 
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called colloidal restabilisation and the minimum salt concentration at which 
the system begins to restabilise is defined as the critical stabilisation 
concentration (CSC). This restabilisation phenomenon at high salt 
concentrations is well known in hydrophilic colloidal systems and is governed 
by hydration forces (Peula-García, 2010). In our case, the CSC will be 
redefined as the minimum DNA concentration at which the system begins to 
restabilise and such procedure of restabilisation will be attributed to the 
formation of lipoplexes stabilised by the complexation of the DNA with the 
cationic liposomes.    
4.1.9. Circular Dichroism 
The DNA structure when bound to the liposomes can be predicted by 
circular dichroism spectroscopy in the far-UV spectral region. Circular 
dichroism is a phenomenon that affects chiral molecules such as DNA and 
proteins. The difference in absorption of the left (9:) and right (9;) circularly 
polarised light defines circular dichroism. CD spectropolarimeters normally 
present the results as a spectrum that correlates the wavelength, λ (nm), with 
the ellipticity, θ (deg).  The conversion occurs according the following rule: 
 1 = ∆9 = 9: − 9; = =>?@, AB ?, (4.5)  
Applying the Lambert-Beer law to the CD theory, in order to remove 
concentration and path length dependence, 
 ∆9 = ∆C1D (4.6) 
where ∆ε is the extinction coefficient (M-1 cm-1 or mol-1 dm3 cm-1), C is the 
molar concentration (M) and l is the optical path length that crosses the 
sample (cm) (Rodger, 1997). 
 The most known arrangement for DNA molecules, discovered in 1953, 
is a right-handed double helix of the B-form. However DNA can adopt many 
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other structures, for example right-handed A-type typical from RNA or C-form 
mostly found in DNA fibers (Figure 4.2) (Baase, 1979; Kypr, 2009; Lu, 2003; 
Miyahara, 2012; Vorlíčková, 2012).  
 
 
 
Figure 4.2. Representative scheme of DNA A-, B- and C-form (Lu, 2003). 
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 The circular dichroism spectra were recorded with a Jasco 720 
spectrophotometer from 220 to 315 nm using quartz cuvettes with an optical 
path length of 0.5 cm. The concentration of DNA was kept constant and equal 
to 0.05 mg/mL for calf thymus DNA (ctDNA) and 0.025 mg/mL for plasmid 
DNA (pDNA) (pEGFP-N1, BD Biosciences Clontech). The average molecular 
weight considered for DNA was 348 g/mol (Schindler, 1997; Symietz, 2004). 
Tris buffer (10 mM) was used as solvent. 
4.1.10. In vitro transfection studies 
The gene transfer and transgene expression after cellular transfection 
was monitored using green fluorescent protein (GFP) plasmid (pEGFP-N1) 
encoding for green fluorescent protein, hereafter designed by pDNA, which 
was amplified and isolated with a PlasmidPrep Midi Flow kit (GE Healthcare). 
The concentration and purity of pDNA were determined using a NanoDrop 
1000 (Thermo Scientific) apparatus. Two cell culture lines were used in this 
study, SH-SY5Y and HeLa. SH-SY5Y cell line was grown in Minimum Essential 
Medium (MEM) (Lonza) and Ham’s F-12 (Lonza)  (1:1), supplemented with 
10% (v/v) heat inactivated fetal bovine serum (FBS – Gibco), 2 mM L-
Glutamine (Lonza), 100U Penicillin/Streptomycin (Gibco) and 1% MEM non-
essential amino acid solution (Sigma). HeLa cell line was grown in Dulbecco’s 
Modified Eagle’s Medium (Lonza) supplemented with 10% FBS and 100U 
Penicillin/Streptomycin. Cells were cultured in a humidified 5% CO2 
atmosphere at 37°C. For transfection studies, cells were seeded at 
approximately 70% confluence in 6-well tissue culture plates, 24 h before the 
experiments. Before transfection, growth medium was removed and cells 
were washed twice with PBS, pH 7.4. Cells were then incubated with 200 µL of 
lipoplexes prepared with liposomes and pDNA in OPTI-MEM (Gibco). The final 
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concentration of pDNA was 8 µg/well. The negative control corresponded to 
cells treated with liposomes without pDNA. After 5 h, the medium was 
replaced by fresh growth medium and transfection was assessed after 48 h 
incubation time by flow cytometry (FACS Canto II, BD Biosciences) and CLSM.  
4.1.10.1. Pulse cytophotometry 
Pulse cytophotometry, usually entitled flow cytometry or FACS 
(Fluorescence-activated cell sorter) is a biophysical technique used to count 
cells through detection of a biomarker inside the cell structure. The detection 
is performed by suspending the cells in a fluid that passes through a laser 
capable of detecting the biomarkers. This technique is useful because it can 
analyse multiple parameters of individual cells within heterogeneous 
populations (Givan, 2001; Shapiro, 2003). Twenty thousand events were 
measured for each sample. Experimental data were statistically analysed 
applying one-way analysis of variance (ANOVA) following Tukey test approach. 
4.1.10.2. Confocal Laser Scanning Microscopy 
Microscopy images of transfected cells were obtained using a confocal 
laser scanning microscope (CLSM), Leica SP2 AOBS SE (Leica Microsystems). 
Confocal imaging is an optical microscopy tool that provides a high resolution 
image in a three dimensional form without destruction. This technique has 
the ability to acquire in-focus images from selected depths (optical sectioning) 
and rebuilt a three-dimensional image through computer technology. This 
process was coupled with fluorescence microscopy, allowing the visualisation 
of specimens that emit colour from fluorescent markers when exposed to 
light (Pawley, 2006). 
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4.2. Results and Discussion 
4.2.1. Electric properties and diameter of 
the complexes   
The electric properties of the lipoplexes were firstly studied by 
evaluating their electrophoretic mobility (µe) as a function of the L/D ratio. In 
this way, changes in the electrokinetic behaviour of the systems will be 
univocally related to the presence of the fluorinated lipid F7-CHOL 
(heptafluorocholesterol) in one of the systems. The experimental data of µe as 
a function of L/D ratio for DOTAP:CHOL/DNA and DOTAP:F7-CHOL/DNA 
systems fit to a sigmoidal curve that divides the L/D axis in three different zeta 
potential regions (Figure 4.3.A and Figure 4.4.A): i) a region where lipoplexes 
show a net negative and almost constant electrophoretic mobility; ii) a region 
where the isoelectric point (L/D)0 is reached and an inversion of the 
electrophoretic mobility sign takes place and iii) a region of net positive 
electrophoretic mobility that tends to the value of the pure liposomes. This 
behaviour was previously found in works with other cationic lipoplexes 
(Barrán-Berdón, 2012; Muñoz-Úbeda, 2010; Muñoz-Úbeda, 2011; Rodriguez-
Pulido, 2009). Examples of a sign reversal in the electrophoretic mobility have 
been also reported for different cationic lipoplexes (Zuzzi, 2007) as well as 
other colloidal systems such liposomes (Martín-Molina, 2010), latex particles 
(Martín-Molina, 2003; Martín-Molina, 2008; Martín-Molina, 2009; Popa, 2010; 
Schneider, 2011) and DNA (Besteman, 2007) in the presence of multivalent 
counterions. In all these cases, the change of the sign in the electrophoretic 
mobility is explained in terms of a charge inversion (or overcharging) 
phenomena (Lyklema, 2009). 
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In our case, although the two systems present a similar qualitative behaviour, 
the curve corresponding to DOTAP:F7-CHOL/DNA lipoplexes appears shifted 
towards larger L/D ratio than that reported for lipoplexes without F7-CHOL. In 
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Figure 4.3. Electrophoretic mobility (A) and hydrodynamic diameter (B) of 
DOTAP:CHOL-DNA lipoplexes at different lipid-DNA (L/D) mass ratios in HEPES 
buffer (10 mM, pH 7.4). The DOTAP:CHOL molar ratio is 1:1 and DNA 
concentration is 0.05 mg/mL. 
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particular, the isoelectric point for DOTAP:CHOL/DNA and DOTAP:F7-
CHOL/DNA is within the ranges 3 < (L/D)0 < 4 and 4 < (L/D)0 < 5, respectively. 
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Figure 4.4. Electrophoretic mobility (A) and hydrodynamic diameter (B) of 
DOTAP:F7-CHOL-DNA lipoplexes at different lipid-DNA (L/D) mass ratios in 
HEPES buffer (10 mM, pH 7.4). The DOTAP:F7-CHOL molar ratio is 1:1 and DNA 
concentration is 0.05 mg/mL. 
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This means that more liposomes are required to neutralise the charge of DNA 
in the system with F7-CHOL. Although this fluorinated lipid does not provide 
net charge to the liposomes, its presence in the lipid bilayer seems to reduce 
the electropositive behaviour of the DOTAP liposomes. This feature could be 
related to the strong interaction between DOTAP and fluorinated cholesterol. 
Lipid monolayers studies showed that the area per molecule of DOTAP 
monolayer is reduced if fluorinated cholesterol lipids are included and that 
the lipid mixture monolayer is homogeneous at the low surface pressure of 5 
mN/m in contrast to DOTAP:CHOL monolayer, which become miscible only 
when the pressure reaches 20 mN/m (Paiva, 2013). This could explain, at least 
in part, the differences between the two curves. 
The hydrodynamic diameter of complexes that resulted from the 
interaction of DNA, at a constant concentration, and liposomes increases with 
liposome concentration and up to the isoelectric point (Figure 4.3.B and 
Figure 4.4.B). Further increase of the liposome amount leads to a decrease of 
the diameter of the lipoplexes and at L/D ratios of 9 and 10 the values tend to 
that of the liposomes. The hydrodynamic diameter of the liposomes was 97 ± 
9 nm (PdI = 0.36 ± 0.22) for DOTAP:CHOL and 103 ± 7 nm (PdI = 0.30 ± 0.21) 
for DOTAP:F7-CHOL. The maximum size value of the complexes is observed at 
a ratio close to the isoelectric point. Similar behaviour has been reported for 
other lipoplexes including for complexes of DOTAP liposomes and double 
strand DNA (Barrán-Berdón, 2012; Besteman, 2007). The aggregation of DNA 
and liposomes is discussed as a reversible process resulting from a balance of 
long-range electrostatic repulsion and of short-range attraction (Bordi, 2005; 
Sennato, 2005). It is also described that the formation of complexes occurs 
without the rupture of the vesicles and that large clusters result from the 
aggregation of the liposome-DNA complexes (Sennato, 2005). 
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The mechanism that is proposed in the literature considering the surface 
charges agrees with our results: DNA interacts with the liposomes through 
electrostatic interactions and when the amount of negatively charged DNA 
nearly counterbalances the liposome positive surface charges, the maximum 
aggregation is reached (Ciani, 2007; Sennato, 2005). 
4.2.2. DNA binding affinity to liposomes 
Fluorescence spectroscopy was carried out following the variation on 
the emission of ethidium bromide (EtBr) in aqueous solutions at constant DNA 
concentration and increasing liposome amount. EtBr is an aromatic planar 
cationic probe, which intercalates between base pairs of double-stranded 
DNA leading to a high fluorescence quantum yield, compared to low 
fluorescence intensity when dispersed in water. Since liposomes do not 
quench the fluorescence of EtBr, the decreasing of fluorescence intensity with 
increasing L/D ratio for DOTAP:F7-CHOL/DNA lipoplexes confirms the 
exclusion of the EtBr from the DNA base pair microenvironment (Figure 
4.5.A). A similar tendency was observed for DOTAP:CHOL/DNA lipoplexes. 
Since the intercalation of EtBr unwinds the DNA base pairs near the 
intercalation site by 26°, the conformational flexibility of DNA may decrease 
after it binds to the liposomes (Jones, 1980). The interaction of DNA with 
positively charged liposomes is expected to lead to a conformation 
rearrangement of the DNA macromolecule (Bordi, 2003; Ciani, 2004; 
Goncalves, 2004; Piedade, 2004). The displacement of EtBr from DNA to bulk 
might also be a consequence of the strong electrostatic interactions between 
DNA and cationic liposomes, which will decrease the ionic attractive forces 
between EtBr and DNA (Chen, 2000). 
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Figure 4.5. (A) Emission fluorescence spectra of DNA:EtBr (6:1) in the presence 
of DOTAP:F7-CHOL liposomes at the lipid/DNA (L/D) mass ratios from 0 to 10; 
dotted line shows the emission fluorescence spectrum of EtBr in HEPES buffer 
solution without liposomes and lipoplexes. (B) Emission fluorescence intensity 
of DNA:EtBr (6:1) at 590 nm in the presence of DOTAP:CHOL and DOTAP:F7-
CHOL liposomes at L/D ratios form 0 to 10. The values were normalised to the 
maximum fluorescence intensity (DNA:EtBR in the absence of liposomes). 
DOTAP:sterol ratio is 1:1 and the DNA concentration is 0.025 mg/mL. 
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The maximum emission intensity, which is at 590 nm, decreases comparably 
for both DOTAP:CHOL and DOTAP:F7-CHOL liposomes when added at 
increasing concentrations to DNA:EtBr complex (Figure 4.5.B). The emission 
intensity at 590 nm is slightly lower for lipoplexes of DOTAP:CHOL and DNA 
than for DOTAP:F7-CHOL and DNA at L/D ratios of 2 and 3, indicating that 
more DOTAP:F7-CHOL liposomes are required to compact the same amount 
of DNA. This result is in accordance with the electrophoretic mobility study.  
4.2.3. Morphology of the complexes 
The structure, size and morphology of the lipoplexes are known to be 
key factors in transfection efficiency (Rodriguez-Pulido, 2009). The different 
nature of the liposomes and consequently the L/D ratios in the lipoplexes 
were studied by means of TEM imaging. The micrographs were selected to be 
representative with respect to all observations. Both DOTAP:CHOL and 
DOTAP:F7-CHOL liposomes are unilamellar and present a spherical shape 
(Figure 4.6). The size of the vesicles observed by TEM is in agreement with the 
size distribution obtained by dynamic light scattering. The presence of the 
fluorinated atoms in the bilayer does not affect the overall size of the 
liposomes. TEM micrographs were also taken to lipoplex samples at L/D ratios 
below and above the isoneutrality ratio, (L/D)0. It is expected that liposome 
structure, size and morphology change in the presence of DNA.  
On Figure 4.6 (B-C) and (E-F) is possible to see details of the 
micrographs taken at a L/D ratio < (L/D)0, for DOTAP:CHOL and DOTAP:F7-
CHOL system, respectively.  In this case, lipoplexes present an excess of DNA. 
Not many differences are observed for these lipoplexes when compared to 
the respective liposome. However is notice a more delimited pattern around 
the particles in the presence of DNA. This happens because DNA molecules 
present a negative contrast when exposed to uranyl acetate, evidencing a 
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darker colour. The presence of a more intense colour around the bilayer 
indicates an increase on the density on the surface of the vesicles, confirming 
that DNA is compacted on the surface of the liposomes through strong 
electrostatic interactions, which is in agreement with potential and 
fluorescence studies.  
 
The strong interaction between the liposome and DNA could have other 
consequences. One is that it could lead to a disruption on the liposomes, 
producing smaller complexes, not observed for these systems, meaning that 
they are very stable with and without DNA. Another consequence is that 
when L/D is close to (L/D)0 liposomes could fuse due to the action of the 
condensed DNA (Rodriguez-Pulido, 2008; Rodriguez-Pulido, 2009). From size 
measurements, for both systems, is observed this fusion or complex 
aggregation by the increase of the lipoplex diameter with the approximation 
of the isoneutrality ratio. On Figure 4.7 is presented some micrographs where 
 
 
Figure 4.6. TEM micrographs of liposomes in the absence of DNA (A and D) and 
of lipoplexes at L/D<(L/D)0 (B, C, E, F). (A-C) refers to DOTAP:CHOL system and 
(D-F) to DOTAP:F7-CHOL. Scale bar: 100 nm. 
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L/D ratio is above the isoelectric point, for DOTAP-CHOL (A-C) and DOTAP:F7-
CHOL (D-F) systems. In this case, it was not only notice the increase on the 
density of the liposomes surface, as well as a clear shell covering the entire 
liposome. The exhibition of ramifications is consistent with the liposome 
coated by the DNA molecules. 
 
4.2.4. Boundary concentrations of the 
lipoplexes 
The different electrokinetic regions found experimentally for the 
lipoplexes as a function of the L/D ratio were also analysed from a theoretical 
point of view by using the complexation model presented in section 4.1.7. In 
particular, the model is applied to predict the phase diagrams of the 
 
 
Figure 4.7. Details extrated from the original TEM micrographs of lipoplexes at 
L/D>(L/D)0. (A-C) refers to DOTAP:CHOL system and (D-F) to DOTAP:F7-CHOL. 
Scale bar: 100 nm. 
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lipoplexes in this work, i. e., the calculation of the boundary concentrations 
Sa(P) and Sd(P) as a function of the DNA concentration (P). To this end, the 
electrophoretic data are used to obtain the experimental values of Sa(Pexp) and 
Sd(Pexp) for the DNA concentration that was used in the experiments (Table 
4.1). Then, these inputs are used to solve equations (4.3) and (4.4) in order to 
determine the characteristic parameters P0 and E0 for each system (Table 4.1).  
 
The experimental conditions required for the calculations (Table 4.1) 
are determined as follows: q is estimated assuming a DNA molecule formed 
 
 
 
 
Parameter
1 
DOTAP:CHOL/DNA DOTAP:F7CHOL/DNA 
a (nm) 50.0 50.0 
κ
D (nm
-1) 5.33 5.33 
Ce (C
2 J-1) 1.17 x 10-13 1.17 x 10-13 
Q (e) 28500 28500 
q  (e) 5400 5400 
Pexp (segments/l)
 17.16 x 1015 17.16 x 1015 
Sa(Pexp) (part/l) 1.55 x 10
15 1.74 x 1015 
Sd(Pexp) (part/l) 5.59 x 10
15 3.05 x 1015 
E0  (J) 5.57 x 10
-26 25.40 x 10-26 
P0 (segments/l) 5.60 x 10
15 2.91 x 1015 
 
1 
a, liposome radius; κ
D
, reciprocal Debye length; Ce, liposome capacitance; Q, 
liposome charge; q, charge of DNA segment; P, DNA concentration; Sa(P), liposome 
concentration at aggregation; Sd(P), liposome concentration at disaggregation; E0, 
DNA-liposome interaction energy; P0, DNA concentration in equilibrium with 
lipoplexes. 
 
 
Table 4.1. Phenomenological parameters P0 and E0 for each system and the 
required experimental conditions for their calculation. 
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by 2700 bp fragments on average (obtained from agarose gel electrophoresis 
experiments (Muñoz-Úbeda, 2010; Rodriguez-Pulido, 2009)); Q is calculated 
from the surface area of the liposome and the estimated area for the 
headgroup of the lipid. The phenomenological parameter E0 is much larger for 
DOTAP:F7-CHOL/DNA than for DOTAP:CHOL/DNA lipoplexes. This feature may 
be understood as the strength of the liposome-DNA binding being stronger in 
the case of DOTAP:F7-CHOL/DNA system. On the other hand, P0 < Pexp in both 
cases, which agrees with the assumption that most of the DNA molecules is 
forming the complexes. However, the value of P0 for DOTAP:F7-CHOL/DNA is 
almost half of that obtained for the lipoplexes without F7-CHOL. Although 
more DOTAP:F7-CHOL liposomes are required to form the lipoplexes, most of 
the DNA molecules could be implicated in the complexation once the 
lipoplexes are formed.  
The values of P0 are similar as those reported for other charged 
lipoplexes (Barrán-Berdón, 2012; Muñoz-Úbeda, 2010; Rodriguez-Pulido, 
2009). The values of E0, on the other hand, are much lower than those 
calculated in the present work. This is due to the definition of Ce, which in the 
previous works was defined in the vacuum instead of in an electrolyte 
solution. In any case, we must be aware that P0 and E0 are two 
phenomenological parameters and as the authors of the model stated, it is 
difficult to assign them a real meaning on the basis of a microscopic theory 
(Nguyen, 2001a).  
Once the parameters are calculated, the values of Sa(P) and Sd(P) can 
be predicted for any DNA concentration by varying P in equations (4.3) and 
(4.4). Figure 4.8 shows the theoretical phase diagram of DOTAP:CHOL/DNA 
and DOTAP:F7-CHOL/DNA. Given a constant value of P, the phase diagram 
predicts the existence of negatively charged stable lipoplexes for liposome 
concentrations S < Sa(P), with free anionic polyelectrolyte in excess. If S 
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increases, lipoplexes experience aggregation and the suspension becomes 
unstable (grey region of the diagrams in Figure 4.8). 
In this domain of S concentration, i.e., for Sa(P) < S(P) < Sd(P), the isoneutrality 
of the lipoplexes is reached (the electrophoretic mobility is null). However, 
 
 
 
Figure 4.8. Boundary concentration lines, Sa(P) and Sd(P), for DOTAP:CHOL/DNA 
(up) and DOTAP:F7-CHOL/DNA (down) lipoplexes, according to the aggregation-
disaggregation theory. 
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the theory predicts that complexes at this point attract more cationic 
liposomes than those required to neutralise the negative charge (Nguyen, 
2001a). As a consequence, a charge inversion process takes place. Finally, for 
S > Sd(P), clusters start to partially dissolve giving rise to stable and free 
positively charged lipoplexes in coexistence with the remaining clusters. 
4.2.5. Stability ratio  
Similar results were obtained for the stability rate of DOTAP:CHOL and 
DOTAP:F7-CHOL liposomes as a function of DNA concentration (Figure 4.9): 
the stability of the liposomes decreases as the DNA concentration increases 
until the systems become unstable. Then if the DNA concentration continues 
to increase, both systems are stabilised again. This behaviour is in general 
similar to that found for the electrophoretic mobility measurements in which 
two asymptotic values of |µe| were reached for low and high values of L/D 
ratio. Consequently, regions in which the systems are stable are attributed to 
the formation of lipoplexes that are stabilised electrostatically. In contrast, 
regions where W ∼ 1 corresponds to a range of DNA concentration at which 
the isoelectric point of the lipoplexes is expected to be reached. Furthermore, 
the regions where the systems are stable and unstable agree with those 
predicted by the complexation model in which a reentrant condensation 
procedure is expected to happen. Concerning the numerical values of CCC and 
CSC, slight differences are observed: these critical DNA concentrations are, 
respectively, 0.022 mg/mL and 0.078 mg/m for DOTAP:CHOL. In the case of 
DOTAP:F7-CHOL, the values of CCC and CSC are, respectively, 0.026 mg/mL 
and 0.087 mg/mL. The observed small differences agree with those found in 
the results of electrophoretic mobility, which showed that for the system with 
F7-CHOL lipids more liposomes are required to neutralise the charge of DNA.
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Accordingly, the interaction between DOTAP and fluorinated cholesterol can 
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Figure 4.9. Fuchs stability ratio W (stability factor) of liposomes DOTAP:CHOL (A) 
and DOTAP:F7-CHOL (B), as a function of DNA concentration. Data are 
presented on the logarithmic scale. 
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justify the different electrokinetic and stability behaviour that was found for 
this system.  
The ionic strength of physiological media can affect the process of DNA 
complexation, shifting the stability ratio, DNA-liposome condensation curve 
and the isoelectric point of the lipoplexes, which will have a direct implication 
on the DNA transfection efficiency. In general, salt reduces the electrical 
surface potential of the liposomes and the increase of the ionic strength shifts 
the isoelectric point to higher L/D ratios (Eastman, 1997; Kennedy, 2000; 
Pullmannova, 2012). However, the effect of NaCl on the neutralisation is 
dependent on the salt concentration and on the type of lipids present in the 
system (Eastman, 1997; Hirsch-Lerner, 2005). The DOTAP:CHOL system was 
the least sensitive to increases of NaCl and had better integrity in serum when 
compared to others such as DOTAP:DOPE liposomes. The percentage of DNA 
that was associated to the liposomes in 150 mM of NaCl aqueous solution was 
more than 90% for DOTAP/DNA charge ratios of 1:1 and 1:2 (Hirsch-Lerner, 
2005). 
4.2.6. DNA conformation 
The number of base pairs per turn, the inclination of the base with 
respect to the helix axis, the distance of the bases from the helix axis, the rise 
per base pair and the handedness of the helix characterise the polymorphism 
of the secondary structure of nucleic acids. 
Both ctDNA and pDNA samples (Figure 4.10) were analysed by CD 
spectroscopy.  They both show a negative peak at 246 nm, a positive peak 
around 273 nm with the zero crossing around 260 nm, which is consistent 
with the CD spectra for a B conformation of a double helical DNA. In this case, 
the base pairs are perpendicular to the double helix axis, which confers a 
weak chirality to the molecule, which is characterised by the low peak 
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intensities. The variation in the amplitude of the CD signal may be due to the 
different nucleotide sequences (Kypr, 2009; Marty, 2009). 
 
When DNA is electrostatically bound to the lipid vesicles, a decrease in 
the Δε (M-1 cm-1) signal of the positive peak and an increase in the absolute 
value of the negative peak of the CD spectra are observed (Figure 4.11). Also 
both peaks reveal a red wavelength shift. The binding of DNA to the vesicles 
generates a conformation change or at least a transition on the DNA 
polymorphism. The differences may suggest a partial B- to C-DNA 
conformational transition as stated before in the literature for DOTAP 
complexes (Marty, 2009). The C-form CD spectrum was found for DNA 
condensed or packaged systems, especially monocationic lipid formulations 
(Ranjbar, 2009; Simberg, 2001). 
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Figure 4.10. CD spectra of ctDNA and pDNA in Tris buffer (pH=7.4). 
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DNA is thus more compacted in the presence of the carrier. The use of 
the fluorinated helper lipid (F7-CHOL) has no impact on the conformational 
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Figure 4.11. CD spectra of ctDNA (up) and pDNA (down) for DNA alone and 
complexes of DNA with DOTAP:CHOL and DOTAP:F7-CHOL at the L/D ratio of 
10:1. 
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structure of the DNA when compared with CHOL lipid, since the spectral 
curves are overlapped. Different L/D ratios (1, 2, 6 and 20) were also tested, 
however no significant differences were found between ratios, indicating that 
the DNA conformation does not change with the increase of the lipid 
concentration. 
4.2.7. Cell transfection studies 
The transfection efficiency of lipoplexes was evaluated using two 
different cell lines: SH-SY5Y, a human neuroblastoma derived cell line, and 
HeLa, an immortal cell line, derived from cervical cancer. Cell lines were 
transfected with plasmid DNA (pDNA) encoding green fluorescent protein 
(GFP). Flow cytometry analysis revealed that GFP expression was induced 
similarly by DOTAP:F7-CHOL/pDNA and DOTAP:CHOL/pDNA, in both cell lines 
(Figure 4.12).   
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Figure 4.12. Transfection of SH-SY5Y and HeLa cell lines with green fuorescent 
protein (GFP plasmid (pDNA): cytometry analysis of levels of transfection of 
cells using DOTAP:CHOL and DOTAP:F7-CHOL systems. The L/D ratio was 10:1. 
Results are expressed as mean ± S.D. (n = 3). 
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Comparing the different type of cells, DOTAP:F7-CHOL/pDNA system shows 
higher transfection efficiency in SH-SY5Y line (P < 0.01), whereas for 
DOTAP:CHOL/pDNA the differences are not significant. Naked pDNA did not 
transfect the cells (Figure 4.13).  
 
DOTAP:CHOL was shown to be more efficient than the commercial 
formulation lipofectamine® (Ramesh, 2001) and to transfect different cell 
tissues as lung and heart cell tissues (Templeton, 1997). The system has been 
studied in vivo and shown to be efficient also in transporting genetic material 
to cells (Eliyahu, 2007; Kim, 2007; Ramesh, 2001; Templeton, 1997). 
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Figure 4.13.  Illustrative confocal images of GFP expression for SH-Sy5Y and HeLa 
cell lines when transfected with naked plasmid DNA (A), DOTAP:CHOL/pDNA (B) 
and DOTAP:F7-CHOL/pDNA (C). The scale bar is 50 µm. 
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DOTAP:F7-CHOL is thus a good candidate for in vivo studies, regarding the 
similarities of the in vitro transfection results with DOTAP:CHOL.  
4.3. Conclusions 
We propose the use of F7-CHOL (heptafluorocholesterol) as helper 
lipid in cationic DOTAP liposomes for DNA delivery. This fluorinated derivative 
of cholesterol was chosen because previous studies highlighted the efficient 
gene transfer by lipids containing fluorinated hydrophobic chains (Boulanger, 
2004; Boussif, 2001; Gaucheron, 2001a; Gaucheron, 2001b; Gaucheron, 
2002). The properties of the system with fluorinated cholesterol were 
compared to that of DOTAP:CHOL liposomes. The results show that more 
liposomes are required to form the lipoplexes with DOTAP:F7-CHOL system 
than with DOTAP:CHOL. However, the aggregation-disaggregation model 
predicts that, even if more DOTAP:F7-CHOL liposomes are needed, most of 
the DNA is involved in the complexation process when the lipoplexes are 
formed. Both DOTAP:F7-CHOL and DOTAP:CHOL systems show similar stability 
in the presence of DNA and have identical transfection efficiency. These 
results are in agreement with other studies that describe also comparable 
DNA compaction process, size of lipoplexes and transfection efficiency for the 
commonly used helper lipid DOPE and its fluorinated analogues when mixed 
with cationic lipids (Gaucheron, 2001a). Our study verified that fluorine atoms 
can be included in the cholesterol molecule without dramatically changing the 
properties of the cationic liposomes. 
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 Chapter 5 
5. Bolaamphiphile-based vectors 
The prefix “bola” is associated to the shape of an old South American 
missile weapon that consists of two balls attached together by a cord. It was 
adopted by the science community to represent visually a molecule with two 
hydrophilic head groups linked by a hydrophobic carbon chain. There are few 
molecules in nature with these properties, however, most bolaamphiphiles 
are chemically synthesized (Baek, 2010; Fuhrhop, 1986). Bolaamphiphile 
molecules have their physical stability enhanced and they can be assembled 
into distinct structures that could be used as gene carriers (Jain, 2010). 
Bolaamphiphile molecules usually have two similar head groups, originating a 
symmetric monolayer vesicle. However, some bolaamphiphiles are 
constituted by two different head groups, a positively charged at one end and 
a neutral one at the other end, assembling into asymmetric monolayers. Both 
types of bolaamphiphile can be used as vesicles to encapsulate the active 
principle (Brunelle, 2009; Grinberg, 2010; Kaufman, 2013). There are many 
applications for these molecules and they can be used not only has 
components of lipid vesicles but also in nanocapsules that are prepared by the 
layer-by-layer self-assembly technique. 
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5.1. Bolaamphiphile particles 
Bolaamphiphile molecules can be incorporated on particles through 
the deposition of layers with different charges by layer-by-layer technique 
(Figure 5.1). It consists on the use of a core particle, such as silicon oxide 
(SiO2), calcium carbonate (CaCO3) or polystyrene (PS). These cores are used to 
produce multi-layered films by layer-by-layer deposition of oppositely charged 
polymers (Shchukin, 2004; Zhao, 2006). After deposition of several layers 
(enough to allow the stability of the capsule) the core can be dissolved.  
 
 
The resulting capsule will be smaller than the microparticle used in the 
process due to the shrinking of the species in the absence of the core. The 
active principle can be either entrapped or encapsulated within the carrier. 
 
 
 
Figure 5.1. Schematic representation of the Layer-by-Layer process (Donath, 
1998). 
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5.1.1. Materials and methods 
5.1.1.1. Chemicals 
The bolaamphiphile studied in this work, 22-hydroxy-N,N,N-
trimethyldocosan-1-aminium (BA), was synthetized by Prof. Dr. Bodo Dobner’s 
group (Institute of Pharmacy, Biochemical Pharmacy, Martin Luther University 
of Halle-Wittenberg, Halle an der Saale, Germany) and is shown in Figure 5.2. 
 
Monodisperse polystyrene particles (4.1 ± 0.1 µm, negatively charged) 
in a 10 % w/v aqueous suspension were acquired from Microparticles GmbH 
and used as cores. DNA (deoxyribonucleic acid sodium salt from calf thymus, 
type I), sodium chloride (NaCl), PAH (Poly(allylamine hydrochloride), positively 
charged) and PSS (Poly(sodium 4-styrenesulfonate), negatively charged) were 
purchased from Sigma-Aldrich and used without further purification. Rhod PE 
(1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine 
B sulfonyl), ammonium salt, MW 1249.65), was purchased from Avanti Polar 
Lipids, Inc. The deionized water was purified with Milli-Q apparatus with the 
specific resistance of 18.2 MΩ∙cm. All solutions, except for DNA, were filtered 
through a 200 nm porous membrane. Chloroform was supplied by Merck. 
 
 
 
Figure 5.2. Chemical structure of 22-hydroxy-N,N,N-trimethyldocosan-1-
aminium (BA). 
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5.1.1.2. LbL assembly 
Solutions of PAH and PSS (5 mg/mL) were prepared in NaCl (0.5 M) 
aqueous solution. DNA was dissolved in deionized water at a concentration of 
0.1 mg/mL and was kept at 4°C under magnetic stirring for at least 2 days to 
ensure complete dissolution. A volume of 100 µL of PS microparticles was 
retrieved from the stock solution and used for LbL deposition. The cores were 
washed with 1 mL of deionized water and centrifuged (Eppendorf centrifuge 
5804 R, Eppendorf AG, Germany) at 8000 rpm, during 5 minutes. Then the 
supernatant was discarded and the particles were re-suspended in 1 mL of 
water. This procedure was repeated twice. Before the last centrifugation a 
sample of 20 µL of the re-suspended particles was collected to measure the 
electrophoretic mobility of the system. The washing process was repeated for 
each added layers, as standard method. The layers were deposited onto the 
PS cores in the following order: PAH (1) / PSS (2) / PAH (3) / DNA (4) / BA (5) / 
DNA (6) / BA (7). After addition of each polymer solution (1 mL) the 
suspension was kept at room temperature under sporadic manual agitation 
for 20 minutes following by at least 3 washing steps. Due to the nature of the 
lipid and its affinity to form vesicles in the presence of water, the addition of 
the BA layers was performed as follows. BA (0.1 mg) was first dissolved in 
chloroform, which was evaporated under gaseous N2 to produce a lipid film 
(further details on section 4.1.2). The particles re-suspended in water were 
added to the lipid film. Due to the presence of the charged particles it is 
expected that the BA organizes itself around the microparticles, forming a 
new layer. To remove the BA from the glass surface of the vial, some manual 
agitation was promoted. It is important to avoid the vortex, since it can 
destroy the previous layers. At least 5 independent assays were performed, to 
ensure reproducibility. 
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5.1.1.3. Zeta potential 
The electrophoretic mobility (section 4.1.4), converted into zeta 
potential (ZP, mV), of the microparticles was measured at room temperature 
with a Malvern Zetasizer Nano series instrument by laser Doppler velocimetry. 
The results were averaged from three measurements for each sample. The 
collected 20 µL of each sample was diluted into 1000 µL of deionized water to 
fill the cuvette volume. 
5.1.1.4. Fluorescence spectroscopy 
In order to assess the amount of DNA at the particle surface, the 
supernatant of the microparticles at which DNA layer was added was 
recovered after centrifugation. The unbound DNA was free to interact with 
ethidium bromide (EtBr) molecules emitting fluorescence (Cosa, 2001). A 
calibration curve was established considering the range of possible 
concentrations and allowed the quantification of the remaining DNA in 
solution. This way and with the knowledge of the initial concentration, it was 
possible to determine indirectly the concentration of DNA present at the 
particle surface. Detailed information about this technique can be found in 
section 4.1.5. 
Steady-state fluorescence measurements were carried out using a 
Perkin-Elmer LS-50B luminescence spectrometer (REQUIMTE, Department of 
Chemistry, Faculty of Pharmacy, University of Porto). Ethidium bromide (EtBr, 
5 mg/mL, 100 µL) was added to 500 µL of DNA solution, followed by the 
addition of deionised water up to 1000 µL. Fluorescence emission spectra 
were recorded between 560-700 nm at an excitation wavelength of 540 nm, 
emission and excitation band slits of 10 nm and scan rate of 400 nm/min.  
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5.1.1.5. Confocal Laser Scanning Microscopy 
(CLSM) 
DNA and bolaamphiphile layers were stained for CLSM imaging (Leica 
TCS SP5 II, Leica Microsystems), detailed in section 4.1.10.2. The 
bolaamphiphile solution was previously mixed with 0.2% (w/w) of Rhod PE 
lipid (fluorescent marker) in chloroform, which was evaporated and the film 
was hydrated, in order to mix properly the two lipids in solution. This was 
used as marked layer to perform CLSM imaging. After placing a drop of the 
microparticles on a slide, a drop of DAPI solution was added to stain DNA 
layers. 
5.1.2. Results and Discussion 
The layer by layer deposition was assessed by zeta potential (ZP) 
measurements. PAH and PSS layers were used to provide stability to the shell 
once the core was removed. The use of NaCl promotes the electrostatic 
interactions between the charged layers by reducing the repulsion through 
charge screening (Caruso, 1999; Hall, 2011).  
The ZP signal inversion suggests a successful deposition of the layers 
(Figure 5.3). DNA and BA solutions were prepared without NaCl since it 
induced sample aggregation.  
The DNA concentration per layer was estimated to be 0.035 ± 0.005 
mg/mL (the initial DNA concentration was 0.1 mg/mL). These results were 
reproducible. The last layer must be of BA to protect the DNA layers from 
degradation. 
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CLSM technique allows to acquiring fluorescence images for the 
different dyes and separating them to be sure that the colour derives from the 
specific marker. Images taken from different microparticle samples show the 
presence of DNA and BA layers (Figure 5.4). The blue staining by DAPI solution 
confirms the presence of DNA. DAPI binds strongly to A-T rich regions of the 
DNA molecules and emits light when excited with ultraviolet light 
(Kapuscinski, 1995). The red colour observed in the images is due to the 
presence of Rhodamine labelled PE lipid. This lipid mixes with the 
bolaamphiphile molecules in the bilayer, allowing the visualization through 
fluorescence spectroscopy. Images in transmission mode were also collected 
to confirm that all particles were stained. 
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Figure 5.3. Zeta potential of the successive layers added to the PS cores by the 
LbL technique. 
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5.1.3. Conclusions 
The layer-by-layer assembly is one of the many techniques used in the 
fabrication of particles for gene delivery. Here we described a new system 
that intercalates layers of DNA molecules and a new bolaamphiphile. The zeta 
potential variation gives an indication of the layer deposition through the 
signal change from positive to negative values, according to the charge of the 
polymer that is deposited at the particle surface. Further tests were carried 
 
 
   
   
 
Figure 5.4. CLSM images of multilayered microparticles with PS cores showing 
the presence of DNA (Blue chanel - left), BA layer (red chanel - center) and the 
sobreposition of both chanels (right). Scale bar is 12 µm. 
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out to ensure the presence of DNA within the layers as well the presence of 
the bolaamphiphile. CLSM images confirm the uniform presence of both 
compounds at the particle surface. It is possible to remove the cores of these 
systems in order to obtain a microcapsule. The layers can also be assembled 
using smaller cores to facilitate the internalisation of the particles by the cells. 
5.2. Lipid vesicles 
Bolaamphiphile molecules can self-assemble into monolayered or 
bilayered vesicles, due to their two hydrophilic head groups. These molecules 
can also be part of a mixture of lipids to improve the properties of the vesicles 
for DNA transfection. 
5.2.1. Materials and methods 
5.2.1.1. Chemicals 
DOTAP and Rhod PE (1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl), ammonium salt, 
MW 1249.65) were purchased from Avanti Polar Lipids, Inc. Hepes buffer (4-
(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid, ≥ 99.5%) was supplied by 
Sigma-Aldrich. The green fluorescent protein (GFP) plasmid (pEGFP-N1, BD 
Biosciences Clontech) encoded for green fluorescent protein, hereafter 
designed by pDNA, was amplified and isolated with a PlasmidPrep Midi Flow 
kit (GE Healthcare) and the concentration and purity of pDNA were assessed 
using a NanoDrop 1000 (Thermo Scientific) apparatus. The deionised water 
was purified with Milli-Q apparatus with the specific resistance of 18.2 
MΩ∙cm. Chloroform was from Merck. 
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5.2.1.2. Preparation of Liposomes 
Liposomes were prepared by the thin lipid film hydration method 
(Palmerini, 2006). Briefly, the appropriate lipid mixture (BA:DOTAP) at 
different molar ratios was dissolved in chloroform, which was then 
evaporated under N2 flow. The lipid film was hydrated with 1 mL of 10 mM 
Hepes buffer pH 7.4 (ionic strength 0.00325 M). The suspension was vortexed 
for 15 minutes, sonicated for 15 min at 60°C and extruded through Whatman 
filters of decreasing pore sizes (up to 100 nm pore size membranes) using a 
pressure extruder apparatus, at 60°C. The total lipid concentration was 1 mM. 
5.2.1.3. DLS and electrophoretic mobility 
The hydrodynamic diameter (section 4.1.3) and the electrophoretic 
mobility (section 4.1.4), μe, of liposomes and lipoplexes were measured at 
room temperature with a Malvern Zetasizer Nano series instrument by, 
respectively, dynamic light scattering (DLS) and laser doppler velocimetry. The 
results were averaged from three measurements for each sample and were 
obtained for at least three independent procedure of sample preparation. The 
final concentration of liposomes was 0.1 mg/mL and the concentration of 
pDNA was 0.01 mg/mL. 
5.2.1.4. Morphology studies 
To characterise the type of structures formed by the bolaamphiphile 
alone, Transmission Electron Microscopy (TEM) and Confocal Laser Scanning 
Microscopy (CLSM) were used (described in section 4.1.6 and 4.1.10.2, 
respectively). For the TEM (Jeol JEM-1400, JEOL) analysis, a drop of the 
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suspension was placed on copper grids (Formvar/carbon on 400 mesh – Agar) 
and stained with 2% (w/v) uranyl acetate. For CLSM imaging (Leica TCS SP5 II, 
Leica Microsystems) the BA was mixed with 0.2% of Rhod PE lipid (fluorescent 
marker).  
5.2.1.5. In vitro transfection studies 
The gene transfer and transgene expression after cellular transfection 
was monitored using pDNA encoded with GFP. HEK 293 cell line was used in 
this study and was grown in Minimum Essential Medium (Lonza), 
supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS – 
Gibco), 2 mM L-Glutamine (Lonza), 100U Penicillin/Streptomycin (Gibco) and 
1% MEM non-essential amino acid solution (Sigma). Cells were cultured in a 
humidified 5% CO2 atmosphere at 37°C. For transfection studies, cells were 
seeded at approximately 70% confluence in 12-well tissue culture plates, 24 h 
before the experiments. Before transfection, growth medium was removed 
and cells were washed twice with PBS, pH 7.4. Liposome-pDNA complexes 
were prepared by adding equal volumes of pDNA solution at 0.01 mg/mL to 
the liposome suspension. The lipid:pDNA ratio was 10:1 (w:w), corresponding 
to a N:P ratio of 5 for BA:DOTAP liposomes (charge ratio between the cationic 
groups (amine) of the liposome and the anionic groups (phosphate) of the 
pDNA) (Crook, 1998; Jain, 2012; Paiva, 2013). DNA solution was added drop 
wise to the liposomes and the mixture was kept under magnetic stirring for at 
least 15 minutes. Cells were then incubated with 200 µL of lipoplexes 
prepared with liposomes and pDNA in OPTI-MEM (Gibco). The final 
concentration of pDNA was 2 µg/well. The negative control corresponded to 
cells treated with liposomes without pDNA. After 5 h, the medium was 
replaced by fresh growth medium and transfection was assessed after 48 h 
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incubation time by flow cytometry (FACS Canto II, BD Biosciences), detailed in 
section 4.1.10.1. Twenty thousand events were measured for each sample. 
Experimental data was statistically analysed applying one-way analysis of 
variance (ANOVA) following Tukey test approach. Microscopy images of 
transfected cells were obtained using the CLSM. 
5.2.2. Results and Discussion 
5.2.2.1. Vesicle characterisation 
The properties associated to bolaamphiphiles are very promising with 
respect to delivery systems (Nuraje, 2012). Attempts of extruding samples 
containing only BA were not successful, even at high temperatures (∼100°C). 
The size measurements revealed a very poly-dispersed population with mean 
diameters of 5 ± 2 µm. CLSM and TEM analysis show that BA forms 
microstructures, some of which present a crystal shape (Figure 5.5). Crystal 
structures are expected when the size of the two polar groups is not too 
different. For instance, they could assemble into a bilayer, where the OH- 
groups will be oriented to the inner space and the N- groups to the outer 
space (Figure 2.2.a). Also, they may form a mixed orientation where will be a 
OH- group and a N- group in the inner space, as visible on Figure 2.2.b 
(Fuhrhop, 2004). 
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Previous works report that these amphiphiles self-assemble into small 
nanoparticles (50-100 nm) (Jain, 2012; Popov, 2010), suggesting a formation 
of an asymmetric monolayer, which was confirmed by Langmuir monolayer 
studies and Grazing incidence X-Ray diffraction (Berchel, 2009; Deleu, 2011; 
Dolle, 2011; Hutter, 2012). However these structures are influenced by the 
number of carbons in the hydrophobic part of the molecule as well as the 
forces present in the hydrophilic part. The hydrophobic tail of the BA has no 
double bonds, which would allow the formation of vesicles with a monolayer 
of lipid, where the OH-end group would be directed to the inside of the 
vesicle and the N group to the outside. Due to its long carbon chain, the BA 
could also rearrange itself in a U-shape, also reported in the literature for 
similar molecules (Meister, 2007; Yan, 2009). In this case, a bilayer would be 
 
 
 
 
Figure 5.5. Self-assembled bolaamphiphile structure observed by TEM (top) and 
CLSM (bottom). Scale bar is, respectively, 3 and 10 µm. 
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formed and its structure could be more rigid, generating bigger particles that 
would not respond so well to the extrusion method due to its assembly. 
Mixing this BA with other lipids at appropriate ratios could help the formation 
of large unilamellar vesicles (LUV), where the BA could be intercalated with 
the other lipids. 
The BA was mixed with a well-known and commonly used cationic 
lipid, DOTAP (Zhu, 2010), at BA:DOTAP molar ratios of 1:1, 1:5 and 1:10. For 
the ratio 1:1, it was not possible to carry out extrusion of the sample. The size 
of the structures was smaller than that obtained for the BA alone (Figure 5.6). 
 
At the molar ratios of 1:5 and 1:10, BA:DOTAP vesicles were extruded 
and it was possible to obtain large unilamellar vesicles using filters of pore size 
of 100 nm. Due the similarity of the results for the two ratios, vesicles 
prepared with BA:DOTAP at 1:5 molar ratios were chosen for further studies 
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Figure 5.6. Hydrodynamic diameter of vesicles of BA, DOTAP and their mixture 
at different molar ratios. 
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using cell cultures. In the literature,  mixtures of bolaamphiphiles with other 
lipids, such as cholesterol (Dakwar, 2012) and DOPE (Jain, 2012) have been 
reported, mainly to stabilise the liposomes when they are complexed with 
pDNA. Since the BA does not self-assemble into small vesicles, DOTAP was 
chosen due its charge, which will help the formation of stable nanoparticles 
even when they are complexed with pDNA. Zeta potential of the vesicles was 
measured for the formulations in study (Figure 5.7). 
 
The complex formation with DNA was observed at the ratio of 
lipid:pDNA 10:1 (w:w) (Paiva, 2013). To assess the stability of the system, zeta 
potential measurements were conducted with and without pDNA. Size 
measurements of the liposomes and the lipoplexes revealed similar values of 
that obtained for the liposomes alone, however, the pDNA has an effect on 
the population distribution reduces the polydispersity index (PdI) of the 
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Figure 5.7. Zeta potential values for the studied formulations, before and after 
complexation. 
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sample. Zeta potential values were also obtained for the formulations and 
showed were around 32 mV for all preparations (Figure 5.7). This parameter 
indicates that all lipoplexes are stable and positively charged, which is a 
condition desirable for cell transfections studies (Jesorka, 2008; Lonez, 2008). 
5.2.2.2. Cell transfection studies 
The transfection efficiency of lipoplexes was evaluated using HEK 293 
cell line, a human embryonic kidney derived cell line. Cells were transfected 
with plasmid DNA (pDNA) encoding green fluorescent protein (GFP). Flow 
cytometry analysis revealed that GFP expression was induced similarly by 
DOTAP/pDNA and BA:DOTAP/pDNA (Figure 5.8.A).  Naked pDNA did not 
transfect the cells (Figure 5.8.B). DOTAP has been proven to be an efficient 
and wide used system to complex, deliver and transfect DNA into, for 
example, human hematopoietic stem cells (Martino, 2009) and cervical cancer 
cells (Fletcher, 2005). Combined with other lipids, like cholesterol, DOTAP has 
been studied in vivo and shown to be efficient in transporting genetic material 
to cells (Eliyahu, 2007; Kim, 2007; Ramesh, 2001; Templeton, 1997). These 
results show that the BA mixed with DOTAP at the molar ratio of 1:5, has 
potential as vehicle for pDNA delivery, evidencing good results with respect to 
the DOTAP system. It was observed for all cell trials that BA:DOTAP system 
achieved higher values than DOTAP system. However and according to the 
statistical analysis, the transfection values are not significantly different at the 
0.05 level, indicating that both systems have a similar ability to transfect cells. 
The cytometry technique and confocal analysis showed that DOTAP lipoplexes 
cause more cellular dead than BA:DOTAP lipoplexes, indicating that this 
system is less cytotoxic. 
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5.2.3. Conclusions 
We propose vesicles that combine a bolaamphiphile with cationic 
lipids to form stable and positively charged liposomes capable of compacting 
efficiently genetic material by electrostatic interactions. Comparing the carrier 
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Figure 5.8. Transfection of HEK cell line with green fluorescent protein (GFP) 
plasmid (pDNA) at 10:1 L/D ratio: (A) cytometry analysis of transfection levels 
for DOTAP and BA:DOTAP 1:5 systems. Results are expressed as mean ± S.D. 
(n=3). (B) Illustrative confocal images of GFP expression when transfected with 
naked pDNA (B1), DOTAP (B2) and BA:DOTAP 1:5 (B3). The scale bar is 50 µm. 
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made of BA:DOTAP 1:5 with DOTAP vesicles, they present similar properties 
with respect to size and zeta potential values. The transfection studies show 
that the bolaamphiphile mixed system has a higher transfection potential 
when compared to DOTAP vesicles.  
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Chapter 6 
6. Chitosan-N-maltodextrin 
conjugates 
Grafting other polymers to chitosan has been used as an alternative 
technique to improve its properties with respect to cell uptake and release. To 
further explore this methodology, the synthesis and characterisation of a 
polymer based on chitosan and maltodextrin (MD) were carried out. 
Maltodextrin, an oligosaccharide, is a non-ionic excipient of D-glucose units 
linked by α(1-4) glycosidic bonds that enhances gene expression and has low 
toxicity (Huang, 2002). Maltodextrins are water soluble compounds and are 
produced by partial hydrolysis of starch. They are classified in terms of DE 
(dextrose equivalent), having between 3 and 20 DE. The conjugation of 
chitosan with maltodextrin (DE 18-20) was achieved by reductive amination 
and the resultant copolymer was characterised by Fourier-transform infrared 
spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR). 
Nanoparticles of chitosan-graft-maltodextrin copolymer were analysed by 
dynamic light scattering and electron microscopy techniques. 
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6.1. Experimental Section 
6.1.1. Chemicals 
Chitosan (Ch) 20 kDa (degree of deacetylation > 92%) was supplied by 
Altakitin (Portugal). DNA (deoxyribonucleic acid sodium salt from calf thymus, 
type I), acetic acid, sodium cyanoborohydride and sodium tripolyphosphate 
(TPP) were purchased from Sigma and Maltodextrin (DE 18-20) was from 
Grain Processing Corporation. All reagents were used without further 
purification. Ultrapure water was obtained using a Milli-Q apparatus with the 
specific resistance of 18.2 MΩ∙cm. Uranyl acetate was purchased from 
Electron Microscopy Sciences.  
6.1.2. Synthesis of chitosan-graft-
maltodextrin  
The synthesis of the graft copolymer is based on reductive amination 
(Janciauskaite, 2008; Kaneko, 2007; Park, 2001). Chitosan 20 kDa was 
dissolved in 1% acetic acid, followed by the addition of maltodextrin solution, 
according to the molar ratio of chitosan glucosamine units and maltodextrin 
of 1:1 (Chn:MD 1:1) and 1:5 (Chn:MD 1:5). Sodium cyanoborohydride (molar 
ratio 10:1 with respect to maltodextrin) was added to the mixture under 
magnetic stirring. The reaction was carried out for 4 days at 40°C under 
stirring. The unreacted maltodextrin was removed by dialysis for 4 days using 
Float-A-Lyzer G2 (Spectrum) dialysis membrane (MWCO 3.5-5 kDa) against 
ultrapure water. The reaction product (chitosan:maltodextrin 1:1 or 1:5) was 
lyophilised at -80°C using a Virtis BT6K EL lyophiliser.  
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6.1.3. Fourier-transform infrared (FTIR) 
spectroscopy  
The infrared spectroscopy measures the frequency of the vibrations of 
chemical bonds between atoms when occurs excitation, at the medium 
infrared (4 000 to 200 cm
-1
) electromagnetic spectrum (Reichenbächer, 2012). 
The absorption frequencies of radiation depend on the functional groups 
present and the configuration of the atoms in the molecule. The infrared 
vibrational spectrum of a molecule consists of a sequence of bands, each of 
which results from a transition between pairs of vibrational levels related to 
the ground electronic state (Ramachandran, 2001). 
The main goal of an infrared experiment is to determine the intensity 
ratio between the transmitted radiation by the sample () and the incident 
radiation () as a function of the frequency of the light: 
  =


 (6.1) 
where  is the transmittance (Ebnesajjad, 2006). The infrared spectrum is 
usually plotted as a function of transmittance or absorbance. The absorbance 
(	
) is related to the transmittance by the Lambert-Beer Law:  
 	
 = − log  =  (6.2) 
where  is the molar absorptivity at the measured frequency,  is the 
concentration of chemical bonds responsible for the absorption of infrared 
radiation and  is the optical path length (Evans, 1992).  
FTIR spectroscopy is a multiplexing spectroscopy, where all optical 
frequencies from the source are observed simultaneously over a period of 
time. The resulting signal, which is a time domain digital signal, is called an 
interferogram and contains intensity information about all frequencies 
present in the infrared beam. This information can be extracted by switching 
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the signal from a time domain digital signal to a frequency domain digital 
signal, which is accomplished by applying a Fourier transform over the 
interferogram (frequency-domain functions) (Griffiths, 2007). 
The infrared spectra were recorded using an ALPHA FTIR spectrometer 
(Bruker) in absorbance mode with a high sensitivity DLATGS detector at room 
temperature. Pellets of potassium bromide (KBr) with 1% (w:w) were 
prepared and pressed at a pressure point of 10 000 g.  
6.1.4. Nuclear magnetic resonance (NMR) 
spectroscopy 
Nuclear magnetic resonance spectroscopy is based on the magnetic 
properties of the atomic nucleus and, therefore, is a non-invasive and non-
destructive technique. This technique provides information about the 
molecule structure and bonds through the interaction between the magnetic 
moments of the sample nuclei and an applied electromagnetic wave (Schnell, 
2001).  
NMR is a quantum phenomenon based on the magnetic properties of 
atoms nuclei. Subatomic particles (protons, neutrons and electrons) have the 
intrinsic quantum property of spin. Atoms with no overall spin (
12
C, 
16
O) have 
electrons pair up in atomic orbitals, meaning that the electron energy cancel 
each other. However atoms where their electrons cannot pair up (
1
H, 
13
C, 
19
F, 
31
P) will have magnetic moments (µ) and, consequently, will possess an 
overall spin (I). The nuclear magnetic moment of the nucleus will line up with 
the externally applied magnetic field of strength B0 (Becker, 2000). The NMR 
method introduces into the system a beam of electromagnetic radiation that 
will induce in the nucleus a transition from a lower state of energy to a higher 
one. The nuclei will be distributed throughout the various spin states available 
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and the number of nuclei (N) in each spin state can be determined by the 
Boltzmann distribution: 
  

=  !/#$% (6.3) 
where γm is the magnetogyric ratio, h is the Planck constant, B0 is the external 
magnetic field strength, &! is the Boltzmann constant and T refers to the 
temperature (Becker, 2000). 
 Hydrogen atoms are present in most of the molecules and its nucleus 
has one of the strongest resonances, thus the applicability of 
1
H NMR is vast. 
Two kinds of information are retrieved from the analysis of a NMR spectrum.  
Identical nuclei have different absorption positions if they have different 
chemical surroundings, meaning that one atom can be located by studying 
their position and the closest atoms. The different absorption peaks usually 
are denominated as chemical shifts. The second information retrieved from 
the spectra relates with the peak area. For the same type of nuclei (with the 
same chemical shift) it is possible to predict the number of nuclei since it is 
proportional to the area of the absorption peak in study (Gerothanassis, 
2002). Carbon isotopes (
12
C and 
13
C) are also used to retrieve information 
about the atoms distribution in one molecule, although it is far less sensitive 
when compared to 
1
H NMR. 
13
C spectra have a separate resonance peak for 
each chemical shift, due to the characteristics of the proton nuclei, that has a 
precise chemical shift dependent on the attached atoms and their 
electronegativity. This way, 
13
C spectra have a very low overlapping of the 
resonance peaks (Günther, 1994). 
The NMR spectra were recorded on a Bruker Avance III 400, operating 
at 400.15 MHz for protons and 100.62 MHz for carbons, in deuterium oxide 
(D2O) solution at a temperature of 25°C and 80°C. To improve the solubility of 
Ch, few drops of trifluoroacetic acid were added to the solution. The chemical 
shifts in the spectra were referenced to internal sodium trimethylsilyl-[2,2,3,3-
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d4]-propionate (TSP). Standard 1D 
1
H NMR experiments with 30° pulses, 
acquisition time 2 s, relaxation delay 2 s, 64 transients of a spectral width of 
4000 Hz were collected into 32 K time domain points. Two-dimensional (2D) 
1
H/
1
H correlation spectra (COSY), 
1
H/
1
H total correlation spectra (TOCSY), 
gradient-selected 
1
H/
13
C heteronuclear single quantum coherence (HSQC) and 
1
H/
13
C heteronuclear multiple bond coherence (HMBC) spectra were acquired 
using the standard Bruker software. 2D 
1
H/
1
H COSY spectra were acquired 
with a multiple quantum filter, gradient pulses for selection, a gradient ratio 
of 16:12:40 and a relaxation delay of 1.5 s. A total of 2048 data points in F2 
and 512 data points in F1 over a spectral width of 4000 Hz were collected. The 
1
H/
1
H TOCSY spectra were recorded by use of homo-nuclear Hartman-Hahn 
transfer and dipsi2 sequence for proton–proton transfer, with a mixing time 
of 60 ms (Cavanagh, 1990). A total of 4096 data points in F2 and 512 data 
points in F1 over a spectral width of 4000 Hz were collected. 
1
H/
13
C HSQC 
experiments via double inept transfer, using sensitivity improvement and 
decoupling during the acquisition were carried out with a spectral width of ca. 
4000 Hz for 
1
H and 10000 Hz for 
13
C, a relaxation delay of 1.5 s, FT size 2 K × 
256 W. 
1
H/
13
C HMBC spectra with a spectral width of 12000 Hz in the carbon 
dimension and 4000 Hz in the proton dimension were recorded and typical 
acquisition parameters: 90° pulses for protons and carbons, 7 µs and 12.5 µs, 
respectively, a relaxation delay of 1.5 s, 512 increments and an FT size of 2 K x 
1 K. 
6.1.5. Preparation of nanoparticles 
Chitosan and chitosan-graft-maltodextrin nanoparticles were prepared 
with sodium tripolyphosphate (TPP). All solutions were prepared in 0.3% 
acetic acid solutions to ensure complete dissolution of chitosan. Nanoparticles 
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were obtained by adding the TPP solution drop wise to the chitosan or 
copolymer solutions under magnetic stirring for about 15 minutes at room 
temperature. Solutions with a desirable volume were mixed to have the final 
concentrations of 1.00 and 1.25 mg/mL of chitosan or chitosan-graft-
maltodextrin, and 0.20 and 0.25 mg/mL
 
of TPP; the volume ratio of initial 
solutions of chitosan/TPP was 2.5.  
6.1.6. Preparation of polyplexes 
Complexes of chitosan or chitosan-graft-maltodextrin nanoparticles 
and DNA were prepared at different mass ratios of polymer/DNA ranging from 
0.25 to 5. The DNA concentration was kept constant for all assays (0.025 
mg/mL). Stock solutions of the polymers were prepared according to the mass 
ratios and to mix equal volumes of both solutions. DNA solution was added 
drop wise to the nanoparticles and the mixture was kept under magnetic 
stirring for at least 30 minutes.  
6.1.7. DLS and zeta potential measurements 
Particle size distribution and zeta potential were determined by 
dynamic light scattering and laser Doppler velocimetry, respectively, using a 
Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK), at 25°C. These 
techniques are described in sections 4.1.3. and 4.1.4. Size measurements 
were carried out at a scattering angle of 173°. Zeta potential was given by 
means of electrophoretic mobility and the light is collected at the scattered 
angle of 17°. Experimental data were statistically analysed applying one-way 
analysis of variance (ANOVA) following Tukey test approach. 
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6.1.8. Transmission electron microscopy 
(TEM) 
Each sample (5 μL) was placed on copper grids (Formvar/carbon on 
400 mesh – Agar) and let to adsorb for 5 minutes. The staining was performed 
with 2% (w/v) of filtered aqueous solution of uranyl acetate for 45 seconds. 
The grids were visualised using a Jeol JEM 1400 electron microscope at 80 kV. 
A description of this technique can be found in section 4.1.6. 
6.1.9. Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) allows a direct observation and 
characterisation of the sample either at micrometer or nanometer scale. It 
produces three-dimensional images of the surface by scanning the sample 
holder with a focused beam of electrons. The electron interaction emits a 
signal that is converted into valuable information about the topography, 
morphology, crystallography and composition of the sample surface.  Due to 
the focused electron beam, SEM micrographs have a large depth of field, 
generating sample surface images with high resolution, allowing superior 
magnifications. The visualisation of details can go up to 1 nanometer in size 
(Goldstein, 1981). 
The nanoparticles were characterised by Cryo-SEM (JEOL JSM 6301F/ 
Oxford INCA Energy 350 / Gatan Alto 2500). Solutions were placed on the 
support and frozen in liquid nitrogen. A sectional cut was applied to observe 
the nanoparticles. Polyplexes were observed using SEM (FEI QUANTA 400 FEG 
/ EDAX Pegasus X4M) at a voltage of 15 kV. Liquid state samples were allowed 
to dry on a mica surface pre-coated with a gold-palladium (Au-Pd) layer, 
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placed on carbon tape. After drying, samples were coated with a second layer 
of Au-Pd. 
6.2. Results and Discussion 
6.2.1. Characterisation of chitosan-N-
maltodextrin copolymer 
Maltodextrin (MD) chains were covalently conjugated to chitosan by 
reductive amination at molar ratios of chitosan glucosamine units and 
maltodextrin (Chn:MD) of 1:1 and 1:5 (Figure 6.1).  
 
The initial reaction mixture presented a clear yellow colour, whose 
intensity decreased during time, indicating the reaction progression. After 
dialysis and lyophilisation, the resulting compound was soluble in water (at 
least up to 50 mg/mL). This is a good indication of polymer structural changes 
and suggests that maltodextrin moieties increase the solubility of chitosan. 
The analysis of the resultant compound by FTIR spectroscopy indicates that 
 
 
 
Figure 6.1. Synthesis of chitosan-N-maltodextrin graft copolymers. 
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NH2 groups of chitosan were substituted (Figure 6.2). Chitosan and 
maltodextrin show similar bands in the FTIR spectra, except in the region 
between 1500 and 1700 cm
-1
 (Figure 6.2).  
 
Chitosan has a broad band between 1550 and 1700 cm
-1
 characteristic 
of N-H bend of primary amines (Park, 2001). This broad band disappears after 
reacting with maltodextrin and only the characteristic band at 1650 cm
-1
 from 
the maltodextrin molecule is visible. The absence of the N-H band from 
primary amines suggests that the substitution was successful (Park, 2001). 
Further analyses were carried out by NMR spectroscopy. Typical 400 MHz 
1
H 
NMR spectrum of Chn:MD 1:1 is presented in Figure 6.3. The spectra obtained 
for chitosan and maltodextrin are also included for comparison.  
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Figure 6.2. Region range between 1500 and 1800 cm
-1 
of the FTIR spectra of 
chitosan, maltodextrin and chitosan-graft-maltodextrin (chitosan 
glucosamine:maltodextrin ratio of 1:1). 
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The assignment of the resonance signals in the spectra of chitosan-
graft-maltodextrin (Ch-MD) was based on the analysis of the one- (1D) and 
two-dimensional (2D: 
1
H/
1
H COSY, 
1
H/
1
H TOCSY, 
1
H/
13
C HSQC), 
1
H/
13
C HMBC) 
NMR spectroscopic data. The results were compared and are consistent with 
the NMR data published before for chitosan and maltodextrin (Hirai, 1991; 
Lavertu, 2003; Peres, 2010; Pigman, 1970). However, the appearance of new 
resonance signals was observed in 
1
H NMR spectra of Ch-MD, as a result of 
 
 
Figure 6.3. 400.15 MHz 
1
H NMR spectra of chitosan (Ch), maltodextrin (MD) and 
chitosan-graft-maltodextrin (Ch-MD at ratio Chn:MD 1:1) polymers in D2O, at 
80°C. The assignment of 1H resonances is included and the new signals due to 
the reaction of reductive amination are indicated by asterisk. 
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the reductive amination process for preparation of chitosan-graft-
maltodextrin. The assignments of the resonance signals in the spectra of Ch-
MD, chitosan and maltodextrin are shown in Figure 6.3. The 
1
H NMR spectra 
of Ch-MD are dominated by the intense, broad and overlapped resonance 
signals of the hydroxymethine and hydroxymethylene protons of the 
saccharide residues of the polysaccharide structures of chitosan and 
maltodextrin. Characteristic signals due to the anomeric protons of the 
chitosan glucosamine and maltodextrin glucose units were detected at ca. 
4.75 ppm and 5.40 - 4.90 ppm, respectively. The broadening of the anomeric 
resonance signal of chitosan (4.75 ppm) indicates more restricted mobility of 
the molecules in Ch-MD and suggests higher molecular mass of the polymer 
structures. The broad signals at 5.40, 5.23 and 4.97 ppm were attributed to 
the anomeric protons of α(1→4)- and α(1→6)-linked glucose units of 
maltodextrin connected in chains of variable length. A doubling of H2 
resonance of chitosan and appearance of additional signals with identical 
intensity at 2.89, 3.03 and 5.11 ppm was observed in the 
1
H NMR spectra of 
Ch-MD compared to the spectra of chitosan and maltodextrin. The analysis of 
2D 
1
H/
1
H COSY, 
1
H/
1
H TOCSY, 
1
H/
13
C HSQC, 
1
H/
13
C HMBC) spectra confirmed a 
covalent bonding of maltodextrin to the chitosan amino group by reductive 
amination. The broad signals at 2.89 (d, J= 8.8 Hz) and 3.03 (dd, J=8.8, 11.7 Hz) 
ppm were assigned to the protons of the new imino-methylene group formed 
due to coupling the reaction between maltodextrin and amino group of 
chitosan (Figure 6.1). The signal at 5.11 (d, J= 8.8 Hz) ppm was attributed to 
the anomeric proton of the second glucose units in the maltodextrin chain 
included in the reductive amination process of chitosan. The two resonance 
signals for H2 (HCNH2) of chitosan observed in 
1
H NMR spectra of Ch-MD were 
assigned to H2 of N-substituted (2.59 ppm, dd, J=7.8, 8.5 Hz) and N-non-
substituted (2.76 ppm, dd, J=7.8, 8.5 Hz) glucosamine residues of Ch. The 
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mole fraction of the substituted and non-substituted chitosan glucosamine 
residues in Ch-MD was found to be 3:1, as it was determined from the relative 
peak intensities of the corresponding proton resonances. The results indicate 
that the Ch-MD samples are composed of chitosan-N-maltodextrin graft 
copolymers. The content of 2-acetamido-2-deoxy-β-D-glucopyranose units 
(2.5%) in Ch-MD was calculated from the ratio of the integral intensity of the 
signal at 2 ppm due to acetyl protons in residual chitin and those of chitosan 
anomeric protons (4.75 ppm). From here, the actual content of 2-amino-2-
deoxy-β-D-glucopyranose units available to participate in the reaction of 
reductive amination was estimated. The degree of substitution of 
maltodextrin to chitosan was defined from the integral intensity of the 
resonance signal at 4.75 ppm (H1 of Ch, corrected for the content of 2-
acetamido-2-deoxy-β-D-glucopyranose) and the signal at 2.59 ppm due to H2 
of N-substituted chitosan glucosamine residues. An alternative possibility is 
the ratio of the integral intensity of the signals of H2 of N-substituted (2.59 
ppm) and N-non-substituted (2.76 ppm) glucosamine residues. The degree of 
substitution of 74% and 81% was calculated for Chn:MD 1:1 and Chn:MD 1:5, 
respectively. The molar ratio of saccharide residues of the polysaccharide 
structures of maltodextrin and chitosan (MD:Ch) for these samples was found 
to be 6:1 and 11:1, as it was determined from the integral intensity of the 
resonance signal of the corresponding anomeric protons in their 
1
H NMR 
spectra. Janciauskaite et al. synthetised chitosan-graft-dextran polymers and 
achieved similar degrees of substitution for dextrans with different molecular 
weight for the same molar ratio of chitosan glucosamine units and dextran, 
discarding the molecular weight of the graft copolymer as a property to take 
into consideration. For the tested ratio 1:1, they obtained a degree of 
substitution of 47% by NMR. In our case, a maltodextrin substitution of 74% 
was obtained for the same ratio. This difference may be related to the 
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different degrees of deacetylation of chitosan, because a low content of 
deacetylated groups leads to more amine groups available for reaction. The 
molecular weight of chitosan might also play a role because larger molecules 
could present problems derived from stereo chemical conformations 
(Janciauskaite, 2008). An increase of maltodextrin molar concentration did not 
significantly increase the degree of substitution. Above Chn:MD 1:1 ratio, it is 
difficult to attach more maltodextrin molecules to chitosan chains, probably 
due stereo chemical constrains of the NH2 groups. Chn:MD 1:5 sample was not 
considered for further studies because its high substitution degree (81%) 
leads to fewer free NH2 groups available for interacting with charged 
molecules.  
6.2.2. Chitosan-N-maltodextrin 
nanoparticles 
Ch-MD self-assembles into nanoparticles with mean diameters of 310 
± 90 nm and a zeta potential of 29 ± 3 mV (Table 6.1). These nanoparticles 
present a high polydispersity index (PdI = 0.71) probably due to the 
polydispersity of the copolymer. The size of nanoparticles prepared with Ch-
MD copolymer (Chn:MD 1:1 ratio) and TPP as cross-linking agent (normally 
used to prepare chitosan nanoparticles) was not significantly different from 
that of Ch-MD nanoparticles (P>0.05) (Table 6.1 and Figure 6.4). Both Ch-MD 
and Ch-MD:TPP nanoparticles show similar morphology to that of 
chitosan:TPP nanoparticles (Figure 6.4).  Calvo et al. observed a strong 
influence of both chitosan and TPP concentrations on the size of chitosan 
nanoparticles (Calvo, 1997). Chen et al. observed as well this phenomenon for 
chitosan/dextran nanoparticles prepared by complex coacervation (Chen, 
2007). 
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The concentration effect of both species used in nanoparticle 
formation should be considered carefully because of the generated forces 
between the oppositely charged species. High concentrations of one of the 
species might lead to aggregation since it interferes with their stability as 
individual colloids (Gaspar, 2011; Richardi, 2009). Csaba et al. studied the 
impact of TPP on the properties and DNA transfection efficiency of the 
nanoparticles. Nanoparticles of chitosan cross-linked with TPP and then 
complexed with DNA show higher transfection efficiency than the system 
obtained by direct complexion of DNA to chitosan (Csaba, 2009). 
Nanoparticles of chitosan and cyclodextrin, prepared by ionotropic 
gelification using TPP, resulted in vectors with high DNA association capacity 
and low cytotoxicity (Teijeiro-Osorio, 2009). Using complex coacervation 
 
 
 
  
 
 
Chitosan-graft-maltodextrin 
Polymer concentration
 a
 (mg/mL) 
TPP concentration
 a
 
(mg/mL) 
1.00 1.25 
0.00 
310 ± 90 nm 
PdI = 0.71 
29 ± 3 mV 
0.20 
400 ± 200 nm 
PdI = 0.64 
15 ± 1 mV 
240 ± 40 nm 
PdI = 0.57 
18 ± 1 mV 
0.25 
300 ± 100 nm  
PdI = 0.69 
14 ± 1 mV 
200 ± 40 nm  
PdI = 0.77  
15 ± 1 mV 
a
 Final concentration in nanoparticle suspension 
 
 
Table 6.1. Mean particle diameter (z-average diameter), polydispersity index 
(PdI) and zeta potential of chitosan-graft-maltodextrin nanoparticles. 
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method, Chen et al. prepared small nanoparticles based on chitosan and 
dextran that were used to encapsulate positively charged drugs (Chen, 2007). 
The zeta-potential values of Ch-MD decrease with the addition of TPP, 
indicating less positive charges available, which can be an advantage when 
considering the compatibility with cellular membranes (Table 6.1) (Gao, 
2008). The high polydispersity of Ch-MD-TPP particles might be explained by 
maltodextrin chains located at the surface of the nanoparticles (Csaba, 2009). 
It can also result from the inhomogeneity of intermolecular cross-linking by 
TPP. 
 
 
 
 
 
 
Figure 6.4. Morphological characterisation of chitosan-graft-maltodextrin (A), 
chitosan-TPP (B) and chitosan-graft-maltodextrin-TPP (C) nanoparticles at the 
final concentrations of 1.25 mg/mL of polymers and 0.25 mg/mL of TPP by Cryo-
SEM (up, scale bar 2 µm) and TEM (down, scale bar 500 nm). 
 
A        B             C 
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6.2.3. Chitosan-N-maltodextrin/DNA 
complexes 
Alatorre-Meda et al. suggested that DNA compaction is completely 
achieved when polyplexes reach a positive zeta potential (above the 
isoneutrality point) (Alatorre-Meda, 2011; De Smedt, 2000; Tang, 1997). The 
transition of the zeta potential signal of a DNA solution to which chitosan was 
added occurs at a ratio of polymer:DNA between 0.5 and 1 (Figure 6.5). The 
positive values in the case of titration of DNA solution with Ch-TPP 
nanoparticles appear at polymer:DNA ratios between 0.25 and 0.5. The 
isoelectric point of Ch-MD nanoparticles:DNA appears at ratio of 3.5 and Ch-
MD-TPP particles:DNA at 2. The results indicate that more Ch-MD and Ch-MD-
TPP are required to neutralize the same amount of DNA when compared to, 
respectively, chitosan and Ch-TPP, which might be explained by the lower 
number of free positive charges in Ch-MD copolymer. The primary amine 
groups become unavailable when chitosan reacts with maltodextrin, thus DNA 
might complex with Ch-MD copolymer not only through electrostatic 
interactions but also through hydrogen bonding and hydrophobic interactions 
(Mao, 2010). 
SEM images show that Ch-TPP and Ch-MD particles (with TPP or not)  
have a rough surface (Figure 6.6, bigger particles were considered for 
visualisation purposes). The complexes of nanoparticles and DNA exhibit a 
smooth surface, evidencing that a layer may be coating the particles, which is 
consistent with the presence of DNA around the nanoparticles (Gaspar, 2011). 
EDS (Energy dispersive X-ray spectroscopy) analysis confirmed the presence of 
both DNA and chitosan macromolecules. 
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Figure 6.5. Zeta potential of chitosan:DNA and chitosan-maltodextrin:DNA 
polyplexes at different polymer:DNA mass ratios. DNA concentration is 0.025 
mg/mL. 
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6.3. Conclusions 
A copolymer based on chitosan and maltodextrin molecules for the 
preparation of DNA vectors is proposed. This compound shows improved 
properties as water solubility and self-assembly into spherical nanoparticles 
when compared to chitosan. Nanoparticles with diameters of about 200 nm 
can be obtained by cross linking chitosan-graft-maltodextrin with TPP. Their 
spherical shape and lower zeta-potential values (about 15 mV) when 
compared with chitosan particles (55 mV) may favour their uptake by cells. In 
 
 
 
 
 
Figure 6.6. Morphology of chitosan and chitosan:maltodextrin nanoparticles 
complexed with DNA, characterised by SEM: (A) Ch-TPP, (B) Ch-TPP:DNA 2:1, (C) 
Ch-MD, (D) Ch-MD:DNA 2:1 (E) Ch-MD-TPP, (F) Ch-MD-TPP:DNA 2:1. 
 
A        C             E 
B        D             F 
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addition, the maltodextrin chains, which are expected to be at the particle 
surface, will contribute to the stabilisation of the system.  
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Chapter 7 
7. Concluding remarks 
In this thesis three different systems are proposed with impact on 
gene therapy. The study of physical, chemical and biological properties of 
these systems allowed a better understanding of the process involved on the 
transport and release of DNA. They have shown potential as gene carriers 
and, therefore, further studies either in vitro or in vivo can be performed. 
 
The use of F7-cholesterol as helper lipid in cationic (DOTAP) non-viral 
gene vectors is proposed. This fluorinated derivative of cholesterol was 
chosen because previous studies highlighted the efficient gene transfer by 
lipids containing fluorinated hydrophobic chains. Studying the physical forces 
between two lipids in a monolayer is of great importance to understand their 
behaviour when they are part of a bilayer structure like a liposome. 
Monolayer studies showed that the mixture of DOTAP with F7-cholesterol is 
completely miscible. Regarding the interaction of the lipid monolayer with 
DNA molecules, the monolayer system adsorbs DNA even at ionic strength 
close to the physiological values, thus F7-cholesterol is a promising candidate 
for the preparation of gene delivery vectors. 
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Liposomes of DOTAP and fluorinated cholesterol were prepared and 
compared to the DOTAP/cholesterol system in terms of biophysical properties 
when complexed with DNA. The results showed that a higher lipid amount is 
required to form complexes with DNA in the case of DOTAP/F7-cholesterol 
system. However, the aggregation-disaggregation model predicts that, even if 
more DOTAP:F7-CHOL liposomes are needed, most of the DNA is involved in 
the complexation process when the lipoplexes are formed. Also, both systems 
showed similar stability in the presence of DNA and have identical 
transfection efficiency. This study confirmed that fluorinated cholesterol 
molecule could be included in cationic liposomes without dramatically 
changing their properties. 
 
A new synthesised bolaamphiphile was used to prepare two different 
systems for DNA delivery. The layer-by-layer assembly was used to deposit 
layers of DNA and bolaamphiphile at the surface of the particles. The zeta 
potential variation gives an indication of the layer deposition through the 
signal reversal, according to the charge of the molecule used. Further assays 
were done to ensure the presence of DNA within the layers as well as the 
presence of the bolaamphiphile. CLSM images confirm the uniform presence 
of both compounds on the particles.  
A type of vesicles that combine bolaamphiphile with cationic lipids is 
also proposed to form stable and positively charged liposomes capable of 
condensing efficiently genetic material by electrostatic interactions. 
Comparing the carrier made of BA:DOTAP 1:5 with DOTAP vesicles, they 
present similar properties with respect to size and zeta potential values. The 
transfection studies show that the bolaamphiphile mixed system has a higher 
transfection potential when compared to DOTAP vesicles.  
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Chitosan-N-maltodextrin was synthesised via reductive amination by 
covalently conjugating chitosan molecules to maltodextrin chains. This 
copolymer is proposed for the preparation of DNA polymer-based vectors. 
This compound shows improved properties as water solubility and self-
assembly into spherical nanoparticles when compared to chitosan. 
Nanoparticles with diameters of about 200 nm can be obtained by cross 
linking chitosan-graft-maltodextrin with TPP. Their spherical shape and lower 
zeta-potential values (about 15 mV) when compared with chitosan particles 
(55 mV) may favour their uptake by cells. In addition the maltodextrin chains, 
which are expected to be at the particle surface, will contribute to the 
stabilisation of the system.  
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Abbreviations 
AIDS Acquired immunodeficiency syndrome 
ANOVA One-way analysis of variance 
AuNPs Gold nanoparticles 
BA 22-hydroxy-N,N,N-trimethyldocosan-1-aminium (Bolaamphiphile) 
BAM Brewster angle microscopy 
Ca. Approximately 
CCC Critical coagulation concentration 
CCD Charge-coupled device 
CD Circular dichroism 
β-CD β-cyclodextrin 
Ch Chitosan 
Ch-MD Chitosan-N-maltodextrin 
CHOL Cholesterol 
CLSM Confocal laser scanning microscopy 
COSY Two-dimensional (2D) 1H/1H correlation spectroscopy 
CSC Critical stabilisation concentration 
ctDNA Calt thymus DNA 
d Doublet 
dd Double of doublets 
DAPI 4’,6-diamidino-2-phenylindole 
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DC-Chol 3β-[N-(N',N'-dimethylaminoethane)-carbamoyl]cholesterol 
hydrochloride 
DDAB Didodecyldimethylammonium bromide 
DE Dextrose equivalent 
DLATGS Deuterated l-alanine-doped triglycine sulfate 
DLS Dynamic light scattering 
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DMPG 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
DNA Deoxyribonucleic acid 
DOGS Dioctadecylaminoglycylspermine 
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
DOPG 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
DOSPA 2,3 Dioleyloxy-N-[2(sperminecarboxaminino)ethyl]-N,N-dimethyl-1-
propanaminium trifluroacetate 
DOTAP 1,2-dioleoyl-3-trimethylammonium-propane (chloride salt) 
DOTMA 1,2-di-O-octadecenyl-3-trimethylammonium propane 
EDL Electrical double layer 
EDS Energy dispersive X-ray spectroscopy 
Et al. and co-workers 
EtBr 3,8-Diamino-5-ethyl-6-phenylphenanthridinium bromide (Ethidium 
Bromide) 
F7-CHOL 25,26,26,26,27,27,27-heptafluorocholesterol (F7-cholesterol) 
FACS Fluorescence-activated cell sorter 
FBS Heat inactivated fetal bovine serum 
FTIR Fourier transform infrared spectroscopy 
G Gaseous 
GC Classical Gouy-Chapman model 
GFP Green fluorescent protein 
HEK 293 Human embryonic kidney 293 cells 
HeLa Human cervical cancer immortal cell line 
HEPES 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid 
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HIV Human immunodeficiency virus infection 
HMQC 1H/13C heteronuclear multiple bond coherence spectroscopy 
HSQC 1H/13C heteronuclear single quantum coherence spectroscopy 
i. e. That is 
iep Isoelectric point 
IR Infrared 
IRRAS Infrared reflection absorption spectroscopy 
J Coupling constant 
JL1  Antigen of human cortical thymocyte 
KRS-5 Thallium bromide and iodide mixed crystal 
LbL Layer-by-layer 
LC Liquid-condensed 
L/D Liposome/DNA mass ratio 
(L/D)0 Liposome/DNA mass ratio at isoelectric point 
LDV Laser Doppler velocimetry 
LE Liquid-expanded 
LUV Large unilamellar vesicles 
MC Monte Carlo simulations 
MCT Mercury cadmium telluride 
MD Maltodextrin 
MEM Minimum essential medium 
miRNA Mediated gene regulation circuits of ribonucleic acid 
MLV Multilamellar vesicles 
MNPs Magnetic nanoparticles 
Mw Molecular weight 
MWCO Molecular weight cut off 
NMR Nuclear magnetic resonance 
N/P Nitrogen/phosphate 
NPs Nanoparticles 
PAH Poly(allylamine hydrochloride) 
PAMAM Polyamidoamine 
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PBS Phosphate buffered saline 
PdI Polydispersity index 
pDNA Plasmid DNA (pEGFP-N1) 
PEG Polyethylene glycol 
PEI Polyethylenimine 
pH Potential hydrogen 
PhD Doctor of philosophy 
PLGA Poly(lactic-co-glycolic acid) 
PLL Poly(L-lysine) 
PS Polystyrene 
PSS Poly(sodium 4-styrenesulfonate) 
PTFE Polytetrafluoroethylene 
pzc point of zero charge 
QDs Quantum dots 
Rhod PE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) (ammonium salt) 
RNA Ribonucleic acid 
S Solid 
S.D. Standard deviation 
SEM Scanning electron microscopy 
SH-SY5Y Human neuroblastoma cell line 
siRNA Small interfering ribonucleic acid 
SPIONs Super paramagnetic iron oxide nanoparticles 
SUV Small unilamellar vesicles 
T-cells T lymphocites cells 
TEM Transmission electron microscopy 
TOCSY 1H/1H total correlation spectroscopy 
TPP Sodium tripolyphosphate 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol 
TSP Sodium trimethylsilyl-[2,2,3,3-d4]-propionate 
UV-VIS Ultraviolet-visible spectroscopy 
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ZP Zeta potential 
Symbols 
A Area 
 Absorbance 
Am Average molecular area 
a.u. Arbitrary units 
a Liposome radius 
B0 External magnetic field strength 
C Molar concentration 
Ce Liposome electrical capacitance 
D Diffusion coefficient 
 Dielectric constant 
E0 DNA-liposome interaction energy 
  Stokes coefficient 
	 Henry’s function 
ℎ Planck’s constant 
 Transmitted radiation 
  Incident radiation 
  Fluorescence intensity 
  Boltzmann’s constant 
kr  Rate constant for rapid coagulation regime 
ks Rate constant for slow coagulation regime 
l Optical path length 
N  Number of nuclei 
P DNA concentration 
P0 DNA concentration in equilibrium with lipoplexes 
Q Liposome charge 
q Charge of DNA segment 
  Hydrodynamic radius 
 
 
 
172 LIST OF ABBREVIATIONS 
 
Sa(P) Liposome concentration at aggregation 
Sd(P) Liposome concentration at disaggregation 
  Absolute temperature  
  Transmittance 
W Fuchs stability ratio 
X Molar fraction 
 
Greek lyrics 
 
α Brewster angle 
γ Surface tension 
γm Magnetogyric ratio 
ε   Relative permittivity 
ε
0
  Absolute permittivity of vacuum 
   Molar absorptivity 
∆ε Extinction coefficient 
∆V Surface potential 
ζ Zeta potential 
  Viscosity 
θ Ellipticity 
κD Reciprocal Debye length 
λ  Wavelength 
 Magnetic moment 
 Electrophoretic mobility 
µ⊥,m  Vertical component of the molecular dipole moment 
ν Wavenumber 
π Lateral surface pressure 
πc Critical lateral surface pressure 
   Diffuse double layer contribution 
  
 
LIST OF ABBREVIATIONS 173 
 
Units 
% (v/v)  Volume percent 
% (w/v)  Weight-volume percent 
% (w/w)  Weight percent 
m  Length  (meter) 
Å  Length (10-10 m) 
g  Mass (gram) 
mol  Mole 
M (mol/m3)  Molar concentration  
kg/m3  Mass concentration  
m3 = 103 L  Volume (cubic meter or liter) 
Da= g/mol  Unified atomic mass unit 
ppm parts per million 
s  Time (seconds) 
min  Time (minutes) 
h  Time (hours) 
°  degree 
°C  Temperature (Celsius) 
K  Temperature (Kelvin) 
V  Voltage (Volts) 
Hz = s-1  Frequency (Hertz) 
W  Power (watt) 
N  Force (newton)  
Ω∙m  Electrical resistivity (ohm∙meter) 
 
Units prefix 
 
G giga 109 
M mega 106 
 
 
 
174 LIST OF ABBREVIATIONS 
 
k kilo 103 
 unit 100 
d deci 10-1 
c centi 10-2 
m mili 10-3 
µ micro 10-6 
n nano 10-9 
p pico 10-12 
 
 
 
 
LIST OF FIGURES 175 
 
 
 
List of Figures 
Figure 2.1. Schematic representation of the DNA transfection process (Patil, 2005a). ....................... 8 
Figure 2.2. Schematic representation of possible arrangements of asymmetrical bolamphiphiles in 
crystals: a) parallel a,a; b) parallel a,b; c) antiparallel a,b and b,a (Fuhrhop, 2004). ........ 18 
Figure 3.1. Chemical structures of DOTAP, CHOL (cholesterol) and F7-CHOL 
(heptafluorocholesterol). .................................................................................................. 47 
Figure 3.2. Representative phases of a surface pressure-area isotherm of a langmuir monolayer. .. 48 
Figure 3.3. Langmuir film balance system. ......................................................................................... 49 
Figure 3.4. Pressure-area isotherms of monolayers of DOTAP, cholesterol (CHOL), F7-cholesterol 
(F7-CHOL), DOTAP/cholesterol 1:1 mixture (DOTAP/CHOL) and DOTAP/F7-cholesterol 1:1 
mixture (DOTAP/F7-CHOL) on PBS buffer and of DOTAP/F7-cholesterol 1:1 mixture on 
0.1 mg/ml of DNA dissolved in PBS. Brewster angle microscopy images of the mixtures of 
DOTAP and the sterols at different surface pressures are also shown. ............................ 54 
Figure 3.5. Surface potential isotherms of monolayers of DOTAP, cholesterol (CHOL), F7-cholesterol 
(F7-CHOL), DOTAP/cholesterol 1:1 (DOTAP/CHOL) and DOTAP/F7-cholesterol 1:1 
(DOTAP:F7-chol) on PBS buffer. ........................................................................................ 56 
Figure 3.6. Different regions of the IRRAS spectra of monolayers of (1) DOTAP, (2) DOTAP/F7-
cholesterol 1:1, (3) F7-cholesterol, (4) DOTAP/cholesterol 1:1 and (5) cholesterol on PBS 
buffer (dashed line) and on 0.1 mg/ml DNA dissolved in PBS buffer (solid line) subphases. 
Different regions of the IRRA spectra are presented in separate plots and the spectra are 
 
 
 
176 LIST OF FIGURES 
 
offset for clarity: DNA marker bands (a), CH2 stretching vibrations (b), and OH stretching 
band (c). The surface pressure is in all cases 35 mn/m. .................................................... 60 
Figure 4.1.  Lipid film hydration method. ............................................................................................ 74 
Figure 4.2.  Representative scheme of DNA A-, B- and C-form (Lu, 2003). .......................................... 84 
Figure 4.3.  Electrophoretic mobility (A) and hydrodynamic diameter (B) of DOTAP:CHOL-DNA 
lipoplexes at different lipid-DNA (L/D) mass ratios in HEPES buffer (10 mm, pH 7.4). The 
DOTAP:CHOl molar ratio is 1:1 and DNA concentration is 0.05 mg/ml. ........................... 88 
Figure 4.4.  Electrophoretic mobility (A) and hydrodynamic diameter (B) of DOTAP:F7-CHOL-DNA 
lipoplexes at different lipid-DNA (L/D) mass ratios in HEPES buffer (10 mm, pH 7.4). The 
DOTAP:F7-CHOL molar ratio is 1:1 and DNA concentration is 0.05 mg/ml. ...................... 89 
Figure 4.5.  (A) Emission fluorescence spectra of DNA:EtBr (6:1) in the presence of DOTAP:F7-CHOL 
liposomes at the lipid/DNA (L/D) mass ratios from 0 to 10; dotted line shows the 
emission fluorescence spectrum of EtBr in HEPES buffer solution without liposomes and 
lipoplexes. (B) Emission fluorescence intensity of DNA:EtBr (6:1) at 590 nm in the 
presence of DOTAP:CHOL and DOTAP:F7-CHOL liposomes at L/D ratios form 0 to 10. The 
values were normalised to the maximum fluorescence intensity (DNA:EtBr in the 
absence of liposomes). DOTAP:sterol ratio is 1:1 and the DNA concentration is 0.025 
mg/ml. ............................................................................................................................... 92 
Figure 4.6.  TEM micrographs of liposomes in the absence of DNA (A and D) and of lipoplexes at 
L/D<(L/D)0 (B, C, E, F). (A-C) refers to DOTAP:CHOL system and (D-F) to DOTAP:F7-CHOL. 
Scale bar: 100 nm. ............................................................................................................. 94 
Figure 4.7.  Details extrated from the original TEM micrographs of lipoplexes at L/D>(L/D)0. (A-C) 
refers to DOTAP:CHOL system and (D-F) to DOTAP:F7-CHOL. Scale bar: 100 nm. ............ 95 
Figure 4.8.  Boundary concentration lines, Sa(P) and Sd(P), for dotap:chol/dna (up) and DOTAP:F7-
CHOL/DNA (down) lipoplexes, according to the aggregation-disaggregation theory. ...... 98 
Figure 4.9.  Fuchs stability ratio W (stability factor) of liposomes DOTAP:CHOL (A) and DOTAP:F7-
CHOL (B), as a function of DNA concentration. Data are presented on the logarithmic 
scale. ............................................................................................................................... 100 
 
 
 
LIST OF FIGURES 177 
 
 
Figure 4.10.  CD spectra of ctDNA and pDNA in TRIS buffer (pH=7.4). ................................................ 102 
Figure 4.11.  CD spectra of ctDNA (up) and pDNA (down) for DNA alone and complexes of DNA with 
DOTAP:CHOL and DOTAP:F7-CHOL at the L/D ratio of 10:1. .......................................... 103 
Figure 4.12.  Transfection of SH-SY5Y and HeLa cell lines with green fuorescent protein (GFP plasmid 
(pDNA): cytometry analysis of levels of transfection of cells using DOTAP:CHOL and 
DOTAP:F7-CHOL systems. The L/D ratio was 10:1. Results are expressed as mean ± S.D. (n 
= 3). ................................................................................................................................. 104 
Figure 4.13. Illustrative confocal images of GFP expression for SH-SY5Y and HeLa cell lines when 
transfected with naked plasmid DNA (A), DOTAP:CHOL/pDNA (B) and DOTAP:F7-
CHOL/pDNA (C). The scale bar is 50 µm. ........................................................................ 105 
Figure 5.1.  Schematic representation of the Layer-by-Layer process (Donath, 1998). .................... 118 
Figure 5.2.  Chemical structure of 22-hydroxy-n,n,n-trimethyldocosan-1-aminium (BA). ................ 119 
Figure 5.3.  Zeta potential of the successive layers added to the PS cores by the LbL technique. .... 123 
Figure 5.4.  CLSM images of multilayered microparticles with PS cores showing the presence of DNA 
(blue chanel - left), BA layer (red chanel - center) and the sobreposition of both chanels 
(right). Scale bar is 12 µm. .............................................................................................. 124 
Figure 5.5.  Self-assembled bolaamphiphile structure observed by TEM (top) and CLSM (bottom). 
Scale bar is, respectively, 3 and 10 µm. .......................................................................... 129 
Figure 5.6.  Hydrodynamic diameter of vesicles of BA, DOTAP and their mixture at different molar 
ratios. .............................................................................................................................. 130 
Figure 5.7.  Zeta potential values for the studied formulations, before and after complexation. .... 131 
Figure 5.8.  Transfection of HEK cell line with green fluorescent protein (GFP) plasmid (pDNA) at 10:1 
L/D ratio: (A) cytometry analysis of transfection levels for DOTAP and BA:DOTAP 1:5 
systems. Results are expressed as mean ± S.D. (n=3). (B) Illustrative confocal images of 
GFP expression when transfected with naked pDNA (B1), DOTAP (B2) and BA:DOTAP 1:5 
(B3). The scale bar is 50 µm. ........................................................................................... 133 
 
 
 
178 LIST OF FIGURES 
 
Figure 6.1.  Synthesis of chitosan-N-maltodextrin graft copolymers. ................................................ 147 
Figure 6.2.  Region range between 1500 and 1800 cm-1 of the FTIR spectra of chitosan, maltodextrin 
and chitosan-graft-maltodextrin (chitosan glucosamine:maltodextrin ratio of 1:1)....... 148 
Figure 6.3.  400.15 MHz 1H NMR spectra of chitosan (Ch), maltodextrin (MD) and chitosan-graft-
maltodextrin (Ch-MD at ratio Chn:MD 1:1) polymers in D2O, at 80°C. The assignment of 
1H resonances is included and the new signals due to the reaction of reductive 
amination are indicated by asterisk. ............................................................................... 149 
Figure 6.4. Morphological characterisation of chitosan-graft-maltodextrin (A), chitosan-TPP (B) and 
chitosan-graft-maltodextrin-TPP (C) nanoparticles at the final concentrations of 1.25 
mg/ml of polymers and 0.25 mg/ml of TPP by Cryo-SEM (up, scale bar 2 µm) and TEM 
(down, scale bar 500 nm). ............................................................................................... 154 
Figure 6.5.  Zeta potential of chitosan:DNA and chitosan-maltodextrin:DNA polyplexes at different 
polymer:DNA mass ratios. DNA concentration is 0.025 mg/ml. ..................................... 156 
Figure 6.6.  Morphology of chitosan and chitosan:maltodextrin nanoparticles complexed with DNA, 
characterised by SEM: (A) Ch-TPP, (B) Ch-TPP:DNA 2:1, (C) Ch-MD, (D) Ch-MD:DNA 2:1 
(E) Ch-MD-TPP, (F) Ch-MD-TPP:DNA 2:1. ........................................................................ 157
 
 
 
LIST OF TABLES 179 
 
 
 
List of Tables 
Table 3.1.  More common Mid-IR group frequencies of phospholipids and DNA (Banyay, 2003; 
Blume, 1996; Gromelski, 2006). ........................................................................................ 52 
Table 3.2.  Average molecular area (Am) and surface potential (∆v) of the lipid monolayers at 
constant surface pressures. .............................................................................................. 55 
Table 3.3.  Symmetric CH2 vibration band of the lipid monolayers obtained by IRRAS. .................... 62 
Table 4.1.  Phenomenological parameters P0 and E0 for each system and the required experimental 
conditions for their calculation. ........................................................................................ 96 
Table 6.1.  Mean particle diameter (z-average diameter), polydispersity index (PdI) and zeta 
potential of chitosan-graft-maltodextrin nanoparticles. ................................................ 153 
  
